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1 Introduction 
 
Fever is a clinical symptom of various tropical infectious diseases. In developing countries, 
where diagnostic facilities are limited, etiologies of acute febrile illness remain largely 
unknown, whereas case fatality rates are often high and the range of potential causes is 
broad [1]. 
 
In Southeast Asia, malaria has long been considered one of the infectious diseases with the 
highest impact on public health, and has become a focus of international attention with the 
emergence of multi drug resistant parasite strains at the Thai-Cambodian border. Thus, 
control and prevention of the disease has intensified over the past decades, and as a result 
malaria incidence has dropped significantly [2-3]. Meanwhile acute febrile illness remains a 
major cause of morbidity in the region. Surveys in Thailand, Vietnam, Lao People 
Democratic Republic (Lao PDR) and Cambodia suggest that diseases such as leptospirosis, 
rickettsiosis, scrub typhus and dengue fever are important causes of fever in the region, all 
of which are characterized by unspecific malaria-like symptoms and thus are difficult to 
distinguish clinically. Although by the distribution of rapid diagnostic tests, parasite-based 
malaria diagnosis has become more feasible at peripheral health services, presumptive 
treatment of acute febrile illness with anti-malarial drugs continues to be a widespread 
practice. Malaria-negative fever cases are currently treated with antibiotics, most of which 
are ineffective against the above mentioned, potentially life-threatening diseases. This 
indiscriminate treatment of fever cases is not only posing a risk to the health of patients 
but is resulting in the unwarranted use of expensive anti-malarial drugs and the 
reinforcement of drug-resistance in the area [4]. 
 
For these reasons the World Health Organization Western Pacific Regional Office 
(WHO/WPRO), in cooperation with the Cambodian National Centre of Parasitology, 
Entomology and Malaria Control (CNM), the Cambodian Pasteur Institute (IPC), the 
Wellcome Trust Oxford University Tropical Medicine Research Collaboration in Mahosot 
Hospital, Vientiane, Lao PDR, and the Institute for Tropical Medicine at the University of 
Munich initiated a cross-sectional, observational study to investigate the causes of non-
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malaria febrile illness in rural areas of Cambodia and Lao PDR. Findings of the Cambodian 
arm of the study are presented in this work. 
 
1.1 Background information on Cambodia 
1.1.1 Country profile 
The Kingdom of Cambodia is an agricultural country, 181,035 square kilometers in size and 
located in the heart of Southeast Asia. Cambodia is bordered by Thailand in the west and 
north, by Lao PDR in the north and by Vietnam in the east, as shown in figure 1. The 
southeast of the country adjoins the gulf of Thailand, forming the 443 kilometers of 
coastline. The country’s central region is characterized by the Tonle Sap Lake and expansive 
green rice paddies, whereas the borders in the north and west of the country are lined with 
mountainous ridges, of which the highest peak reaches 1,771 meters of altitude. Despite 
significant developments in infrastructure in recent years, some of the hilly and thickly 
forested areas along the borders remain very isolated [5]. 
 
 
Figure 1: Location of Cambodia (map created with stepmap.de®) 
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Cambodia’s climate is tropical and characterized by the monsoon seasons. The rainy season 
starts in late April and lasts until early October, with the heaviest rainfall in the months of 
August and September. 
 
 
Figure 2: Cambodian landscape impression (Tara Müller, 2009). 
 
According to the Demographic Health Survey 2010 and Cambodia’s Ministry of Health 
(MoH), there are currently 13.4 million people living in Cambodia, the vast majority  
(80.5 %) of which live in rural areas [5-6]. The annual population growth rate was 1.5 % in 
the year 2008 [6]. Appendix 9.1 summarizes important socio-demographic data of 
Cambodia. Cambodia has a relatively broad-based population-pyramid structure because 
45.0 % of the population is less than 20 years old [6]. However, the percentage of people 
age 30-39 is less than would be expected. On the one hand this can be explained by the 
recent history of the country, marred by 30 years of civil war and the brutal regime of Pol 
Pot and the Khmer Rouge from 1975 to 1979, during which around one third of the 
Cambodian people lost their lives. On the other hand the birth rate during this time was 
very low while infant mortality was extremely high. Nowadays, the life expectancy at birth 
is 60 years for male and 64 years for female individuals, and the infant mortality is 
45/1,000 live births [6]. 
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Since the early 1990s the political and economical situation of the country has stabilized, 
due to the Paris Peace Accord signed in 1991 and the promulgation of the Constitution of 
the Kingdom of Cambodia in 1993. Still, Cambodia remains one of the poorest countries in 
the world, with around 28.0 % of the population living below the poverty line [5-6]. The 
main economic sector is agriculture, especially cultivation of rice, but economic activity is 
rising in new sectors, such as garment production and tourism. However, in the year 2010, 
the gross domestic product (GDP) per capita was approximately US$ 800 [5-6]. 
 
1.1.2 Health situation and health system 
Despite the progress made over the last years, the health status of Cambodia’s population 
is still among the lowest in Southeast Asia [5, 7]. In 2005, the World Bank performed a 
detailed analysis of health status and health care utilization related to poverty level and 
geographical factors in Cambodia. The report showed that, according to the village leaders, 
the major problems with health services on village level are insufficiency of drugs, long 
distances to quality health care as well as the relative high costs of healthcare [7]. 
 
In 2006 the MoH subdivided the 24 Cambodian provinces into 77 “Operational Districts” 
(OD). Appendix 9.2 shows a flowchart of Cambodia’s health system structure. Each OD 
comprises 10 to 20 health centers and at least 1 referral hospital and thus should be able to 
provide equal quality health services to all its inhabitants. In practice, however, only 16.6 % 
of the population with health issues are consulting a provider in the public sector, whereas 
the vast majority (80.6 %) makes use of services in the private sector (private doctors, 
traditional healers) or rely on self treatment [7-8]. The reasons for the underutilization of 
the public health system are various. To begin with, there is a serious shortage of qualified 
health professionals due to the years of war and genocide, in which educated people, 
especially with an urban background, were either killed or fled the country. This severe loss 
of human resources and the resulting truncated education of health staff had a 
disproportionate and regressive impact on the health sector. Nowadays, the new 
generation of health professionals prefers to stay in more developed urban areas and most 
of them work in the better paid private sector, which adds to the public-staff shortage in 
the rural and remote areas of Cambodia. Inadequate financing is also a major strain on the 
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public health sector. Since governmental salaries for health centre staff is insufficient, 
many staff subsidize their living by side-practicing in the private sector. This again leads to 
irregular opening hours and possibly further loss of quality service provision in the public 
health care sector [6, 8]. 
 
Like in many other developing countries, major health threats in Cambodia emanate from 
unsafe water, unsafe food supplies and vector-transmitted diseases. Only 56.0 % of the 
rural Cambodian population have access to an improved water source [6]. In addition the 
modernization of the country leads to an increasing number of road and mining accidents, 
indoor and outdoor pollution and an increasing use of solid fuel and chemicals, all of which 
pose a further threat on public health. Environmental hazards like floods and storms 
present another serious danger [6]. Furthermore the incidence of non-communicable 
diseases continues to increase, and the level of diabetes, hypertension and cardiovascular 
disease is rising steadily, all of which puts a further strain on the health system [9]. 
Moreover, Cambodia is classified as one of the 22 countries worldwide with a high burden 
of tuberculosis (639 cases/100,000 population/year), and the prevalence of human 
immunodeficiency virus (HIV) in adults is estimated to be around 0.7 % [6]. According to 
WHO-data from 2010 the leading infectious cause of both morbidity and mortality in 
Cambodia are acute respiratory infections (ARI), malaria and gastro-enteric infections. 
Outbreaks of dengue fever also contribute substantially to the leading causes of morbidity 
(see appendix 9.3) [6]. The HIS-report (health information system, MoH) from 2007 
however, lists diarrhea, dysentery and cholera as the top 3 health problems among 
inpatients in national and referral hospitals, closely followed by ARI, malaria and dengue 
fever (see appendix 9.4) [9]. As shown in table 1, on the health center (outpatients) level 
the most commonly diagnosed diseases were ARI followed by diarrhea and dysentery. In 
42.0 % (“others” in table 1) of the health center cases there was either no diagnosis 
established or it was not possible to report the diagnosis on the designated form [9]. 
Unfortunately only the presumptive diagnosis as well as age and gender of the patients are 
reported to the HIS, whereas information on symptoms that the patients present 
themselves with in the health center is not retrievable, which makes it difficult to estimate 
the actual incidence of acute febrile illness. In addition, a large proportion of febrile illness 
patients are consulting in the non-reported private health sector. Furthermore, febrile 
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illnesses pose a financial burden to households in rural Cambodia. A study on the cost of 
dengue fever and febrile Illness in Cambodian children conducted in 2006 found that to 
finance the febrile illnesses, 67.0 % of the included households incurred an average debt of 
US$ 23.5 (range: US$ 0.5-50.0). This was more than double the average amount 
households spent on food in 2 weeks, which was average US$ 9.5 per week prior to 
interview. Hospitalization significantly increased incurred debt from US$ 4.5 for an out-
patient, to US$ 23.1 (p < 0.01), which is why children from poor families often did not get 
hospitalized [10]. 
 
Table 1: Health problems and number of cases registered at all Cambodian health 
centers in 2007 [9] 
Health problem Number of cases  Health problem Number of cases 
Upper ARI 1,521,265  Dengue fever 9,061 
Lower ARI 835,085  Malnutrition  9,022 
Simple diarrhea 285,736  Genital ulcer 3,332 
Dysentery 269,436  Goiter problem 1,394 
Skin infection 200,781  Genital warts 853 
Vaginal discharge 153,441  Substance abuse 669 
Eyes diseases 79,549  Mine accidents 469 
High blood pressure 72,877  Other tetanus 152 
Malaria 46,187  Pertussis 60 
Severe diarrhea 30,759  Diphtheria 31 
Other mental health 28,564  Measles 29 
Traffic accident 25,711  Neonatal tetanus 21 
Urethral discharge 18,164  Acute flaccid paralysis 4 
Cough more than 21 d 11,966  Others 2,670,558 
   Total 6,382,870 
 
1.2 Malaria and fever management in Cambodia 
1.2.1 Malaria: a short introduction 
Malaria is a life-threatening disease caused by protozoan parasites of the genus 
Plasmodium, which are transmitted to humans through the bites of infected, female 
Anopheles mosquitoes. In 2008 there were 247 million estimated cases of malaria and 
nearly 1 million deaths worldwide [2]. The disease is endemic in tropical and many 
subtropical regions of the world. Countries of sub-Saharan Africa account for the majority 
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of all malaria cases, with the remainder mostly clustered in India, Brazil, Afghanistan, Sri 
Lanka, Thailand, Myanmar, Indonesia, Vietnam, Cambodia, and China. Of over 100 different 
Plasmodium species (spp.), only 5 can infect humans, namely P. falciparum, P. vivax,  
P. ovale, P. malariae and P. knowlesi [11]. Each of the 5 species has a distinct morphology, 
causes a distinct immune response in the host and differs in its life-cycle and geographical 
distribution. Whereas P. vivax is the most frequent species worldwide, P. falciparum is the 
most lethal. P. malariae and P. ovale, which is found mostly in West-Africa, are less 
frequent and generally cause a milder form of the disease [2]. P. knowlesi, which is 
originally responsible for the simian malaria is increasingly reported to infect humans, 
especially in Asia [12]. 
 
The complex life cycle of the Plasmodium parasites, illustrated in figure 3, starts with the 
Anopheles mosquito biting an infected host and ingesting gametocytes of the parasite into 
its gut. These gametocytes develop into oocysts, which burst after 1 to 2 weeks of 
incubation, and release sporozoites into the mosquito’s hemo-lymph, through which they 
gain access to its salivary glands. If this mosquito then feeds on a human, the sporozoites 
are transmitted to the human’s bloodstream. Via the bloodstream they migrate into the 
human liver, where they grow into merozoites, using hepatocytes as their host cells. This 
transformation takes about 1 week and corresponds to the clinical incubation period. The 
grown merozoites burst the liver-cells and are released into the blood stream where they 
infect the red blood cells (RBCs). In the RBCs they replicate until the cells burst and more 
merozoites are released into the bloodstream, where they infect more and more RBCs. 
Each new release of merozoites into the bloodstream is leading to fever-paroxysms with 
intense chills and sweating in the infected human. When the merozoites mature into 
gametocytes outside of the RBCs, they can be taken up by another mosquito and restart 
the whole cycle again [11, 13]. There are some differences in the life cycle of the different 
Plasmodium species, for example the frequency of fever-paroxysms varies depending on 
the speed of RBC-bursting and replication of the merozoites which is every 2 days for  
P. vivax and P. ovale, and every 3 days for P. malariae. P. falciparum is the only species 
which can infect erythrocytes in all stages of their development and thus causes the 
highest frequency of paroxysms and the most severe anemia in patients. P. vivax,  
P. malariae, and P. ovale can all cause relapses, due to their feature of dormant merozoites 
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in the liver, like this P. malariae can persist in the host for decades before manifesting any 
symptoms. The classical symptoms of uncomplicated malaria are fever, chills and sweating. 
Attendant symptoms can be headache, malaise, fatigue, muscular pains, occasional 
nausea, vomiting or diarrhea. Severe or complicated malaria, mostly caused by  
P. falciparum, is usually complex and key processes such as jaundice, kidney failure and 
severe anemia can cause serious and even fatal course of disease [11]. The diagnosis of 
malaria is usually established with the combination of clinical features and the microscopic 
evaluation of an eosin-methylene-blue-stained blood film (May-Grünwald-Giemsa stain). 
However, the accuracy of this technique depends largely on the quality of supplies and 
reagents, the presence and maintenance of satisfactory microscopes, and the technical 
competence of the microscopist [14]. 
 
 
Figure 3: Schematic life cycle of Plasmodium parasites in the human body (Tara Müller, 2010). 
 
New techniques like rapid diagnostic tests (RDTs) are based on specific malarial antigens, 
such as histidine-rich protein 2 (HRP2) and Plasmodium lactate dehydrogenase (pLDH), that 
react with antibodies on a plate or pad and show a visible band if positive. Both RDTs and 
microscopy can be used to determine the specific Plasmodium species the patient harbors 
[14]. More advanced techniques with high levels of sensitivity and specificity are  
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enzyme-linked immunosorbent essay (ELISA), polymerase chain reaction (PCR) and loop-
mediated isothermal amplification (LAMP) assays [11]. 
 
Currently, the recommended first-line treatment for malaria is artemisinin-combination 
therapy (ACT). ACT consists of artemisinin combined with quinolones or antifolates. The 
combination of quinolones, such as quinine, chloroquine, mefloquine, and amodiaquine, 
and antifolates, such as sulfadoxine and proguanil, is recommended to ensure the 
complete elimination of residual parasites and to prevent that drug-resistance can be 
contained [2, 11]. The spread of drug resistance is a major problem in malaria control, 
especially as there are no clinically approved malaria vaccines available to date, even 
though some already are in development and testing [13]. 
 
1.2.2 Current malaria situation in Cambodia 
Despite all efforts and improvements, malaria remains a major health concern and a big 
challenge for the public health system of Cambodia. According to the national report 
system in the year 2010, the total number of treated malaria cases in the public sector was 
56,217 [3]. Overall the number of treated malaria cases is decreasing over the past  
10 years, as shown in figure 4 [3, 15]. In the year 2009, a sudden increase of case numbers 
occurred in some provinces. The reasons for this increase are suggested to be due to heavy 
rain and unusual climate, as well as migration of the population from non-endemic to 
endemic malaria areas (especially in the border provinces with Thailand and Vietnam) [16]. 
 
According to the official data the majority of malaria cases in Cambodia are caused by the 
species P. falciparum. As shown in figure 5, P. falciparum was responsible for 59.0 % of 
13,345 microscopy confirmed cases in Cambodia in the year 2010, whereas P. vivax was 
found in 33.0 % and mixed infections with both species accounted for the remaining 8.0 %. 
Infections with the other 3 species, P. ovale, P. malariae and P. knowlesi have not reported 
by the CNM to date [3]. 
Introduction 
10 
 
 
Figure 4: Number of treated malaria cases (clinically suspected cases) as well as incidence rate 
and mortality of malaria in Cambodia from 2000 to 2010 (CNM annual report 2010). 
 
 
Figure 5: Malaria parasite species distribution of 13,345 malaria-cases confirmed by microscopy, 
in Cambodia 2010 (CNM annual report 2010). 
 
However, a large scale malaria survey conducted by Incardona et al. in 2005 showed that 
the malaria situation is more complex than it appears regarding the national data [17]. In 
this study of 11,652 individuals, one major observation was that a large asymptomatic 
reservoir was present with only 23.0-33.0 % of the enrolled parasite carriers being febrile. 
It was also noticed that in some areas there was a larger than expected proportion of  
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P. vivax infections (up to 50.0 %), especially in areas of low transmission. P. malariae 
infections are not reported by the CNM, whereas in the malaria survey by Incardona et al.  
8 cases of P. malariae were detected (4 of them mixed infection with P. falciparum) [17]. 
Furthermore, the malaria incidence varies in different areas of the country, due to the 
nature of mosquito-borne transmission of the disease. Border regions in the north-west 
and north–east are considered hyper-endemic, whereas in the central plain fields there is 
little or no transmission. Moreover, the level of transmission is seasonal, and generally 
there are more cases reported during the wet season (April-October), though in the highly 
endemic areas this variety is of little relevance [3, 17-18]. In the more elevated and 
forested areas transmission is perennial, given that the 2 major mosquito vectors are 
Anopheles dirus, which predominates in the rainy season, and Anopheles minimus, which 
predominates in the dry season [3, 19]. A. dirus is a vector which is very difficult to control, 
due to its exophilici
 
 behavior and its ability to adapt to environmental changes. In 
Cambodia, natural forests are being increasingly replaced with coffee, tea and rubber 
plantations. However, thick forests still cover around 37.0 % of the countries landmass, 
providing sufficient breeding places for the mosquitoes [19]. 
It is estimated that around 1.6 million people in Cambodia are exposed to a high risk of 
malaria infection [3, 18]. Analysis of the risk factors showed that in particular the male 
population between the ages of 15-49 years is affected, contributing to about 51.0 % of 
confirmed malaria cases in 2009. Females of the same age group only accounted for  
18.0 %, children from 5-14 years for 17.0 %, children from 0-4 years for 7.0 %, and adults 
above the age of 50 years for 7.0 %. Other risk factors include the “distance-to-forest”, 
“distance-to-healthcare” and the use of insecticide treated bed nets (ITN) [16-17]. The 
malaria situation in Cambodia became of global interest since the area close to the Thai-
Cambodian border is considered an epicenter of multi-drug resistant (MDR) Plasmodium 
falciparum [3, 15, 20]. Reports on drug-resistant malaria in this area have emerged as early 
as the late 1950’s. The situation has progressively worsened and today the region is 
considered one of the worlds established MDR-malaria areas [15, 21]. In recent years the 
Cambodian Government, and several international organizations which are active in the 
country, have focused their efforts on improving Cambodia’s strategy in the fight against 
                                                 
i  Exophilic/endophilic: the tendency of mosquitoes to rest outdoors or indoors in between blood meals. 
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malaria. The National Malaria Control Program (NMCP), is an exemplary, evolving initiative 
of the Government of Cambodia, supported by the GFATM, the United States Agency for 
International Development (USAID), the WHO, the World Bank, and several other donors 
[16]. The NMCP’s key functions are strengthening clinical management of malaria cases, 
improving access to treatment and good quality drugs, providing surveillance and health 
education, promoting preventive behavior, and finally the containment of artemisinin- and 
mefloquine-resistance. Other important achievements include the creation of “The Society 
for Malaria Control in Cambodia” (SMCC) in 2003, as well as the introduction of Village 
Malaria Workers (VMW) in 2001, to reach out to people even in the most remote areas 
[16, 18]. These combined efforts resulted in Cambodia being cited as “a shining example 
for malaria control” in the year 2005 [8]. Nevertheless, current estimates of the malaria 
burden in Cambodia rely on the data collected by the public HIS, which includes only 
symptomatic patients that consult in public health sector facilities [15, 17-18]. As 
mentioned earlier, only a small proportion of people, especially in remote areas, are 
seeking consultation in the public facilities. Cases treated in the unregulated private sector 
or at home, as well as asymptomatic carriers are not detected. Therefore, actual malaria 
figures are a lot higher than reported and malaria prevalence is still high in Cambodia [3, 8, 
15, 17-18]. 
 
1.2.3 Malaria diagnosis and treatment at village level in Cambodia 
According to the “National Treatment Guidelines for malaria in the Kingdom of Cambodia” 
established by the CNM in 2004 [22] the diagnosis of malaria should be obtained through 
taking the patients history, performing a clinical examination and an additional diagnostic 
test for confirmation. A patient is suspected of having malaria if showing clinical signs, like 
fever, chills and sweating, especially if they are combined with the following risk factors: 
• The patient is living or working in or close to the forest. 
• The patient recently moved to an area of high transmission. 
• The patient is living in an area of high transmission and is not using a bed net. 
• The patient is pregnant. 
• The patient is a child. 
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In either of these cases, the patient should be tested for malaria by microscopy or RDT. 
RDTs were introduced nationwide in Cambodia in the year 2001 and ever since have played 
a very important role in diagnostics at village level (VMW, health centers), since they are 
very easy to perform, to transport and to store, and there is no additional equipment 
needed. RDTs used in Cambodia are manly HRP2ii
                                                 
ii HRP-2 is a water soluble protein that is released from parasited erythrocytes of infected individuals and is 
specific for P. falciparum. The test is an immunoassay; anti-HRP-2 monoclonal antibodies on the test’s 
membrane build a coloured complex with the Plasmodium-HRP-2. 
 based, which can detect P. falciparum 
only, and are widely available at pharmacies, drug stores, private practitioners, hospitals 
and health centers. These tests show sensitivity and specificity both over 90.0 % and 
currently cost less than US$ 1 per piece [18]. RDTs based on pLDH, which can additionally 
detect non-falciparum Plasmodium spp., are utilized mainly in the private sector [personal 
communication with CNM- and health centre staff]. The disadvantage of these tests is their 
lack of stability in hot and humid conditions, and the decrease of their sensitivity for 
concentrations of less than 200 parasites per µl blood, which is why additional quality 
assurance laboratories are needed to ensure the performance of RDTs [14]. However, 
currently microscopy remains the gold standard for malaria diagnosis in Cambodia, and 
tools are provided in most of the health centers. The CNM regularly trains health center 
staff and VMWs in laboratory and clinical diagnosis and cross-checks slides from randomly 
chosen health centers in its own laboratory for quality assurance. All confirmed malaria 
cases that occur in public health centers are reported to the HIS/MoH and the CNM [16]. 
The algorithm shown in figure 6 is used as guideline for correct treatment of malaria in 
health centers since 2004. In 2011 a reviewed recommendations for malaria treatment will 
be released, which will no longer contain a recommendation for treatment with 
chloroquine [3]. If a patient’s test is positive for malaria, treatment depends on the severity 
of the clinical conditions. Uncomplicated malaria is defined by the symptoms fever, chills 
and sweating. Other common clinical signs include headache, back or muscle pain, joint 
pain, pallor, jaundice, abdominal pain, nausea, loss of appetite, diarrhea, abdominal 
swelling and enlarged spleen or liver. In this case, the recommended treatment is a 
combination of artesunate and mefloquine as first-line treatment, or alternatively quinine 
and tetracycline as second-line treatment [22]. Severe or complicated malaria is defined by 
the classic malaria symptoms, as mentioned above, plus 1 or more of the complications 
listed in table 2. 
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Figure 6: Malaria diagnosis and treatment algorithm for health center level, Cambodia 2004 to 
2011 (Ministry of Health, Treatment guidelines for Malaria, 2004). 
 
Table 2: Defining symptoms of severe malaria according to the national malaria 
treatment guidelines [22] 
• Prostration • Circulatory collapse 
• Impaired consciousness  • Pulmonary edema (radiological features) 
• Respiratory distress  • Abnormal bleeding 
• Hyperlactatemia or metabolic acidosis • Severe anemia or very pale color 
• Renal failure or scanty urine, oliguria  • Macroscopic hemoglobinuria 
• Frequent vomiting • Jaundice  
• Hypoglycemia ( < 0,4 g/l) • Multiple convulsions 
 
The recommended treatment for severe malaria is immediate intramuscularly injection of 
artemether, which should be continued once daily for up to 5 days. The therapy should 
then be continued by mefloquine tablets. If this therapy is not available, the patient should 
be immediately forwarded to the next referral hospital. If the test is negative but clinical 
conditions are still highly suspicious of malaria, as well as in case of P. vivax or P. malariae 
infection, chloroquine is the recommended medication. Furthermore, it is recommended 
to “look for other illness” if RDT and slide results are malaria-negative [22]. 
 
The overall surveillance and control of malaria treatment in Cambodia remains an 
enormous challenge, as it is unknown how faithfully diagnosis and treatment algorithms 
are adhered to in the unregulated private sector, even though up to 75.0 % of patients are 
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believed to seek malaria diagnosis and treatment in the latter [18]. Anti-malarial drugs and 
rapid diagnostic tests of unproven quality are distributed in pharmacies without any 
prescription needed. However, the CNM annual report of 2010 notes that the percentage 
of patients, who receive anti-malarial treatment without diagnostic confirmation at public 
facilities, has reduced from almost 50.0 % in the year 2000, to under 20.0 % in the year 
2010, as shown in figure 7 [3]. Moreover, figure 7 shows that in 2010 of 178,364 people 
with suspected malaria (tested cases), only 25.8 % were confirmed by microscopy or RDT 
[3], suggesting that the symptoms (fever) occurred due to another infection than malaria, 
and patients are frequently being subjected to inappropriate treatment regimes. Notice of 
this problem gave the first motivation to investigate non-malarial causes of fever within 
this observational study. 
 
 
Figure 7: Number of tested, treated and confirmed malaria cases in Cambodia 2000 to 2010  
(CNM annual report 2010). 
 
1.2.4 Existing diagnostic tools for non-malaria febrile illness in Cambodia 
Diagnostic facilities for infectious diseases at peripheral public health posts in Cambodia 
remain very limited. In many health centers, malaria is the only disease that can be 
diagnosed by laboratory, using microscopy or RDTs. In the national treatment guidelines 
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for malaria it is mentioned that symptoms of malaria can be very similar to those of other 
diseases and that it is possible to have malaria and another infection at the same time. 
Diseases that are taken into account for differential diagnosis of uncomplicated malaria are 
viral infections like influenza, measles, and dengue fever, and bacterial infections of ears, 
throat or chest. Meningitis and encephalitis, typhoid fever, septicemia, pneumonia, 
hemorrhagic dengue fever in children and eclampsia in pregnant women are listed as 
differential diagnoses for complicated malaria [3, 22]. Nevertheless, there are currently no 
consistent guidelines on how to diagnose and treat those diseases in peripheral Cambodian 
health centers. 
 
Currently, serological antibody tests and antigen-based RDTs for febrile illnesses like 
dengue fever, typhoid fever, leptospirosis or melioidosis are only available in specialized 
laboratories in Cambodia. Even though rapid tests for these illnesses do exist, their large-
scale production and distribution in developing countries are not profitable for 
international firms, even thought they would be urgently needed [23]. Furthermore, there 
are limitations these tests regarding their sensitivity, specificity and feasibility in peripheral 
health posts. The diagnosis of typhoid fever and melioidosis can also be established by 
blood culture bottles, but since they require immediate laboratory processing and multiple 
blood withdrawal to improve the level of sensitivity [24], they are not suitable for 
peripheral routine settings. Molecular diagnostic tools like PCR are currently only available 
in specialized laboratories in the capital city Phnom Penh. Subsequently, acute febrile 
illnesses in peripheral health services are generally diagnosed and treated based on the 
presumptive clinical diagnosis. In general, malaria-negative fever cases are treated 
indiscriminately with antibiotics, most commonly cotrimoxazol, if clinical signs include 
intestinal disorders or amoxicillin, if clinical signs point towards a respiratory infection [22]. 
In the private sector and most pharmacies, little plastic bags with “drug cocktails” 
(containing anti-malarials, antibiotics and painkillers) are sold to treat undifferentiated 
fever [18]. 
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1.3 Suspected etiologies of non-malaria febrile illness in Cambodia 
Little is known about the etiologies of acute undifferentiated fever in Cambodia. Based on 
the results from several studies on the etiologies of febrile illness in the neighboring 
countries (Thailand, Lao PDR and Vietnam), the most frequently diagnosed diseases have 
been further investigated in this study. A detailed overview of these studies and their 
findings is presented in appendix 9.8. Even though most of these studies have been 
performed on specific populations and regions and their findings vary, it can be observed 
that leptospirosis, rickettsiosis, scrub typhus, dengue fever, influenza and typhoid fever are 
the most common non-malarial febrile illnesses in the Southeast Asian region [25-32]. In 
the following chapter details about these diseases and their incidence in Cambodia will be 
outlined. HIV-infections, viral hepatitis and tuberculosis can also cause acute 
undifferentiated fever but were not evaluated in this study due to ethical reasons. 
 
1.3.1 Leptospirosis 
Leptospirosis is a zoonotic disease worldwide distribution with an annual incidence around 
10-100/100,000 in the tropics, caused by pathogenic spirochetes of the genus Leptospira 
[33]. Currently, this genus compromises 20 species [34], which are listed in figure 8, and 
can been further grouped into “pathogenic”, “intermediate/opportunistic” and “non-
pathogenic/saprophytic” Leptospira spp., based on their phylogenetic relatedness. 
Simultaneously, a serologically based taxonomy is used grouping strains to serovars, based 
on their differences in the reaction to hyper-immune rabbit sera. To date, 300 different 
serovars have been described. For epidemiological understanding serovars are sometimes 
merged into serogroups [33-34]. 
 
Leptospirosis is transmitted to humans by direct contact with infected animal body fluids, 
or indirect contact with contaminated water, vegetation or soil. The natural reservoir is 
maintained by chronic renal infection of feral and domestic animals, which excrete the 
organism with their urine. Rats and rodents are currently recognized as the most important 
reservoir. Therefore, the disease especially poses a threat to the health of the rural 
population living or working in endemic areas, and not having access to a safe water source 
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or sanitation system [33, 35]. Clinical manifestations of leptospirosis are highly variable. 
The bacteria cause damage to the endothelial lining of small blood vessels that can result in 
vasculitis, which may affect all organs. Differences in virulence factors and pathogenesis 
between serovars are still poorly understood. Even though some serovars tend to cause a 
milder form of the disease, in principle any serovar may cause severe disease in different 
hosts [35]. First symptoms generally occur abruptly after an incubation period of 5 to 14 
days, range from 2 to 30 days, and often resemble the flu including high fevers, severe 
headache and generalized myalgia. Other common symptoms are conjunctival suffusion, 
prostration, nausea, vomiting, diarrhea, abdominal pain and skin rash [35-36]. This wide 
range of unspecific symptoms makes the clinical diagnosis of this disease extremely difficult 
especially in its early stage [33, 37]. 
 
 
Figure 8: Left: Grouping of currently recognized Leptospira species (Tara Müller, 2009).Right: 
Electron micrograph scan of Leptospira on a 0.1 µm polycarbonate filter (Centers for Disease 
Control and Prevention, Public Health Image Library, 2008). 
 
Severe complications of the disease, like Weil’s disease, defined by jaundice combined with 
oligo- or anuria and bleeding, are believed to be secondary and thus can appear 
subsequently to the acute infection. They can affect different organs and appear in various 
combinations, which complicate the differential diagnosis even more, and can result in 
fatal renal failure, cardiopulmonary failure, widespread hemorrhage, and shock. Case 
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fatality rates of leptospirosis range from 5.0-50.0 %. Late sequels of leptospirosis include 
neuropsychiatric symptoms such as chronic fatigue, chronic headache, paresis, paralysis, 
mood swings, or depression, as well as ocular symptoms like chronic uveitis or iridocyclitis 
[34-37]. After the Leptospira have gained access to the patient’s bloodstream, usually 
trough the lymphatic system, they disperse rapidly and can potentially invade all organs 
and tissues. Causing an immune response of the host, they are cleared from the blood after 
7 to 10 days, but can remain settled in the convoluted tubules of the kidneys or other 
immunologically privileged sites like the eyes or the central nervous system, where they 
can cause sequels. Thus Leptospira may be detected in the patient’s urine or cerebrospinal 
fluid (CSF) for up to 60 days after infection. Hence, the clinical samples for the diagnosis of 
leptospirosis have to be chosen according to the stage of disease [35]. There are several 
different approaches for the laboratory based diagnosis of leptospirosis, but a rapid and 
reliable standard method is still lacking. Table 3 gives an overview of the most frequently 
used methods and their characteristics. Figure 9 shows an image of a positive MAT under a 
darkfield-microscope. Currently the microscopic agglutination test (MAT) is considered as 
the golden standard. However, the MAT is usually only positive 10-12 days after the 
appearance of the first clinical symptoms and signs, therefore it is not suitable for early 
diagnosis, similar to all other currently evaluated serological tests [35, 37-38]. 
 
 
Figure 9: Photomicrograph of leptospiral MAT with live antigen using darkfield microscopy 
technique (Centers for Disease Control and Prevention, Public Health Image Library, 2008). 
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Table 3: Overview of currently available laboratory tests for Leptospira spp., their test 
principle as well as their advantages and disadvantages 
Method Principle Advantage Disadvantage 
Culture 
 
Growth of live Leptospira on 
special media (Ellinghausen & 
McCullough modification by 
Johnson & Harris) 
Possible from any kind 
of clinical sample 
Very slow growth (up to 8 
weeks), requires special 
media, low sensitivity (14.0-
50.0 %) 
Darkfield-
Microscopy 
 
Oblique light is thrown on to 
Leptospira in serum, by the use 
of a special condenser, while 
central light is interrupted. 
Leptospira stand out as silvery 
threads against a dark 
background (see figure 9) 
Easy access, useful for 
observing cultures or 
agglutination level in 
MAT. Can be used in 
combination with other 
tests like ELISA. 
Technically demanding, 
high rates of false positives 
due to artifacts, thus not 
suitable for definite 
diagnosis. Sensitivity and 
specificity around 60.0 %. 
Staining 
 
Methods include: 
Silver- staining, 
direct immuno-fluorescence 
staining, 
immuno-peroxidase staining 
Useful for observing 
cultures or agglutination 
level in MAT. 
Difficult preparation, high 
rates of false positives, due 
to artifacts, thus not 
suitable for accurate 
diagnosis 
PCR 
 
Amplification of specific DNA 
segments 
 
Highly specific, rapid 
testing in the early 
stage of the disease, 
when there are no 
antibodies yet. 
Requires designated lab 
space and skilled staff. 
Various techniques haven’t 
been broadly evaluated yet. 
MAT  Determines antibodies by 
mixing it in various dilutions 
with live or killed, formolized 
Leptospira. Antibodies present 
in the serum cause Leptospira 
to stick together to form 
clumps, that can be observed in 
darkfield microscope. 
Currently the golden 
standard because of its 
high specificity for 
different serovars. 
Live Leptospira have to be 
kept in culture to provide 
antigens. Time-consuming 
and laborious, antibodies 
might not be detectable if 
the causative strain is not 
included in the panel. 
ELISA and 
other 
commercial 
tests* 
 
A broadly reactive so-called 
genus-specific antigen is 
generally used to detect IgM-, 
and sometimes also IgG-
antibodies. 
 
Sensitivity around 80.0 
% easy to perform, 
useful for genus-specific 
screening. Can be 
standardized. Can 
detect antibodies 24-
48hours earlier then 
MAT. 
 
Convalescence sample 
needed. Also detects 
presence of saprophytic 
Leptospira, gives no 
information about the 
serovar. 
Difficult to distinguish acute 
infection. 
*Other commercial serological test: Macroscopic slide agglutination test (SAT), Indirect fluorescent 
antibody test (IFAT), Latex agglutination test (LA), Dipstick tests (LEPTO Dip-S-Tick, LeptoTek Lateral Flow), 
and many more[35]. 
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Due to this lack of feasible diagnostic tools especially in peripheral settings, it is currently 
recommended to initiate effective chemotherapy as soon as the diagnosis is clinically 
suspected [35, 39]. Antibiotic treatment of the disease should be initiated as soon as 
possible, preferably in the first 5 days after infection. Depending on the severity, 
intravenous or oral application of ß-lactam antibiotics is indicated. Severe cases should be 
treated with intravenous penicillin, mild forms can be treated with oral amoxicillin, 
ampicillin, erythromycin or doxycycline, alternatively third-generation cephalosporins can 
be used [35-36]. The benefit of antibiotics after the fifth day of the disease is controversial. 
However, most clinicians treat with antibiotics regardless of the date of onset of the illness 
[35]. 
 
Leptospirosis is endemic in the tropical and sub-tropical regions of Southeast Asia [33]. 
Reports on human infections in the region are numerous and several studies conducted in 
recent years have increased the awareness of the disease. Nevertheless, it is believed that 
due to the non-specificity of symptoms and the lack of simple diagnostic tools and facilities, 
the disease is been widely underreported [33, 40-45]. In Cambodia the first study on 
leptospirosis was conducted from 1999 to 2001 in the National Pediatric Hospital, Phnom 
Penh, and found 12.0 % of 202 patients with a positive immunoglobulin M (IgM) titer and 
2.5 % with a positive PCR-result [41]. The second study, dating from 2003, was conducted 
in the provincial Takeo Hospital and found a prevalence of 9.1 % of 121 patients by MAT 
and PCR [42]. From 2006 to 2007 the biggest surveillance study on leptospirosis in 
Cambodia to date was conducted and showed that almost 30.0 % of the 612 recruited 
patients had at least 1 biological test (ELISA, MAT or PCR) positive for leptospirosis. 
Thirteen different serogroups had been identified, predominately L. panama, L. pyrogenes 
and L. australis, which indicates a big variety of reservoir hosts in Cambodia. Furthermore, 
the findings of this study show that there was no significant linkage of the infection to risk 
factors like gender, age or occupation, suggesting that the population is rather 
permanently exposed to the risk of contact or infection with Leptospira [44]. Studies in the 
neighboring countries found high sero-prevalence rates (18.8 % to 23.9 %) in their subject 
populations, too [40, 43, 45]. Especially in Thailand, the incidence of leptospirosis has 
dramatically increased over the last 10 years, with a peak of 14,285 cases in the year 2000 
[43, 46-47]. One reason for this increase may be the rising awareness and consequently 
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more accurate reporting of the disease. Findings in Thailand furthermore indicate that the 
incidence of leptospirosis is seasonal, being highest in the wet season [36, 43, 46-47]. 
 
1.3.2 Rickettsiosis 
Rickettsiosis is the general term for diseases caused by infection with intracellular bacteria 
of the genus Rickettsia, which further comprises 2 subdivisions, the spotted fever group 
(SFG) and the typhus group (TG). In recent years, numerous novel species of Rickettsia have 
been isolated around the world and the improvement in molecular technologies has 
helped to clarify the genetic relationships within the order of Rickettsiales [48-49]. To date, 
there are 25 recognized species of Rickettsia, of which 16 are considered as human 
pathogens. All currently known species are listed in appendix 9.5. Figure 10 gives an 
overview of the species which are endemic in Southeast Asia. Common characteristics of all 
Rickettsia are that they are obligate intracellular small rods and that they are associated 
with arthropods, such as ticks, fleas and lice that may act as vectors or as reservoir. Rats, 
rodents or other small mammals act as maintenance hosts. The majority of SFG-Rickettsia 
are tick-borne, except for R. felis which is associated to fleas, whereas TG-Rickettsia can be 
flea (R. typhii) or lice borne (R. prowazekii). The infection can result from direct bites of the 
vector as well as contamination of disrupted skin, for example with flea feces [48-49]. 
 
Clinical signs of rickettsiosis usually appear 6-10 days after the vector bite and include 
various unspecific symptoms like fever, headache, myalgia, night-sweats, local or 
generalized lymphadenopathy, conjunctival suffusion and gastrointestinal disorders like 
nausea, vomiting, diarrhea and abdominal pain. More specific signs that should raise 
attention are a macular, sometimes petechial skin rash (“spotted-fever”) and the presence 
of a so called “eschar”, a small epidermal necrosis with surrounding erythema, at the 
arthropod bite site. Figure 11 shows a picture of an eschar after a tick-bite on the hip of a 
patient at Calmette Hospital in Phnom Penh. However, none of these symptoms are 
present in every infection. SFG-rickettsiosis can manifest as a mild, severe and sometimes 
even fatal disease, depending on the involved species and the general condition of the host 
[49-50]. The bacteria target endothelial cells in humans, where they cause disruption of 
cell-to-cell adherence which can lead to increased micro-vascular permeability and 
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vasculitis. As a result, severe complications such as gangrenous extremities, bowel 
perforation, liver dysfunction, renal failure, meningo-encephalitis, pneumonia and 
disseminated intravascular coagulation (DIC), can occur [50-51]. The flea-borne R. typhii is 
causing murine typhus in humans, which is a relatively mild, often self-limiting disease with 
non-specific symptoms and is therefore believed to be frequently under-diagnosed  
[49, 52]. 
 
 
Figure 10: Left: Overview of Rickettsia species described in Southeast Asia (SEA) and their 
classification (Tara Müller, 2009). Right: Gimenez stain of tick hemolymph cells infected with 
Rickettsia rickettsii (Centers for Disease Control and Prevention,  
Public Health Image Library, 2008). 
 
Since Rickettsia are intracellular organisms, staining after Gram is not applicable, but other 
methods such as staining after Giemsa or Gimenez [53] can be used for microscopic 
observation (see figure 10). The current gold standard in diagnostics is serological 
detection of rickettsial IgG- or IgM- antibodies, most frequently by specific micro-
immunofluorescence assays (IFA) or ELISA [48-49]. However, a large panel of antigens can 
only be tested in reference centers with the facilities for further testing such as cross-
absorption-studies and western-blotting for the exact determination of the species. 
Moreover, convalescence sera samples are needed, so these methods are inappropriate for 
rapid diagnostics. In remote settings the Weil-Felix agglutination test is still used, though in 
recent years it has been labeled unsuitable for correct diagnosis [23]. Molecular tools like 
PCR-based methods, which are highly sensitive and specific, are very effective but likewise 
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require designated facilities and skilled personnel. Culture of Rickettsia from blood or 
tissue samples is possible but very laborious and challenging, since they are obligate 
intracellular organisms and thus depend on living host-cell-cultures [48-50]. 
 
Treatment of choice for SFG-rickettsiosis is antibiotic therapy with doxycycline. 
Fluorochinolones and some macrolides are considered as alternatives. For TG-rickettsiosis 
such as murine typhus, the same drugs can be used whereas a single oral application is 
usually sufficient. Penicillin and other ß-lactam antibiotics as well as cotrimoxazol, which 
are frequently used in the presumptive treatment of acute febrile illnesses, are not 
efficient against Rickettsia [48-49]. 
 
No data in regard to rickettsial infections in Cambodia has been published recently. In the 
1990s, 2 prevalence studies were carried out and revealed serological evidence of 
rickettsial antibodies in their study population. Both studies included a very specific 
population and therefore they are not appropriate to estimate the incidence of rickettsiosis 
in the whole country. The first study recruited 40 patients with undifferentiated febrile 
illness among displaced Cambodians at the Thai-border and found 26 (70.0 %) of them 
serologically positive for murine typhus [54]. The second study observed a group of 248 
Indonesian peacekeeping soldiers that had been stationed in Cambodia from 1992 to 1993 
and found a sero-conversion rate of 24 per 1,000 for R. typhii [55]. However, numerous 
studies that have been conducted in the neighboring countries outline the importance of 
rickettsiosis in the region (see appendix 9.8). Furthermore, reports on new SFG-rickettsial 
infections in humans are becoming more and more frequent from this region, especially 
from Thailand [56]. Hence, it is supposable that rickettsiosis plays an equally important role 
in Cambodia. However, given that diagnostic facilities are lacking the disease is largely 
unrecognized at present. 
 
1.3.3 Scrub typhus 
Scrub typhus or the Tsutsugamushi-fever is a common zoonosis in the Asian and Pacific 
region, with approximately 1 million reported cases per year [57]. The causative agent, 
Orientia tsutsugamushi belongs to the order of Rickettsiales. For a long time it had been 
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classified in the genus of Rickettsia, since it shows many similarities like being an obligate 
intracellular, gram-negative rod associated with arthropods. However, improvements in 
the genetic analysis of the organism have distinguished it as belonging to the reformative 
genus of Orientia, as is shown in figure 10 [48-50]. The disease is transmitted to humans by 
the bite of larval trombiculid mites (chiggers), primarily of the genus Leptotrombidium, 
which usually feed on rats or field rodents [57]. Risk-factors for scrub typhus include 
occupational activities in rural endemic areas, such as working in rice fields or other fields 
that can serve as a biotope for the mite, clearing of land, road building or military 
operations. Risk of transmission increases during the rainy season when the general 
number of rodents is higher, as well as the number of rodents with attached mites [50, 56]. 
 
As the bite of the chiggers is often painless and located in areas hard to examine, like skin 
folds, axillaries or the genital region, it usually remains undetected. Sometimes a papule 
forms at the bite site that later ulcerates to a black crust or even an eschar similar to the 
rickettsial infections, shown in figure 11. As for rickettsiosis, the eschar is the most helpful 
clue in the clinical diagnosis if it is present [56]. General symptoms occur after a variable 
incubation period from 1-2 weeks and typically include fever, headache, myalgia, 
generalized lymphadenopathy, and a transient macular or maculopapular skin rash 
dominating the trunk. If no complications occur, the disease is usually self-limiting, but 
gastrointestinal, hepatic and respiratory involvement is frequent, the latter eventually 
causing serious to fatal complications such as interstitial pneumonia, interstitial edema, 
hemorrhage and acute respiratory distress syndrome. Infection of the central nervous 
system has been reported as well, ranging from aseptic meningitis to severe meningo-
encephalitis [50, 56]. This variability in the severity of the course of disease might be linked 
to the high genetic diversity and the high plasticity of the O. tsutsugamushi genome [58]. 
The pathological mechanisms of the infection are still poorly understood and even the 
target cells are not known with certainty. It is believed that the main pathologic change is 
caused by the destruction of endothelial cells, leading to local or generalized vasculitis. 
Furthermore, the infiltration of macrophages [59] and peripheral leukocytes during acute 
infection [60] has been demonstrated. The interesting fact that scrub typhus infection 
inhibits the viral replication of HIV will enhance further research that will hopefully reveal 
more about its patho-mechanisms [50, 59-60]. 
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Figure 11: Large eschar on the hip of a patient with confirmed scrub typhus at Calmette Hospital, 
Phnom Penh (Institut Pasteur du Cambodge, 2010). 
 
Representing yet another disease with notoriously unspecific clinical signs and symptoms 
and no rapid diagnostic test available, scrub typhus goes mostly undiagnosed in countries 
like Cambodia. Therefore, treatment has to be presumptive, with the diagnosis relying on 
clinical clues combined with exposure to risk factors. The confirmatory tests of choice 
currently are serologic methods such as IFA or indirect fluorescent antibody test (IFAT), 
which are only applicable in comprehensive laboratory facilities and are not appropriate for 
rapid diagnostics, since they require the collection of a convalescence sample. Several 
promising molecular methods have been published, but again these are limited to 
reference laboratories [61-62]. 
 
Antibiotic treatment of choice is a 1 week course of doxycycline as oral application in mild 
cases or parenteral application in severe cases. Azithromycine or chloramphenicol can be 
used as second line treatment [49-50]. In northern Thailand, scrub typhus cases that 
showed a poor response to these drugs have been reported [63], however, no mechanisms 
of drug-resistance or its geographic distribution have been described so far. 
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A study conducted in 2010 by Duong et al. showed that all of the recruited, scrub typhus 
positive patients originated from and were infected in southeastern provinces of 
Cambodia, but were all infected with different strains, implicating a high genetic diversity 
of O. tsutsugamushi in Cambodia [58]. Unpublished recent data of the Department of 
Virology at IPC on dengue virus negative samples, suggests an approximate incidence rate 
of scrub typhus around 2.0 % in Cambodia. In neighboring Thailand, several studies of the 
clinical features, epidemiology [25-26, 28-31, 52, 56] and drug sensitivity [63] have been 
conducted in the past decade. Since 2001, 3,000-5,000 cases per year have been reported 
to the Public Health Ministry of Thailand [56]. Studies from Lao PDR [45, 51] found similar 
results and underline the importance of the disease in the Indochinese area. Hence, there 
is need to determine its impact in Cambodia, where the awareness of scrub typhus is still 
extremely low at all levels of the health system. 
 
1.3.4 Dengue fever 
Dengue fever is an acute febrile viral illness of global importance, known to be endemic in 
over 100 countries, with 2.5 billion people living in areas of risk, worldwide [64-65]. Around 
75.0 % of the current global disease burden is carried by countries of Southeast Asia and 
the Western Pacific region [65]. The plus strand ribonucleic acid (RNA)-virus belongs to the 
genus of Flavivirus, in the family of Flaviviridae, and presents in 4 different serotypes 
(DENV1-4). While the infection with one distinct serotype confers life-long immunity, 
secondary infection with a different serotype increases the risk of a complicated course of 
disease significantly. Different models to explain this phenomenon have been postulated 
but a consensus is still lacking. Therefore, shifts in the serotype prevalence regularly lead to 
devastating outbreaks of dengue fever around the world [64]. Being transmitted to humans 
by sting of the Aedes mosquito, dengue fever is predominant in urban and suburban areas 
since these are the preferred breeding sites of the vector, but can also occur in rural areas. 
In Southeast Asia, A. aegypti and A. albopictus (shown in figure 12) are the main vectors 
[64]. 
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Figure 12: Aedes albopictus mosquito (Centers for Disease Control and Prevention,  
Public Health Image Library, 2008). 
 
After an incubation period of 3-14 days the infection clinically manifests in variable forms 
of severity, or in the case of primary infection may even be asymptomatic (50.0-90.0 % of 
the cases) [64]. Exact pathological mechanisms remain uncertain, but it has been 
postulated that the viral replication happens in the cells of the macrophage-mononuclear 
linage. The comparatively mild and self-limiting dengue fever is characterized by a sudden 
onset of high fever, severe headaches, retro-orbital pain, myalgia, gastro-intestinal 
symptoms and sometimes a skin rash. More severe and potentially fatal manifestations are 
the dengue hemorrhagic fever (DHF) and the dengue shock syndrome (DSS), which 
particularly affects children [65-66]. DHF is characterized by the same symptoms as dengue 
fever, with additional hemorrhagic pneumonia, hepatomegaly and internal bleeding, all 
due to an increased level of vascular permeability, leakage of plasma and disorders in 
hemostasis. Due to the overlap in symptoms, dengue fever and DHF are often difficult to 
distinguish from each other. DSS hits patients that have suffered from a severe loss of 
plasma that leads to a hypovolemic shock and circulatory failure. Usually it occurs after the 
first febrile episode has ended, typical signs include a sudden fall of temperature, a rapid 
pulse and hypotension. If immediate volume-replacement therapy is not applied, the 
patient is likely to die within 24 hours [64-65]. 
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In general, oral or parenteral volume replacement and rehydration therapy is the most 
important component of dengue fever treatment. Furthermore, antipyretics are indicated 
in case of hyperpyrexia (> 39 °C), whereas salicylates should be avoided since they may 
enhance bleeding and acidosis [65]. 
 
Given the broad spectrum of clinical signs, laboratory testing is needed to confirm the 
diagnosis of a dengue virus infection. Depending on the stage of illness there are different 
approaches. In the early phase of disease, up to 5 days after onset of fever, direct viral 
isolation by sophisticated techniques, such as mosquito- and tissue culture- inoculation, or 
the detection of viral RNA by reverse transcriptase (RT)-PCR [67], are the most sensitive 
and reliable tools, followed by the detection of the viral antigen NS-1 [65]. In the 
subsequent phase of disease the detection of IgM-antibodies by ELISA or the rise in the 
IgG-antibody-titer in paired sera samples present the methods of choice [68]. Even though 
serological testing remains the most conventional method, there are several drawbacks. 
For example, paired convalescence sera samples are needed, which are often difficult to 
obtain from outpatients in rural settings. Furthermore, IgM-antibodies are often absent in 
the acute phase of the disease as well as in secondary infections, which have a higher 
potential for turning into DHF or DSS. Finally, IgM-antibodies can cross-react with other 
viruses from the same family, such as the Japanese encephalitis virus or the yellow fever 
virus. Consequently, a diagnostics algorithm for dengue fever should aim at the use of 
direct viral detection in the early phase and antibody detection in the late phase of the 
infection [68]. 
 
In the past decade, dengue fever has continued to be ranked in the top 10 causes of 
morbidity and mortality in Cambodia, (see appendices 7.3 and 7.4) with around 100,000 
cases and more than 100 deaths reported annually [66]. While the fatality rate is 
decreasing, the disease still poses a serious public health threat, especially for children  
[9, 66]. The number of hospitalized dengue fever cases increases sharply during the rainy 
season, due to the better breeding conditions for the mosquitoes. In 2007 Cambodia has 
faced the last heavy outbreak of dengue fever with 404,165 estimated cases, 407 of which 
ended fatal [66, 69]. The “National Dengue Control Program” developed by the CNM in 
cooperation with several international organizations, has implemented a broad spectrum 
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of activities that will hopefully help to improve the disease control and prevent another 
outbreak in the future [16]. In Cambodia, the diagnosis of dengue fever is usually 
established clinically. Surveillance studies showed that the majority of the clinical 
diagnoses were positively confirmed by serology [69]. However, dengue fever cases are 
largely reported from urban areas and are likely to be underreported in rural areas. 
Furthermore, the national dengue fever case-definition only allows reporting of children 
less than 16 years of age. To estimate the burden of dengue fever in rural areas, IPC has 
conducted an active surveillance study in Cambodia’s largest province, Kampong Cham, 
from 2006-2008. The findings confirm that dengue fever incidence was underestimated in 
rural areas, and the virus distribution is highly focal with incidence rates ranging from 
1.5/1,000 person-seasons (rural) to 211.5/1,000 person-seasons (urban) [70]. A study on 
dengue as a cause of undifferentiated febrile illness in Vietnam showed that one third of 
the recruited study subjects in peripheral health posts had acute dengue fever [71]. 
Therefore, there is need to determine the importance of dengue fever among malaria-
negative febrile patients in Cambodian health centers. 
 
1.3.5 Influenza virus 
Influenza, commonly referred to as the flu, is an infectious disease caused by RNA viruses 
of the family Orthomyxoviridae, which can affect birds and mammals. Influenza-infection is 
airborne and is usually transmitted between humans by coughs or sneezes, creating 
aerosols that contain the virus. It can also be transmitted by direct contact with bird- or 
other infected animal-droppings or nasal secretions, or even through contact with 
contaminated surfaces. There are 3 subtypes of the influenza virus, type A-C. The influenza 
A virus is the most virulent subtype and can cause the most severe disease in humans [72]. 
Based on the 2 major surface glycoproteins, the influenza A virus can be further subdivided 
into distinct serotypes based on the hemagglutinin (H)- and neuraminidase (N)-antigens 
which cause a specific immune-response in the host. Influenza pandemics, which spread 
around the world seasonally, are the result of the occasional antigenic shifting within the 
influenza A viruses [72-73]. Influenza B is less common than influenza A and almost 
exclusively infects humans. It is less genetically diverse than influenza A, with only one 
influenza B serotype, and usually causes a milder form of the disease. Even less common is 
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the influenza C virus, which infects humans, dogs and pigs, and sometimes causes both 
severe illness and local epidemics. The most common symptoms of the disease are chills, 
fever, sore throat, myalgia, severe headache, dry coughing, weakness, fatigue and general 
discomfort. In more serious cases, influenza viruses can cause pneumonia, which can be 
fatal, particularly for the young and the elderly. It has been reported that between 3 and 5 
million cases of severe influenza disease occur each year, of which up to 1 million end fatal 
[73]. In routine medical practice the diagnosis is often established clinically. For the specific 
identification and sub-typing of the virus in cases of severe illness, pandemics or for 
research purposes, RT-PCR assays can be performed [73]. The treatment is mostly 
symptomatic, but anti-viral treatment with neuraminidase-inhibitors is available for severe 
cases or in the case of pandemics. Furthermore, seasonal vaccines are available for 
prevention measures [72]. 
 
In Cambodia, a hospital based surveillance system for influenza like illness (ILI) has been 
established in 5 sites with a weekly reporting and sampling scheme since 2006 [74]. In 
addition, surveillance of ARI cases has been established in 2 sentinel sites. In each of those 
sites naso-pharyngeal swabs are collected weekly to provide epidemiological data. Samples 
are tested at IPC in Phnom Penh, which is the national influenza reference centre in 
Cambodia [75]. Analysis of this data showed that influenza A viruses (mainly strains H1N1 
and H3N2) circulate from June to December, with a clear seasonal peak in October during 
the rainy season. Furthermore, Cambodia is endemic for the avian influenza (H5N1) in 
poultry and has reported 8 fatal cases in humans to date [74-75]. 
 
1.3.6 Other possible causes of non-malaria febrile illness in Cambodia 
There are numerous other possible causes of febrile illness in Cambodia, most of which are 
difficult to distinguish from malaria clinically. For example, enteric fever caused by the 
Salmonella enterica serotype typhi (S. typhi) and serotype paratyphi A, B and C  
(S. paratyphi) is endemic in Cambodia. Enteric fever (typhoid fever) affects humans 
worldwide, the transmission is usually oral-fecal, and therefore populations with unsafe 
water supply and limited sanitary facilities are especially at risk [76-77]. In the year 2000, it 
was estimated that typhoid fever caused 21.7 million illnesses and 217,000 deaths 
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worldwide, most of which occur in Southeast Asia [76]. Symptoms usually develop 1 to 3 
weeks after exposure, and can be mild or severe. The classical symptoms include high 
fever, dry cough, malaise, headache, constipation or diarrhea, rose-colored spots on the 
chest, and enlarged spleen and liver [77]. The presence of clinical symptoms characteristic 
of typhoid fever or the detection of a specific antibody response is suggestive of typhoid 
fever but not definitive. If it is available, bone marrow aspirate culture is the gold standard 
for the diagnosis of typhoid fever. Since it requires a high level of expertise and equipment 
which are often not present in peripheral settings, blood culture is the mainstay of the 
diagnosis, even though it is less sensitive [77-80]. Serological methods like the Widal-Felix-
test are generally not recommended due to their lack of sensitivity and specificity, but are 
still frequently used in remote settings where blood culture is not available. Some newer 
serological techniques include rapid diagnostic test strips which are very easy to handle 
and show promising results, but there are no official recommendations on their use yet 
[78-79, 81]. The current standard treatment of typhoid fever consists of fluoroquinolone-
antibiotics like ciprofloxacin; former recommendations included chloramphenicol, 
ampicillin, amoxicillin and trimethoprim-sulfamethoxazole [77, 82]. In Cambodia, data 
about prevalence and incidence of typhoid and paratyphoid fever remains scarce. The 
latest study on typhoid fever in hospitalized children found 3.7 % (5/134) of positive blood 
cultures with S. typhi [83]. Another study, conducted from 2006-2009 among Cambodian 
patients presenting with acute fever of unknown origin, showed that S. typhi was detected 
in 0.9 % (41/4,985) of blood cultures, and showed reduced susceptibility to 
fluoroquinolones [82]. 
 
Another bacterial infection that can mimic malaria and is difficult to diagnose clinically is 
melioidosis. This illness is caused by the agent Burkholderia pseudomallei, a gram-negative 
aerobic saprophyte found in contaminated soil and water. It is thought that the majority of 
melioidosis cases result from percutaneous inoculation, more rarely from ingestion or 
inhalation of the agent [84]. Many infections are initially subclinical but may result in 
latency and can manifest even after several decades. Clinical symptoms include septicemia, 
cavitating pneumonia, bone and soft tissue infections, disseminated abscesses and 
lymphadenitis. The case fatality rates of melioidosis range from 15.0 to 50.0 %, partially 
due to the difficulties in diagnosis and treatment [85]. For the diagnosis, conventional 
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techniques including Gram stain, API 20NE-galleries and bacterial culture remain the 
mainstay, but are often not applicable in resource limited areas. Serological methods are 
only used in remote areas or for epidemiological purposes [86]. The treatment is difficult 
due to a natural resistance to a broad spectrum of antibiotics, including penicillins and 
aminoglycosides. Carbapenem-antibiotics, third-generation cephalosporins and 
sulfamethoxazole with trimethoprim are currently the first choice for empiric treatment 
[84, 87]. Southeast Asia and northern Australia are the main endemic foci of melioidosis 
[84-85]. In northeast Thailand, melioidosis was shown to be the third most common cause 
of death from infectious diseases after HIV/AIDS and tuberculosis, with a mortality rate of 
46.2 % [85]. In Cambodia the available data on melioidosis is limited, a study conducted in 
2008 showed that 16.0 % of examined Cambodian children carried B. pseudomallei 
antibodies [86]. The first prospective study on pulmonary melioidosis in Cambodia from 
2007 to 2010 showed that mortality was very high (61.5 %) due to the lacking access to 
efficient antibiotics and under-recognition of the disease by clinicians [84]. Another recent 
study, conducted in a hospital in Phnom Penh, reported 58 patients from different 
provinces of Cambodia with melioidosis, the observed fatality rate was equally high with 
52.0 % [87]. 
 
Last but not least, the Japanese encephalitis virus (JEV), genus Flavivirus, member of the 
Flaviviridae family, like dengue virus, can also cause malaria-like symptoms in humans and 
is difficult to diagnose clinically. Japanese encephalitis is a mosquito-borne disease with a 
high rate of mortality and disability. It is endemic to large parts of Asia and the Pacific, 
putting around 3 billion people at risk for the disease worldwide [88]. With large scale 
vaccination programs in India and China the worldwide incidence of the disease is 
decreasing, meanwhile the transmission is likely to increase in countries with rapid 
population growth and the lack of vaccination programs and surveillance, like Cambodia, 
Lao PDR or Bangladesh. JEV is mainly transmitted by the mosquito Culex 
tritaeniorrhynchus, which prefers to breed in irrigated rice paddies. Water-birds and pigs 
act as main reservoir and amplifying hosts [88]. Humans are a dead-end host for the virus 
and viremia typically remains very low. Most human infections are mild or can even be 
asymptomatic, but sometimes result in severe disease, especially in young children. The 
complicated course of disease is characterized by rapid onset of high fever, headache, neck 
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stiffness, disorientation, coma, seizures, spastic paralysis and death with a case fatality rate 
as high as 30.0 % and disability rate of 40.0 % of survivors [88]. Currently the treatment is 
entirely supportive. Laboratory-based diagnosis can be established using serological 
methods like hemagglutination inhibition test and IgM–capture enzyme-linked 
immunosorbent assay (MAC-ELISA), since direct virus detection from plasma or CSF by PCR 
remains very rare due to the extremely low viremia [89]. In Cambodia, human cases of 
Japanese encephalitis have been described since 1965, over the years pediatric hospital 
based studies revealed that 18.0-31.0 % of children with meningoencephalitis had JEV [90]. 
The latest Cambodian surveillance data from 2006 to 2008 showed that of 586 pediatric 
patients (mean age 6.2 years) presenting with meningoencephalitis, JEV was detected in 
19.0 %. The percentage of Japanese encephalitis cases at individual sentinel sites ranged 
from 13.0-35.0 % of all meningoencephalitis cases, which occurred year-round [90]. 
Cambodia shares similar agrarian practices and ecologic characteristics with its neighboring 
countries Thailand and Vietnam, who have both demonstrated a considerable JEV burden 
and have introduced the vaccine into routine immunization programs in the 1990s. Since 
2009, the JEV-vaccine is also used in 3 Cambodian provinces (Kampong Cham, Svay Rieng 
and Prey Veng) [91]. 
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2 Material and methods 
2.1 Study objectives and design 
2.1.1 Study objectives 
The aim of this cross-sectional, observational study was to identify the most common 
causes of acute undifferentiated febrile illness in basic health posts in rural areas of 
Cambodia with the primary objective to develop evidence to guide management of acute, 
malaria-RDT negative fever cases. Secondary objectives were to determine available 
diagnostic tools applicable in field conditions, to enhance further research and to build 
capacity for laboratory testing and research within the country. Finally, it was intended to 
show that an extensive AUFI-study is feasible in a peripheral, non-hospital setting and to 
provide a study protocol that may be used in other countries. 
 
2.1.2 Study sites 
The 3 study sites (C-1 to C-3) for this cross-sectional, observational study were located in 
basic health centers in rural areas in the west (C-1 and C-2 in Pailin City, Pailin province) 
and east (C-3 in Snoul, Kratie province) of Cambodia, as shown on the map in figure 13. 
Pailin city is at 371 km distance to Phnom Penh (Ministry of Health, Cambodia, 2009). The 
surrounding area is hilly and forested, with lots of little villages spread around. Many 
people here work in the forests or as gem- miners. Pailin City has been a base for research 
projects in the past, since multi-drug-resistant malaria parasite strains started to emerge 
from this area close to the Thai border [4].The sites C-1 and C-2 were chosen here because 
the malaria incidence in this area has dropped significantly during the last 5 years due to 
the extensive control measures that have been established in the region. Furthermore, 
these 2 health centers (Suon Komar and Oh Chra) were easily accessible and the staff had 
participated in research projects before. 
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C1 - Soun Komar 
 
Figure 13: 2 maps of Cambodia, displaying the 3 study sites C-1-3. Left: Schematic map; 
Right: Satellite map displaying exact locations of C-1 in red, C-2 in blue, C-3 in green  
(Tara Müller, 2009, created with Google earth®, coordinates provided by Ministry of Health). 
 
Suon Komar Health Centre (C-1) lies within the compound of the referral hospital of Pailin 
city, and is therefore connected with its network, which makes it easy to reach for the 
people of the area; its operational district is covering 5,151 households with a total 
population of 22,336. Oh Chra Health Centre (C-2) lies in a more remote setting at the 
outskirts of town and its OD is covering 4,016 households with a total population of 14,283.  
 
 
Figure 14: Left: Outskirts of Pailin City and the surroundings. Top right: Suon Komar Health Center 
(C-1). Bottom right: Oh Chra Health Center (C-2) (Tara Müller, 2010). 
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Figure 15: Left: Snoul town center; Right: Snoul Health Center (Tara Müller, 2010). 
 
The site C-3 in Snoul was chosen to outline geographical differences compared to the Pailin 
area; it was the first time that a research project took place in this health center. Snoul 
Health Centre lies on the fringes of Snoul, a small town at the eastern side of the country, 
in Kratie province, 255 km from Phnom Penh. The health center is covering an operational 
district with 8,310 households with a total population of 43,867 (Ministry of Health, 
Cambodia, 2009). This remote area, close to the Vietnamese border, is characterized by 
vast rubber plantations and is mostly inhabited by plantation-workers and farmers. 
According to the national data, Kratie province is an area of low transmission for malaria 
[16]. 
 
2.1.3 Study duration 
In Pailin the study started on the 1st of January 2008. After 3 months of pilot phase, the 
study period ended on the 31st of December 2010. In Snoul, the study commenced 4 
months later, on the 1st of May 2008 and finished on the 31st of December 2010. 
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2.1.4 Subject population 
Male and female persons who visited the 3 health centers during the study from January 
2008 to December 2010 were eligible to participate in the study if they were between 7 
and 49 years old on the day of recruitment The first study group, Group F (fever), consisted 
of outpatients that presented with an acute febrile illness, defined by a body temperature 
over 38.5 °C measured on tympanic membrane, which had lasted for not longer than 8 
days. The patients had to be eligible for a malaria test according to the national guidelines, 
as explained in chapter 1.2.2. Lastly, the patients had to have an understanding of the 
study and agree to its provision by giving written informed consent (see appendix 9.6). In 
case of under-aged participants the parents or guardians had to agree. If the patients were 
in a critical clinical condition that warranted immediate hospitalization they were not 
enrolled in the study. An asymptomatic, comparative group, Group N (non-febrile) was 
recruited from family members or friends that accompanied the patients to the health 
center or people who consulted there for reasons not related to infectious diseases like 
minor injuries or pregnancy consulting. Inclusion criteria for the Group N were the absence 
of a febrile illness and the understanding and signature of the informed consent. Recruiting 
healthy Cambodian people for a study that involves blood drawing is very difficult, due to 
the general reluctance of Cambodians to give blood. Even though this is not an 
independent age- and gender-matched Group N, it was thought to be interesting to 
compare the febrile study population to asymptomatic people from the same background. 
In total, 1,475 individuals have participated in this study, 1,193 of which belonged to the 
febrile Group F, and 282 individuals belonged to the healthy Group N. Table 4 summarizes 
the inclusion and exclusion criteria for both study groups. 
 
Table 4: Inclusion and exclusion criteria for Group F and Group N 
 Inclusion criteria Exclusion criteria 
Group F Age 7-49 years 
Eligible for malaria testing 
Fever (temperature > 38.5 °C) 
Fever duration < 8 days 
Informed consent 
Critical clinical condition 
Group N No fever (temperature < 37.5 °C) 
Informed consent 
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2.1.5 Sampling and data processing 
Following the enrolment, the patient’s history was taken and a physical clinical 
examination was performed to detect possible reasons for the fever, such as infected skin 
lesions, infections of the urinary tract or respiratory tract. Furthermore, a RDT for malaria 
was conducted. All of these findings, as well as the presumptive diagnosis and prescribed 
treatment of the health center staff, were documented on a designated form  
(appendix 9.7). Thereafter, the following samples were taken from each participant: 
 
• 1 naso-pharyngeal swab, in viral transport medium (VTM) 
• 15 ml of venous whole blood which were separated into 5 ml in an ethylene-
diamine-tetraacetic-acid (EDTA)-tube, 5 ml in a dry tube and 5 ml in a blood culture 
bottle 
• 1 capillary blood spot on filter paper 
• 1 blood smear for microscopy, thick and thin film 
 
The patient’s data and specimen were anonymized immediately at health center level. 
Each sample was labeled with an ID containing the site (CX) and patient number (xxxx), e.g. 
C1-0001. The EDTA-tubes were stored at 4 °C, the blood culture bottles in an incubator at 
37 °C and the VTM- and dry- tubes in a liquid nitrogen tank, all of which had been provided 
by the study sponsors and maintained by IPC. Every morning a taxi service brought the 
collected samples from the sites to the IPC laboratory in Phnom Penh within maximum 48 
hours. The clinical data was forwarded to the CNM for translation. If the laboratory result 
could have had a direct bearing on the patient management and was available at the 
appropriate time, it was immediately sent back to the health center staff. Figure 16 gives 
an overview of the data-flow in the study. 
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Figure 16: Flowchart of data and specimen processing within the study (Tara Müller, 2011). 
 
2.1.6 Laboratory testing and ethical approval 
Molecular diagnostic tests were run on all blood samples to detect the deoxyribonucleic 
acid (DNA) of Plasmodium spp., Leptospira spp., Rickettsia spp., Orientia tsutsugamushi, or 
the ribonucleic acid (RNA) of dengue and influenza virus. The testing took place in the 
Department of Molecular Epidemiology and the Department of Virology at IPC in Phnom 
Penh. Nested polymerase chain reaction (nPCR) was chosen as the main diagnostic tool in 
this study, since it is both highly sensitive and specific and no convalescence samples are 
needed in comparison to most routine serological methods. The positive amplified PCR 
products were further sent to Paris for nucleotide sequence analysis at Genopole®; the 
sequence was then compared to published sequences to assess the diagnosis with a 
specificity of 100 %. Even though in current literature realtime-PCR is considered as the 
new standard, it is often not available in study settings like this. That is why it was chosen 
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to use and evaluate nested PCRs as a primary diagnostic tool. The blood smears were 
analyzed with a high resolution microscope by experienced staff in the IPC laboratory for 
evaluation and quality assurance. In addition, the Department of Bacteriology evaluated 
blood culture bottles for all febrile individuals, to test for community acquired septicemia, 
typhoid fever and melioidosis. HIV, tuberculosis and viral hepatitis have not been 
evaluated. 
 
All of the tests have been approved by the Cambodia Ethics Committee for Health Research 
on June 11th 2007. 
 
2.2 On site diagnostics at health centers 
The only diagnostic tests performed directly in the field were rapid diagnostic tests (RDTs) 
for malaria diagnosis. These tests were distributed by the WHO and are able to detect and 
distinguish P. falciparum (PF) and non-falciparum malaria parasites (non-PF). These tests 
(ICT MALARIA Cassette Test®, reference: ML02 25 TEST KIT) are a combination of HRP2 and 
pLDH, thus can differentiate between single infection with PF, single infection with non-PF 
malaria parasites, which are in Cambodia mostly due to P. vivax. Mixed infections with PF 
and non-PF malaria parasites can be detected, too. Figure 17 displays an image of the 
possible test results, a mixed infection would result in 3 pink lines on the test strip. 
 
Blood smears for microscopic diagnosis have been prepared on site as well. Thick and thin 
blood films were fixed on the slide with methanol and were then stained with a modified 
Giemsa stain, Accustain® (Sigma-Aldrich®, Germany, reference: 058K4349), for 30 minutes. 
Slides were usually read in the field for on-site presumptive diagnosis and then sent to IPC 
for a second read by an experienced microscopist (see chapter 2.2.1). 
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Figure 17: Malaria-RDT, showing different results. From left to right: Negative test, positive test 
for P. falciparum (PF), positive test for non-falciparum species (non-PF) (Tara Müller, 2009). 
 
2.3 Processing and testing of samples 
2.3.1 Microscopy 
According to the WHO’s “Basic Malaria Microscopy” manual, at least 100 fields of the thick 
film, which is equivalent of approximately 0.25 μl of blood, were examined using a  
100 x oil-immersion objective to determine if a slide could be considered negative. An 
experienced microscopist can detect malaria parasites at densities of approximately 5-10 
malaria parasites per microliter blood with this method [92]. If parasites were identified, 
they were counted in relation to the number of leucocytes to evaluate the parasite density 
(parasitemia). At least 200 leucocytes have to be counted; in case of low parasitemia (less 
than 99 parasites/200 leucocytes) 500 leucocytes had to be counted. Considering an 
average number of 8,000 leucocytes per microliter blood of any patient, the parasite count 
can be easily converted to parasites/μl blood using the following formula [92]: 
 
Number of leucocytes 
Number of counted parasites x 8,000 
 
= Number of parasites/μl blood 
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The thin film was used to determine the parasite species and to identify mixed infections 
by 2 or more Plasmodium spp.. The specificity of this technique is highly depended on the 
level of training of the microscopist as well as the quality of the slide [92]. Furthermore, 
mixed infections are at risk to be underestimated because the identification of the minor 
species, like P. malariae or P. ovale, is very challenging [93]. Figures 18, 19 and 20 show 
microscope images of thin and thick films of the different malaria parasites, taken in the 
IPC laboratory in Phnom Penh. 
 
 
Figure 18: Microscopic images of P. falciparum. Left: Thick film, right: Thin film  
(100 x oil-immersion objective, Tara Müller, 2010). 
 
 
Figure 19: Microscopic images of P. vivax. Left: Thick film, right: Thin film  
(100 x oil-immersion objective, Tara Müller, 2010). 
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Figure 20: Microscopic images of a thin blood film with P. knowlesi, P. malariae and P. ovale from 
left to right (100 x oil-immersion objective, Tara Müller, 2010). 
 
2.3.2 Blood culture 
For each febrile patient 5 ml of whole blood were injected in an aerobic blood culture 
bottle (Pharmaceutical Factory No. 2, Vientiane, Lao PDR) based on tryptic hydrolysate of 
casein and soy peptone, blood to media ratio was 1:10. These were incubated at 37 °C in 
the field, and then sent back to IPC with the other samples in a special temperature 
surveillance container. The bottles were weighed before departure for the study site and 
then on return to measure the weight of blood and hence estimate the volume of blood 
added to the bottles. Upon arrival at IPC they were incubated and observed for another 5 
days at 37 °C in the Department of Bacteriology. If bacterial growth was observed the 
cultures were furthermore tested for their antibiotic sensitivity, using standard 
bacteriological procedures. 
 
2.3.3 C-reactive protein level detection 
C-reactive protein (CRP) is an acute-phase protein whose plasma levels rise as a response 
to inflammatory processes in the body, especially bacterial infections. Other reasons for 
elevated levels can be a myocardial infarction, cancer, or trauma. CRP-levels were 
evaluated on all plasma samples using an immunoturbidimetric essay on latex particles. 
The human CRP agglutinates on the latex particles which are loaded with monoclonal anti-
CRP-antibodies. The antigen-antibody-complexes can be measured by the loss of intensity 
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of a light beam (turbidimetry). All CRP-levels were evaluated using the Cobas Integra® 400 
automate (Roche Diagnostics Limited, Switzerland), the cut-off value was 5 mg/l. 
 
2.3.4 DNA and RNA extraction 
After arrival at the Department of Molecular Epidemiology at IPC, the 5 ml of EDTA-blood 
samples were centrifuged for 10 minutes at 2,000 rpm to separate plasma from blood cells. 
All samples were stored at -80 °C. For the extraction of DNA, 200 μl of packed blood cells 
have been thawed, and processed according to the protocol of the QIamp® DNA Mini Kit 
(Qiagen®, Germany, reference: 51306). First 20 μl of Proteinase K and 200 μl of lysis buffer 
were added to the sample, mixed by pulse-vortexing for 15 seconds and then incubated in 
a water bath at 56 °C for 10 minutes. After centrifugation wash steps were performed 
according to the manufacturer’s instructions, using the buffers AW1 and AW2. In the last 
step the DNA was eluted in 50 μl of Buffer AE and incubated for another 5 minutes to 
increase the DNA yield. 
 
For the extraction of viral RNA the QIamp® Viral RNA Mini Kit (Qiagen®, Germany, 
reference: 52906) was used on 200 μl of plasma or 140 μl throat swab-sample, following 
the manufacturer’s instructions. 
 
2.3.5 DNA amplification 
2.3.5.1 Detection threshold evaluation of nested PCR-assays 
The detection thresholds of the nested-PCR assays were empirically evaluated by using 
dilution series of a positive control sample with a known DNA-concentration. The DNA 
concentration of the positive controls was measured with the Nanodrop®-
spectrophotometer (Thermo Fisher Scientific, USA). However, this approach was used to 
approximate the sensitivity of the used assays in “real life” conditions. The obtained results 
will be mentioned in the following detailed description of the applied assays. 
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2.3.5.2 Reagents and conditions for nested PCR assays 
For the detection of Plasmodium spp., Leptospira spp., Rickettsia spp. and  
O. tsutsugamushi specific nPCR assays have been performed in the Mastercycler® 
thermocycler (Eppendorf, Germany), using the following reagents: 
 
• Thermus aquaticus-DNA-Polymerase I (Taq-Polymerase, 5 U/μl), MgCl₂ -solution  
(25 mM) and Reaction-Buffer package, FIREPOL® (BioDyne Solis, Estonia) 
• Deoxynucleotid-triphosphates (dNTPs, 2mM) (BioDyne Solis, Estonia) 
• Purified water (Fresenius Kabi, France, reference.: 343 470.4) 
 
The conditions and volumes of the reagents for the primary and nested PCR reactions were 
applied as listed in table 5. 
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Table 5: Overview of primary and nested PCR reagents and conditions 
Primary PCR reagents cytB LEPTO 47kDA gltA ompB 
10x Buffer 2.5 μl 2.5 μl 2.5 μl 2.5 μl 2.5 μl 
dNTP (2 mM) 2.5 μl 2.5 μl 2.5 μl 2.5 μl 2.5 μl 
MgCl₂ (25 mM) 2.5 μl 2.0 μl 2.5 μl 2.5 μl 2.0 μl 
Forward Primer (10 μM) 1.25 μl 1.25 μl 1.25 μl 1.25 μl  1.25 μl 
Reverse Primer (10 μM) 1.25 μl 1.25 μl 1.25 μl 1.25 μl 1.25 μl 
Taq-Polymerase (5 U/μl) 0.25 μl 0.25 μl 0.25 μl 0.25 μl 0.25 μl 
H₂O eq. 23 μl eq. 23 μl eq. 22 μl eq. 23 μl eq. 23 μl 
DNA 2 μl 3 μl 3 μl 2 μl 2 μl 
Final volume 25 μl 25 μl 25 μl 25 μl 25 μl 
      Primary PCR 
conditions cytB LEPTO 47kDA gltA ompB 
 Denaturation 94 °C  
3 min 30 s 
94 °C 
 3 min 30 s 
94 °C 
 3 min 30 s 
94 °C 
 3 min 30 s 
94 °C 
 3 min 30 s 
 Annealing 57 °C 
1 min 30 s 
63 °C 
1 min 30 s 
60 °C 
1 min 30 s 
55 °C 
1 min 30 s 
58 °C 
1 min 30 s 
 Extension 72 °C    
11 min 30 s 
72 °C 
11 min 30 s 
72 °C 
11 min 30 s 
72 °C 
11 min 30 s 
72 °C 
11 min 30 s 
 40 cycles Hold at 4 °C Hold at 4 °C Hold at 4 °C Hold at 4 °C Hold at 4 °C 
      Nested PCR 
Reagents cytB LEPTO 47kDA gltA ompB 
10x Buffer 5 μl 5 μl 5 μl 2.5 μl 5 μl 
dNTP (2 mM) 5 μl 5 μl 5 μl 2.5 μl 5 μl 
MgCl₂ (25 mM) 5 μl 5 μl 4 μl 2.5 μl 4 μl 
Forward Primer (10 μM) 2.5 μl 2.5 μl 2.5 μl 2.5 μl 2.5 μl 
Reverse Primer (10 μM) 2.5 μl 2.5 μl 2.5 μl 2.5 μl 2.5 μl 
Taq-Polymerase (5 U/μl) 0.4 μl 0.4 μl 0.4 μl 0.4 μl 0.4 μl 
H₂O eq. 48 μl eq. 47 μl eq. 48 μl eq. 48 μl eq. 48 μl 
Primary PCR product 2 μl 3 μl 2 μl 2 μl 2 μl 
Final volume 50 μl 50 μl 50 μl 50 μl 50 μl 
      Nested PCR 
conditions cytB LEPTO 47kDA gltA ompB 
 Denaturation 94 °C 
 3 min 30 s 
94 °C 
 3 min 30 s 
94 °C 
 3 min 30 s 
94 °C 
 3 min 30 s 
94 °C 
 3 min 30 s 
 Annealing 63 °C 
1 min 30 s 
61 °C 
1min 30 s 
58 °C 
1 min 30 s 
55 °C 
1 min 30 s 
59 °C 
1 min 30 s 
 Extension 72 °C 
11 min 30 s 
72 °C 
11 min 30 s 
72 °C 
11 min 30 s 
72 °C 
11 min 30 s 
72 °C 
11 min 30 s 
  30 cycles Hold at 4 °C Hold at 4 °C Hold at 4 °C Hold at 4 °C Hold at 4 °C 
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2.3.5.2.1 CytB-nested PCR for the detection of Plasmodium spp. DNA 
The mitochondrial gene cytochrome B (cytB) is coding for the inhibitory cytochrome bC-1 
complex, which is a transmembrane electron transport-protein of the respiratory chain. 
The cytB gene of Plasmodium is highly conserved but still allows the differentiation of 
species by species-specific punctual mutations, called single nucleotide polymorphisms 
(SNPs) and is a frequently used molecular marker in malaria epidemiology and drug-
resistance studies [94-95]. The primers shown in table 6 were used in this study and are 
specific for the DNA of all Plasmodium spp. which infect humans and primates [95]. The 
detection threshold of this technique was evaluated at approximately 0.1 genome 
copies/µl PCR-mix. As positive control DNA of P. falciparum reference strain 3D7 was 
extracted from 200 μl of packed blood cells, according to the protocol described under 
2.2.2 DNA and RNA extraction. Figure 21 shows a picture of an agarose gel with products of 
primary and nested cytB-PCR of a positive control (T+). 
 
Table 6: Primary and nested PCR-primers for cytB-PCR 
Primary PCR-primers Product size 
PF: 5’-AATGCCTAGACGTATTCCTGA-3’ 
PR: 5’-CGAAGCATCCATCTACAGC-3’ 
1385 bp 
Nested PCR-primers  
NPF: 5’-CTCGAGGAATTCGGATCC*AGAGAATTATGGAGTGGATGGTG-3’ 
NPR: 5’-TCTAGAAAGCTTGGATCC*AAGCATAGAATGCACACATAAACC-3’ 
815 bp 
*tag –sequence, needed for subsequent nucleotide sequencing  
 
 
Figure 21: CytB-PCR products of primary PCR (T+PRIM) and nested PCR (T+NEST)  
on an agarose gel. PM: Smart ladder 200 bp (Tara Müller, 2009). 
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2.3.5.2.2 16SrRNA nested PCR for the detection of Leptospira spp. DNA 
The nested PCR for the 16SrRNA gene was performed as previously described by Merien et 
al., 1992 and 2005. The pair of primers (LEPTO A/B) shown in table 7 amplifies a product of 
331 bp [96] and the nested PCR primer pair (LEPTO C/D) a final product of 289 bp [38]. 
However, this PCR assay had been shown to detect all 7 pathogenic (L. interrogans, 
L. kirschnerii, L. borgpetersenii, L. noguchii, L. alexandrii, L. weilii, L. santarosai) as well as 3 
saprophytic (L. biflexa, L. meyeri, L. wolbachi) and 2 Leptospira spp. of controversially 
discussed pathogenicity (L. inadai, L. fainei) that it was assessed for. The detection 
threshold of the assay was assessed to be 16 genome copies/µl [38]. DNA of L. interrogans, 
kindly provided by the Bacteriology Unit of IPC, was used as positive control (T+). Figure 22 
shows a picture of an agarose gel with products of primary and nested PCR. 
 
Table 7: Primary and nested PCR-primers for 16SrRNA-PCR 
Primary PCR-primers  Product size  
PF: 5’-GGCGGCGCGTCTTAAACATG-3’ 
PR: 5’-TTCCCCCCATTGAGCAAGATT-3’ 
331 bp 
Nested PCR-primers   
NPF: 5’-CTCGAGGAATTCGGATCC*CAAGTCAAGCGGAGTAGCAA-3’ 
NPR: 5’-TCTAGAAAGCTTGGATCC*CTTAACTGCTGCCTCCCGTA-3’ 
290 bp 
*tag –sequence, needed for subsequent nucleotide sequencing  
 
 
Figure 22: 16SrRNA-PCR products of primary PCR (T+PRIM) and nested PCR (T+NEST) 
on an agarose gel. PM: Smart ladder 200 bp (Tara Müller, 2009). 
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2.3.5.2.3 GltA- and ompB- nested PCRs for detection of Rickettsia spp. DNA 
Target genes for the detection and differentiation of SFG- and TG-Rickettsia were the 
citrate synthase gene gltA, which is present in TG- as well as SFG-Rickettsia [97], and the 
outer membrane protein B gene ompB, which is the dominant amplicon for SFG-Rickettsia 
[52]. The target gene ompB demonstrated an increased sensitivity over the gltA gene for 
detection of SFG-Rickettsia in both single-template and multiplex PCR assay [52]. Primers 
were chosen according to the previously described realtime multiplex PCR assay by Stenos 
et al. [97] and Paris et al. [62]. The original design of the ompB primers included coverage 
for 19 different SFG-Rickettsia (R. rickettsii, R. conorii, R. honei, R. australis, R. felis,  
R. heilongjiangensis, R. helvetica, R. akari, R. amblyommii, R. hulinensis, R. IsraeliTT,  
R. japonica, R. massiliae, R. mongolotimonae, R. parkeri, R. rhipicephali, R. sibirica,  
R. slovaca, and R. africae) [62]. The assay had been transformed into 2 nested PCRs using 
the primers shown in table 8 and 9. The primary PCR for ompB had a product of 444 bp 
size, the following nested PCR resulted in the final product which was 298 bp long. The 
products of the primary and nested gltA-PCR were 122 bp and 74 bp long respectively. DNA 
of R. conorii, kindly provided by Mahosot Wellcome Trust in Lao PDR, was used as positive 
control (T+). Figure 23 shows the PCR products of primary and nested ompB-PCR on an 
agarose gel. 
 
Previously described sensitivities for both assays range from 1-26 genome copies/μl, 
depending on use of single-template or multiplex PCR (multiplex PCR was shown to 
decrease the sensitivity) [62]. However, by the technique used in this study, the ompB PCR 
showed a detection threshold of approximately 200 genome copies/μl. 
 
Table 8: Primary and nested PCR-primers for ompB-PCR 
Primary PCR-primers Product size  
PF : 5'-TAAAGCTAAAACCACCGGTGTC-3' 
PR : 5'-TTGTTTGCAACTGTTGTACCGG-3' 
444 bp 
Nested PCR-primers  
NPF: 5'-CTCGAGGAATTCGGATCC*CGACGTTAACGGTTTTTCATTCT-3' 
NPR: 5'-TCTAGAAAGCTTGGATCC*ACCGGTTTCTTTGTAGTTTTCGTC-3' 
298 bp 
*tag –sequence, needed for subsequent nucleotide sequencing  
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Table 9: Primary and nested PCR-primers for gltA-PCR 
Primary PCR-primers Product size 
PF : 5'-TCTATAAAGCTATGGGTATACCG-3' 
PR : 5'-TCTGCTGATTTTTTGTTCAGGG-3' 
122 bp 
Nested PCR-primers  
NF : 5'-CTCGAGGAATTCGGATCC*TCGCAAATGTTCACGGTACTTT-3' 
NR : 5'-TCTAGAAAGCTTGGATCC*TCGTGCATTTCTTTCCATTGTG-3' 
74 bp 
*tag –sequence, needed for subsequent nucleotide sequencing  
 
 
Figure 23: OmpB-PCR products of primary PCR (T+PRIM) and nested PCR (T+NEST)  
on an agarose gel. PM: Smart ladder 200 bp (Tara Müller, 2009). 
 
2.3.5.2.4 47kDa nested PCR for detection of Orientia tsutsugamushi DNA 
For the detection of Orientia tsutsugamushi DNA the gene 47kDa outer surface protein or 
antigen, also known as “high temperature requirement A gene”, was chosen as a target. 
This marker was first described in a realtime-PCR assay by Jiang et al. 2004 [98], and was 
later also used in a multiplex realtime-PCR assay for the differentiation of Orientia and 
Rickettsia by Paris et al. 2008 [62]. The primers used for the primary PCR shown in table 10 
were previously described by Paris et al. (47KDA PF/PR), whereas for the nested PCR, the 
primers previously described by Jiang et al. 2004 (47KDA F/R) were chosen, amplifying a 
final product of 118 bp. The detection threshold of this assay was approximately at  
1,000 genome copies/μl. DNA of O. tsutsugamushi reference strain Kato, kindly provided 
by the Virology Unit of IPC, was used as a positive control (T+). Figure 24 shows the PCR 
products of primary and nested PCR on an agarose gel. 
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Table 10: Primary and nested PCR-primers for 47kDa-PCR 
Primary PCR-primers Product size 
PF: 5'-AAGAGGAACAGTAACAAATGGC-3' 
PR: 5'-TACCACGACGAATTTTTTCTCC-3' 
257 bp 
Nested PCR-primers  
NPF: 5'-CTCGAGGAATTCGGATCC*AACTGATTTTATTCAAACTAATGCTGCT-3' 
NPR: 5'-TCTAGAAAGCTTGGATCC*TATGCCTGAGTAAGATACRTGAATRGAATT-3' 
118 bp 
*tag –sequence, needed for subsequent nucleotide sequencing  
 
 
Figure 24: 47kDa-PCR products of primary PCR (T+PRIM) and nested PCR (T+NEST) on an agarose 
gel. PM: Smart ladder 200 bp (Tara Müller, 2009). 
 
2.3.5.3 Reagents and conditions for RT-PCR assays 
2.3.5.3.1 Semi-nested RT-PCR assay for detection of dengue virus 
The testing for dengue virus had been performed by the Department of Virology within IPC. 
The applied semi-nested reverse transcriptase PCR assay (RT-PCR), based on the PrM/E 
gene amplification [67], allows detection and differentiation of all 4 viral serotypes. In the 
first step the extracted viral RNA is converted into a copy-DNA (cDNA) by the enzyme 
reverse transcriptase (Qiagen®, one step RT-PCR kit, reference: 210212) and the primer D2. 
Then Taq-Polymerase and primer D1 were added for amplification of the cDNA under 
conditions as listed in table 11. 
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Table 11: PCR-primers, reagents and conditions for dengue virus RT-PCR 
PCR-primers for dengue RT-PCR 
D1(+): 5’-TCAATATgCTgAAACgCgCgAgAAACCg-3’ 
D2(-): 5’-TTgCACCAACAgTCAATgTCTTCAggTTC-3’ 
Reagents Volume Steps Time Temperature 
H₂0 13.1 μl RT 60 min 45 °C 
5x Buffer 5.0 μl PCR activation 2 min 92 °C 
dNTP (10 mM) 1.0 μl PCR (35 cycles) 30 s 94 °C 
Primer D1 (10 μM) 1.2 μl Annealing 30 s 55 °C 
Primer D2 (10 μM) 1.2 μl Extension 1 min 72 °C 
Qiagen, one step RT-PCR  1.0 μl Final extension 10 min 72 °C 
  Hold ∞ 4 °C 
 
In the following step a semi-nested PCR with 4 serotype-specific primers (TS1bis, TS2, TS3 
and TS4) and primer D1 was performed, primers and conditions are listed in table 12. The 
different size of the final product determines the present serotype. For the RT-PCR-product 
a size of 511 bp demonstrates the general presence of dengue virus in the sample. The 
products of the subsequent semi-nested PCR can be interpreted as demonstrated in figure 
25. The detection threshold of this technique was approximately 100 copies/ml plasma. 
 
Table 12: PCR-primers, reagents and conditions for dengue virus serotype specific PCR 
Dengue serotype specific PCR-primers Product size 
TS1bis(-): 5’-CgTCTCAgTgATCCggggRC-3’ 
TS2(-): 5’-CgCCACAAgggCCATgAACAg-3’ 
TS3(-): 5’-TAACATCATCATgAgACAgAgC-3’ 
TS4(-): 5’-CTCTgTTgTCTTAAACAAgAgA-3’ 
482 bp 
119 bp 
290 bp 
392 bp 
Reagents Volume Steps Time Temperature 
H₂0 28.6 μl PCR activation 5 min 94 °C 
10x Buffer 5.0 μl PCR(25 cycles) 30 s 94 °C 
dNTP (5 mM) 2.0 μl Annealing 30 s 55 °C 
MgCl2 (25 mM) 5.0 μl Extension 1 min 72 °C 
Primer D1 (10 μM) 1.0 μl Final extension 10 min 72 °C 
Primer TS1bis (10 μM) 1.0 μl  ∞ 4 °C 
Primer TS2 (10 μM) 1.0 μl    
Primer TS3 (10 μM) 1.0 μl    
Primer TS4 (10 μM) 1.0 μl    
Taq pol (Promega, 5 u/μl) 1.0 μl    
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Figure 25: Dengue PCR products on agarose gel, showing the specific band of the 4 different 
dengue virus types (DENV1-4). PM: Smart ladder 100 bp (Tara Müller, 2009). 
 
2.3.5.3.2 Multiplex RT-PCR for detection of influenza virus and influenza A subtyping 
For the detection of influenza viruses type A and B, an in-house multiplex reverse 
transcriptase assay, amplifying the M-gene has been used. In the first step a multiplex RT-
PCR has been performed, using the primers listed in table 13. After 40 cycles of PCR 
amplification, products were divided by their size into nucleic acids of influenza B virus 
(DNA band with the size of 365 bp) and nucleic acids of influenza A virus (DNA band with 
the size of 154 bp). Influenza B positive products were confirmed in a second semi-nested 
PCR using the primers B1 and MIB3 (see table 13) [99]. Influenza A virus positive products 
were further distinguished by a using real-time RT-PCR to detect the hemagglutinin and 
neuraminidase genes (H1, N1, H3, and N2). Primers and probes used for the realtime PCR 
are listed in table 13. 
 
2.3.6 Gel electrophoresis 
The PCR products were subsequently partitioned according to their size and visualized by 
gel electrophoresis. A 2.0 % agarose gel (Ultra Pure Agarose®, invitrogen™, Life 
Technologies, reference: 15510-027) with 0.005 % Ethidium-bromide (eurobio®, France, 
reference: GEPBET02) was used. A loading buffer containing 0.25 % bromophenol, 0.25 % 
xylene cyanol blue and 30 % glycerol was added (2 μl for 10 μl of PCR product). 
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Table 13: PCR-primers for the detection of influenza A and B virus 
 Product size Virus subtype 
PCR-primers for RT-PCR to detect influenza A and B viral RNA 
GRAM/7Fw: 5’- CTTCTAACCGAGGTCGAAACGTA -3’ 
GRAM/161Rv: 5’- GGTGACAGGATTGGTCTTGTCTTTA -3’ 
B1: 5’- GAAAAATTACACTGTTGGTTCGGTG -3’ 
B2B: 5’- AGCGTTCCTAGTTTTACTTGCATTGA -3’ 
154 bp 
 
365 bp 
Influenza A 
 
Influenza B 
PCR-primers for semi-nested PCR to differentiate influenza B virus 
B1: 5’- GAAAAATTACACTGTTGGTTCGGTG -3’ 
MIB3: 5’- CATGAAARCTCACACATCT -3’  
260 bp Influenza B 
PCR-primers and probes for real-time PCR to subtype influenza A virus 
H1h-678Fw: 5’-CACCCCAGAAATAGCCAAAA-3’ 
H1h-840Rv: 5’-TCCTGATCCAAAGCCTCTAC-3’ 
H1h-715probe: CAGGAAGGAAGAATCAACTA[5’]Fam[3’]BHQ1 
H3h-177Fw: 5’-GAGCTGGTTCAGAGTTCCTC-3’ 
H3h-388Rv: 5’-GTGACCTAAGGGAGGCATAATC-3’ 
H3h-306probe: TTTTGTTGAACGCAGCAAAG[5’]Fam[3’]BHQ1 
N2h-1150Fw: 5’-GTCCAMACCTAAYTCCAA-3’ 
N2h-1344Rv: 5’-GCCACAAAACACAACAATAC-3’ 
N2h-1290probe: CTTCCCCTTATCAACTCCACA[5’]Fam[3’]BHQ1 
N1h-1134Fw: 5’-TGGATGGACAGATACCGACA-3’ 
N1h-1275Rv: 5’-CTCAACCCAGAAGCAAGGTC-3’ 
N1h-1206probe: CAGCGGAAGTTTCGTTCAACAT[5’]Fam[3’]BHQ1 
163 bp 
 
 
211 bp 
 
 
194 bp 
 
 
142 bp 
Influenza A (H1) 
 
 
Influenza A (H3) 
 
 
Influenza A (N2) 
 
 
Influenza A (N1) 
 
The loaded PCR-products were finally migrated in the gel floating in a Tris-Borate-EDTA–
Buffer (Sigma Aldrich®, USA, reference: T4415-4L) at a voltage of 160 V for 45 minutes. 5 μl 
of DNA Smart Ladder 200 bp (Eurogentec®, Belgium, reference: MW-1700-02) were added 
in each gel as a molecular marker to determine the product’s size. For dengue-PCR 
products a 100 bp DNA smart ladder (Invitrogen™, Life Technologies, reference:  
15628-019) was used. Once the gel was fully migrated, pictures were taken with an  
UV-trans-illuminator (Biorad®, software: Quantity One® version 4.4.0), radiographing the 
gel with ultra-violet light, which makes the position of the PCR-products visible as a 
fluorescent band. The comparison of this band with the one of the according positive 
control and the correct expected size according to the marker gave the final positive or 
negative result. 
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2.3.7 Nucleotide sequence analysis 
2.3.7.1 Nucleotide sequencing and alignments 
Positive nested-PCR-products were sent to Genopole® Paris, France, for double strand 
nucleotide sequencing. Once the nucleotide sequences were sent back to the laboratory 
they were aligned with published reference sequences using NCBI-BLAST® (National Center 
for Biotechnology Information, USA), to determine the organism corresponding to the DNA 
sequence. 
 
2.3.7.2 Analysis of single nucleotide polymorphisms to detect mixed Plasmodium 
infections 
Within the fragment of the cytB gene amplified by the nPCR described earlier, several 
species-specific SNP combinations have been identified by Steenkeste et al., 2009 [95]. The 
analysis of these punctual mutations in the chromatogram with the software CLC Main 
Workbench® version 4.1.2 (CLC bio®, Denmark) allows the identification of the species and 
of mixed infections. Figure 26 shows the chromatograms of 3 nucleotide sequences 
assembled with a cytB reference sequence of P. vivax. C-109CYB-PLAS-2 is positive for  
P. vivax, C-102CYB-PLAS2 positive for P. falciparum, and C-108CYB-PLAS2 is an example for 
a mixed infection of the P. vivax and P. falciparum, which can be recognized by the double 
peaks at the predetermined positions (as an example position 567, 570 and 615 are 
highlighted in figure 26). 
 
2.4 Data processing and statistical analysis 
All of the laboratory data was recorded in a Microsoft Excel® database, including the 
results of microscopy, the PCR- and sequence-analysis results. All the clinical data, recorded 
on designated forms at the health centers, as explained earlier, was forwarded to CNM, 
where the anonymized forms were translated from the Cambodian scripture into English 
and recorded in a Microsoft Access® database. Statistical analysis was performed using the 
program Epi Info™ version 3.5.3 (Centers for Disease Control and Prevention). For the 
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comparison of results between the 2 groups F and N, Chi-square tests have been applied, 
p-values were calculated with the Mantel-Haenszel test [100]. If the sample size was 
smaller than n = 20, p-values were calculated using the Fisher’s exact test [101]. For the 
comparison of means Student’s t-test was applied [102]. Since the distribution of age and 
gender was different in Group F and Group N, the data was stratified by gender (male, 
female) and age (≥ 25 years, < 25 years). The significance level was α = 5.0 % (p < 0.05). 
 
 
Figure 26: Example of 3 nucleotide sequences, assembled with a P. vivax reference sequence.  
C-109CYB-PLAS-2 is positive for P. vivax, C-102CYB-PLAS2 positive for P. falciparum, and  
C-108CYB-PLAS2 is an example for a mixed infection with P. vivax and P. falciparum. The species 
specific peaks are highlighted in orange color (Tara Müller, 2009). 
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3 Results 
3.1 Results overview 
3.1.1 Overview of study population 
In total 1,475 subjects were recruited in the 3 study sites during the study period from 
January 2008-December 2010. The sites C-1 and C-2 recruited 621 and 650 subjects 
respectively, whereas site C-3 only recruited 204 individuals. The subjects were divided in a 
febrile Group F and a non-febrile Group N. Figure 27 shows the distribution of recruitments 
between the sites as well as the percentage of enrolled subjects in the Groups F and N. 
 
 
Figure 27: Number of recruitments per study site (C-1-3) in Group F (blue) and Group N (red). 
 
In the study population 906 subjects were male and 569 were female (ratio: 1.59). In Group 
F the majority (67.1 %) of subjects were male, whereas in Group N the majority (62.8 %) of 
subjects were female, as shown in figure 28. 
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Figure 28: Gender distribution in the total study population, in Group F and Group N 
(M= male; F= female). 
 
Age distribution in the study population, dived by group and gender is shown in figure 29. 
In Group F the median age for males was 22 years (mean 23.6, CI 95% [22.9; 24.3] years) 
and 20 years for females (mean 22.8, CI 95% [21.6; 23.9] years). In Group N the median age 
was higher than in Group F, the median age was 29 years in the male (mean 30.2, CI 95% 
[28.2; 32.3] years) as well as the female group (31.4, CI 95% [29.9; 32.9] years). 
 
 
  N Median [years] Mean [years] CI 95% [years] 
Group F 
Male 801 22 23.6 [22.9; 24.3] 
Female 392 20 22.8 [21.6; 23.9] 
Group N 
Male 105 29 30.2 [28.2; 32.3] 
Female 177 29 31.4 [29.9; 32.9] 
Figure 29: Age distribution in study population, by group and gender. 
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As shown in figure 30, the number of recruitments in Group F was further affected by the 
season. Most febrile subjects were recruited during the rainy season from April to October, 
especially from July to September, the period of the heaviest rainfalls. In site C-3 the 
season had less impact on the number of recruitments, since it was rather low year round. 
 
 
Figure 30: Seasonality of Group F recruitments in the study sites from January 2008 to December 
2010, in total and by site (C-1-3). Rainy season (May-October) marked by red squares. 
 
3.1.2 Overview of results 
A laboratory based diagnosis was established in 73.2 % of the febrile patients in Group F 
(873/1,193). In 58.7 % of all samples 1 pathogen was detected, in 12.3 % 2 pathogens were 
simultaneously detected, in 1.2 % 3 and in 0.1 % even 4 pathogens were detected at the 
same time. In 33.1 % of the samples no pathogen was detected, as shown in table 14. In 
the asymptomatic Group N, 30.5 % had a positive test result for 1 of the investigated 
pathogens, 9.6 % had 2 and 0.4 % had 3 positive test results. Absence of a pathogen was 
significantly more frequent in Group N (p < 0.01), while mono-infections with 1 pathogen 
were significantly higher in Group F (p < 0.01). The presence of multiple positive test results 
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was not significantly more frequent in one of the groups (p = 0.22 for 2 pathogens; p = 0.29 
for 3 pathogens). 
 
Table 14: Number of simultaneously detected pathogens in samples of Groups F and N 
 Total 
(n = 1,475) 
Group F 
(n = 1,193) 
Group N 
(n = 282) 
 
Number of 
pathogens n % n % n % p-value† 
1 pathogen 786  53.3 700  58.7 86  30.5 < 0.01 
2 pathogens 182 12.3 155 13.0 27 9.6 0.22 
3 pathogens 18 1.2 17 1.4 1 0.4 0.29 
4 pathogens 1 0.1 1 0.1 0 0.0 n/a* 
No pathogen found 488 33.1 320 26.8 168 59.6 < 0.01 
Total 1,475 100.0 1,193 100.0 282 100.0  
*n/a: not applicable 
† P-values stratified by age (≥ 25 years/< 25years) and gender (m/f) 
 
The most frequently detected pathogens in the whole study population were P. vivax  
(26.4 %), P. falciparum (20.7 %), pathogenic Leptospira spp. (9.5 %), dengue virus (5.4 %) 
and influenza A virus (5.9 %). Other detected pathogens were O. tsutsugamushi (3.7 %), 
influenza B virus (1.8 %), bacteria from blood culture (Salmonella spp., E. coli,  
S. pneumoniae, E. cloacae) (0.8 %) and SFG-Rickettsia spp. (0.2 %). Table 15 shows an 
overview of the results in Group F and Group N. The frequency of pathogenic Leptospira 
spp., O. tsutsugamushi or influenza B virus was not different in Group F and Group N  
(p-values > 0.05), whereas the detection of Plasmodium spp., dengue virus and influenza A 
virus was significantly more frequent in Group F (p-values ≤ 0.01). 
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Table 15: Overview of detected pathogens in the study population 
 
Total 
(n = 1,475) 
Group F 
(n = 1,193) 
Group N 
(n = 282) 
 
Detected pathogen n % n % n % p-value† 
Plasmodium spp. 754 51.1 676 56.7 78 27.7 < 0.01 
   P. vivax 389 26.4 359 30.1 30 10.6 < 0.01 
   P. falciparum 306 20.7 277 23.2 29 10.3 < 0.01 
   P. vivax + falciparum 56 3.8 39 3.3 17 6.0 0.07 
   P. ovale 1 0.1 0 0.0 1 0.4 n/a 
   P. knowlesi 2 0.1 1 0.1 1 0.4 n/a 
Pathogenic Leptospira spp. 140 9.5 112 9.4 28 9.9 0.42 
   L. interrogans 85 5.8 61 5.1 24 8.5 0.20 
   L. weilii 47 3.2 44 3.7 3 1.1 0.08 
   L. kmetyi 3 0.2 2 0.2 1 0.4 n/a 
   L. kirschnerii 1 0.1 1 0.1 0 0.0 n/a 
   L .santosaraii 1 0.1 1 0.1 0 0.0 n/a 
   L. genomospecies1 1 0.1 1 0.1 0 0.0 n/a     
   L. wolffii 1 0.1 1 0.1 0 0.0 n/a 
   L. noguchii 1 0.1 1 0.1 0 0.0 n/a 
O. tsutsugamushi 54 3.7 47 3.9 7 2.5 0.48 
Rickettsia spp. 3 0.2 2 0.2 1 0.4 n/a 
Dengue virus 1-4* 80 5.4 75 6.3 5 1.8 0.01 
Influenza A virus 87 5.9 83 7.0 4 1.4 0.01 
Influenza B virus 26 1.8 23 1.9 3 1.1 0.77 
Cultured bacteria** 9 0.8 9 0.8 - - n/a 
*For dengue virus testing only 1,468 samples were available 
**From 1,132 blood cultures: 1 S. typhi and 1 S. paratyphi, 1 E. coli,1 S. pneumoniae, 5 E. cloacae 
† P-values stratified by age (≥ 25 years/< 25years) and gender (m/f); n/a not applicable 
 
Analysis of the CRP concentrations in plasma samples of Group F and N subjects showed 
that in Group F 81.3 % of patients had an elevated CRP level (≥ 5 mg/l), whereas in Group N 
only 25.2 % had an elevated level (p < 0.01), as shown in figure 31. Table 16 shows that the 
mean CRP concentration in samples of Group F was 48.6 mg/l (CI 95 % [45.2; 52.0]), 
whereas in Group N it was 9.9 mg/l (CI 95 % [6.5; 13.3]) (p < 0.01, Student’s t-test). 
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Figure 31: CRP concentrations in Groups F and N. On the left: Percentage of subjects with 
elevated CRP concentration (≥ 5.0 mg/l) [%]. On the right: Mean CRP concentrations [mg/l]. 
 
Table 16: CRP concentrations in plasma samples of Groups F and N 
 Subjects Elevated CRP Mean CRP [CI 95 %]* Range CRP Median CRP 
 n n (%) mg/l mg/l mg/l 
Group F 1,193 970 (81.3) 48.6 [45.2;52.0] 0.2 - 389.6 25.7 
Group N 282 71 (25.2) 9.9 [6.5;13.3] 0.1 -235.9 1.4 
*Mean-CRP of Group F and Group N compared with Student’s t-test p < 0.01. 
 
The CRP concentrations were further grouped into “not elevated” (< 5.0 mg/l), “elevated” 
(5.0-50.0 mg/l) and “highly elevated” (> 50.0 mg/l) and compared in 4 different categories 
of detected infections (malaria parasites, bacterial infections, viral infections and multiple 
infections), shown in table 17. The mean CRP concentration in viral infections was  
12.5 mg/l (CI 95 % [10.1; 14.9]), which was significantly lower than in every other group  
(p < 0.01). 
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Table 17: CRP concentrations in different groups of detected pathogens 
CRP concentration 
[mg/l] 
Malaria parasites 
[n] 
Bacteria 
[n] 
Viruses 
[n] 
Multiple pathogens 
[n] 
< 5.0 (not elevated) 104 31 39 33 
5.0-50.0 (elevated) 259 47 75 84 
> 50.0 (highly elevated) 250 28 3 34 
Total 613 106 117 151 
Mean CRP 
concentration* 
[CI 95 %] 
57.0 
[52.4;61.7] 
mg/l 
47.7 
[34.9;60.4] 
mg/l 
12.5 
[10.1;14.9] 
mg/l 
39.4 
[29.7;49.0] 
mg/l 
*Student’s t-test results: Malaria vs. bacteria (p = 0.14), malaria vs. virus (p < 0.01), malaria vs. multiple  
(p = 0.01), virus vs. bacteria (p < 0.01), virus vs. multiple (p < 0.01), bacteria vs. multiple (p = 0.31). 
 
3.2 Details of detected pathogens 
3.2.1 Malaria parasites 
3.2.1.1 PCR results 
The cytB nested-PCR, followed by nucleotide sequencing and SNP-analysis, was considered 
as the gold standard for malaria diagnosis in this study. As shown in table 18, 56.7 % of the 
Group F subjects had a positive test result for malaria by this PCR. This was significantly 
more common than in the asymptomatic Group N, in which 27.7 % had a positive test 
result (p < 0.01). The nucleotide sequencing results revealed that the predominant species 
in this study population was P. vivax (51.6 %) followed by P. falciparum (40.6 %). Both 
Plasmodium spp. were statistically more frequently detected in Group F than in Group N  
(p < 0.01). In 7.4 % of the positive samples there was evidence of a mixed-infection with 
both Plasmodium falciparum and vivax, which was not significantly more common in one 
or the other group (p = 0.07). For the first time ever in Cambodia, 2 human cases of the 
emerging simian malaria parasite P. knowlesi were detected, one of them in Group N, the 
other one in Group F. P. ovale was found only once (in Group N) and P. malariae was not 
detected at all in the investigated study population. 
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Table 18: CytB-nPCR and nucleotide sequencing results in Groups F and N 
CytB-nPCR- results 
 
Total Group F Group N  
CytB-PCR-result n % n % n % p-value† 
Negative 721 48.9 517 43.3 204 72.3 <0.01 
Positive 754 51.1 676 56.7 78 27.7 <0.01 
Total 1475 100.0 1193 100.0 282 100.0  
Nucleotide sequencing results of positive PCR products 
 Total Group F Group N  
Nucleotide 
sequencing 
result* 
n % n % n % p-value† 
PF 306 40.6 277 41.0 29 37.2 <0.01 
PV 389 51.6 359 53.1 30 38.5 <0.01 
PF/PV 56 7.4 39 5.8 17 21.7 0.07 
PK 2 0.3 1 0.1 1 1.3 n/a 
PO 1 0.1 0 0.0 1 1.3 n/a 
Total 754 100.0 676 100.0 78 100.0  
*PF = P. falciparum, PV= P. vivax, PK= P. knowlesi, PO= P. ovale 
† P-values stratified by age (≥ 25 years/< 25years) and gender (m/f). n/a not applicable. 
 
Table 19 shows the infection status of malaria parasites in Groups F and N. Mono-infection 
with only one kind of malaria parasite was  significantly more frequently detected in Group 
F than in Group N (p < 0.01). It was observed that, when looking at mixed malaria infections 
(P. falciparum + P. vivax), without any other simultaneously detected pathogens, they were 
even more frequent in Group N than in Group F (p = 0.02). The detection of a second 
pathogen additional to the malaria parasites was more common in Group F (19.6 %) than in 
Group N (11.5 %) (p < 0.01). 
 
Figure 32 shows which pathogens were simultaneously detected with malaria parasites. By 
frequency in descending order, these pathogens were Leptospira spp. (n = 58), influenza 
viruses (n = 31), dengue virus (n = 29), O. tsutsugamushi (n = 14) and bacteria from blood 
culture (n = 2)). In 8 cases 2 of the above mentioned pathogens were found simultaneously, 
in addition to the malaria parasites. 
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Table 19: Malaria parasite detection status in Groups F and N 
 Total Group F Group N  
Detection status n % n % n % p-value† 
Mono -malaria 568 75.3 515 76.2 53 67.9 < 0.01 
Mixed malaria 44 5.8 28 4.1 16 20.5 0.02 
Malaria + other 
pathogen(s) 142 18.8 133 19.6 9 11.5 < 0.01 
Total 754 100.0 676 100.0 78 100.0 - 
† P-values stratified by age (≥ 25 years/< 25years) and gender (m/f). 
 
 
Figure 32: Simultaneously detected pathogens with malaria parasites in the study population. Of 
754 subjects with positive malaria PCR, 612 subjects had malaria parasites only (single or mixed 
infections). In the remaining 142 subjects malaria parasites were simultaneously detected with 
pathogenic Leptospira spp., dengue virus, influenza virus or O. tsutsugamushi.  
In 8 cases, 3 pathogens were detected simultaneously. 
 
3.2.1.2 Microscopy and RDT results 
By microscopy 33.9 % (501/1,475) of all slides were positive for malaria parasites. The 
detected species were 52.9 % P. vivax, 32.9 % P. falciparum, 12.7 % mixed P. falciparum 
with P. vivax, and 0.7 % mixed P. falciparum with P. malariae, 0.2 % P. malariae and 0.1 % 
P. ovale. The majority of positive slides (486/501) were detected in Group F, whereas only 
15 positive slides were detected in Group N. By RDT, 26.0 % (383/1,475) of all tested 
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persons were positive for malaria parasites, 43.0 % of which were P. falciparum, 36.5 % 
were non-falciparum and 20.3 % were mixed Plasmodium infections. All of the positive RDT 
results were detected in Group F only. Figure 33 shows the performances of RDT and 
microscopy compared to the cytB-PCR in Group F (figure 33A) and Group N (figure 33B). 
 
 
Figure 33: Comparison of the performance of different diagnostic tests for malaria in Group F (A) 
and Group N (B). (*Pf = P. falciparum, including mixed infections with P. falciparum and  
Non-falciparum; **Non-Pf = P. vivax, P. ovale, P. knowlesi). 
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Table 20 shows the detailed results of microscopy and RDT compared to the results of the 
cytB-PCR. For the detection of any malaria parasite in Group F the sensitivity for 
microscopy was 71.3 %, the specificity was 99.2 %. In the asymptomatic Group N where 
parasite density was low (see also table 21) sensitivity was only 19.2 %, whereas specificity 
was 100.0 %. For any P. falciparum detection (single or mixed), the sensitivity of 
microscopy was 59.5 % in Group F and only 2.2 % in Group N. The specificity for  
P. falciparum detection only, was 99.5 % in Group F and 100.0 % In Group N. 
 
RDTs showed a sensitivity of 55.6 % and a specificity of 98.6 % for the detection of any 
malaria parasite in Group F. In Group N no RDT was positive. For the detection of any  
P. falciparum RDTs showed a sensitivity of 58.9 % and a specificity of 99.4 %. 
 
Table 20: Comparison of results of 3 malaria diagnostic methods in Groups F and N 
  Microscopy RDT* 
 cytB nPCR* 
N PF PV PM PO PF/V PF/M N PF N-PF Mix 
Group F 
N 517 513 4 - - - - - 510 4 2 1 
PF 277 66 134 30 2 - 41 4 89 113 12 63 
PV 359 105 17 215 - 1 21 - 183 42 124 10 
PF/V 39 22 7 8 - - 2 - 27 6 2 4 
PK 1 1 - - - - - - 1 - - - 
PO 0 - - - - - - - 0 - - - 
Group N 
N 204 204 - - - - - - - - - - 
PF 29 24 1 4 - - - - - - - - 
PV 30 25 1 4 - - - - - - - - 
PF/V 17 14 - 3 - - - - - - - - 
PK 1 - 1 - - - - - - - - - 
PO 1 - - 1 - - - - - - - - 
Total  1,475 974 165 265 2 1 64 4 1,092 165 140 78 
* N = Negative, PF = P. falciparum, PV = P. vivax, PM = P. malariae, PO = P. ovale, PK = P. knowlesi,  
N-PF = Non-P. falciparum, Mix= Non-P. falciparum and P. falciparum 
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Microscopically evaluated parasite densities for P. falciparum mono-infections ranged from 
10-364,000 parasites/µl blood, and from 10-116,533 parasites/µl blood for P. vivax mono-
infections. Details of parasite densities regarding the status of infection are shown in table 
21. It was observed that the mean level of parasite density was highest in mono-infections 
(26,031.8 parasites/µl blood CI 95% [20,175.8; 31,887.9] for P. falciparum and  
9,474.6 parasites/µl blood CI 95% [7,680.1; 11,269.0] for P. vivax) and lowest in the 
asymptomatic subjects of Group N (2,414.6 parasites/µl blood CI 95% [0; 5,431.0] for  
P. falciparum and 758.2 parasites/µl blood CI 95% [0; 1,774.1] for P. vivax). 
 
Table 21: Malaria parasite densities by microscopy regarding infection status 
[parasites/µl blood] 
 P. falciparum P. vivax 
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Number 
of slides 160 16 16 5 5 208 24 10 5 
Range of 
parasite 
count 
[p/µl] 
10 – 
364,000 
48 – 
160,000 
9 – 
 80,000 
15 – 
10,200 
9 – 
 8,967 
10 – 
116,533 
60 – 
39,882 
22 – 
13,333 
125 – 
3,075 
Mean 
parasite 
count 
[p/µl] 
26,031.8 18,168.0 8,138.8 2,113.0 2,414.6 9,474.6 6,779.5 3,925.1 758.2 
CI 95%  20,175.8 0 0 0 0 7,680.1 3,039.7 1,230.8 0 
 
31,887.9 38,049.5 17,783.7 5,657.5 5,431.0 11,269.0 10,519.4 6,619.4 1,774.1 
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3.2.2 Leptospira species 
In Group F, 11.4 % (136/1,193) of the samples showed a positive test result for the 
Leptospira 16ssRNA-nPCR. Interestingly, in Group N 11.0 % (31/282) had a positive test 
result, too (p = 0.72). The results of PCR and nucleotide sequencing are shown in table 22. 
Of the 167 positive PCR products, 140 (83.8 %) were identified as DNA from pathogenic 
Leptospira spp. (L. interrogans, L. weilii, L. kirschnerii, L. noguchii, L. santarosai,  
L. genomospecies1) and intermediate Leptospira spp. (L. wolffii, L. kmetyi) by nucleotide 
sequencing. The remaining 27 (16.2 %) PCR-products were identified as DNA of the non-
pathogenic saprophyte L. parva. In total, L. interrogans was the most common species 
(50.9 %) followed by L. weilii (28.1 %), none of which was more frequent in Group F or N  
(p > 0.05). 
 
Table 22: 16SrRNA-nPCR and nucleotide sequencing results in Groups F and N 
16SrRNA-nPCR-results 
 
Total Group F Group N  
Result n % n % n % p-value† 
Negative 1,308 88.7 1,057 88.6 251 89.0 0.72 
Positive 167 11.3 136 11.4 31 11.0 0.72 
Total 1,475 100.0 1,193 100.0 282 100.0  
Nucleotide sequencing results of positive PCR products 
 
Total Group F Group N  
Result n % n % n % p-value† 
L. parva (non-pathogenic) 27 16.2 24 17.6 3 9.7 0.42 
L. interrogans  85 50.9 61 44.9 24 77.4 0.20 
L. weilii 47 28.1 44 32.4 3 9.7 0.08 
L. kmetyi* 3 1.8 2 1.5 1 3.2 n/a 
L. kirschnerii 1 0.6 1 0.7 0 0.0 n/a 
L. noguchii 1 0.6 1 0.7 0 0.0 n/a 
L. santarosai 1 0.6 1 0.7 0 0.0 n/a 
L. wolffii* 1 0.6 1 0.7 0 0.0 n/a 
L. genomospecies1 1 0.6 1 0.7 0 0.0 n/a 
(Total pathogenic L.spp.) (140) (83.8) (112) (82.4) (28) (90.3) 0.42 
Total 167 100.0 136 100.0 31 100.0  
*Belong to the Leptospira spp. of intermediate pathogenicity 
† P-values stratified by age (≥ 25 years/< 25years) and gender (m/f) 
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Leptospira spp. were frequently detected simultaneously with various other pathogens, as 
is shown in table 23. The detection of Leptospira as the only pathogen was not significantly 
more frequent in Group F or Group N (p = 0.15). Simultaneous detection of a second 
pathogen was especially common with P. vivax and P. falciparum. In 10 cases Leptospira 
have been observed with 2 other simultaneous pathogens, all with either P. vivax or  
P. falciparum and a third pathogen (O. tsutsugamushi, dengue virus or influenza virus). 
 
Table 23: Pathogenic Leptospira spp. detection status in Groups F and N 
 Total Group F Group N  
Detection status n % n % n % p-value† 
Mono-detection 64  45.7 45 40.2 19 67.8 0.15 
Leptospira + other 
pathogen(s) 76 54.3 67 59.8 9 32.2 0.15 
Total 140 100.0 112 100.0 28 100.0  
† P-values stratified by age (≥ 25 years/< 25years) and gender (m/f) 
 
3.2.3 Rickettsia species 
The detection of rickettsial DNA in the given study setting was problematic. The results 
obtained with the 2 nested PCR essays (ompB and gltA) were not consistently reproducible. 
Subsequently an exchange of DNA samples with the study partners of the Wellcome Trust 
in Vientiane, Lao PDR was arranged for external quality control, which revealed problems 
with the quality of the stored DNA-samples from Cambodia. It is likely that the method of 
DNA extraction from frozen packed blood cells only provided very low concentrations of 
rickettsial DNA, at the detection limits of the assays. Furthermore, it is probable that the 
repeated thawing of the extracted DNA added to a degradation of its quality and thus 
made it difficult to reproduce the results. Moreover, the nucleotide sequencing of the very 
short gltA-PCR-product (74 bp) was infrequently successful. In an attempt to improve the 
results a realtime PCR strategy was employed (Paris et al., 2008). Using this protocol, it was 
not possible to detect any of the previously positive samples, even though valid data was 
acquired with the positive controls (DNA of R. conorii and R. typhii from Lao PDR). In 
conclusion, the approach used in this study was not adequate for the difficult diagnostic of 
rickettsial infections. Nevertheless, in 3 cases the gltA-nPCR was confirmed in a second run. 
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3.2.4 Orientia tsutsugamushi 
The nested PCR for the 47kDa-gene of O. tsutsugamushi was positive in 3.7 % of all samples 
(54/1,475). There was no significant difference between the prevalence in Group F (3.9 %) 
and Group N (2.5 %), as shown in table 24 (p = 0.48). In 16 cases a second pathogen  
(5 P. falciparum, 7 P. vivax, 3 Leptospira spp., 1 E. cloacae) was detected simultaneously to  
O. tsutsugamushi. In 6 cases, 2 additional pathogens were detected (1 P. vivax with 
influenza virus, 1 P. vivax with P. falciparum, 1 P. vivax with Leptospira spp., 3 P. falciparum 
with Leptospira spp.) and in 1 case even 3 simultaneous pathogens were identified  
(P. vivax, P. falciparum and dengue virus type 4). Table 25 shows the status of detection of 
O. tsutsugamushi, alone or with other pathogens. Neither status was significantly more 
common in one of the 2 study groups (p = 0.92). 
 
Table 24: 47kda-PCR and nucleotide sequencing results in Groups F and N 
47kDa-nPCR + 
nucleotide 
sequencing result 
Total Group F Group N  
n  % n  % n  % p-value† 
Negative 1421 96.3 1146 96.1 275 97.5 0.48 
O. tsutsugamushi 54 3.7 47 3.9 7 2.5 0.48 
Total 1475 100.0 1193 100.0 282 100.0  
† P-values stratified by age (≥ 25 years/< 25years) and gender (m/f) 
 
Table 25: O. tsutsugamushi detection status in Groups F and N 
 Total Group F Group N  
Detection status n %  n % N % p-value† 
Mono-detection 31 57.4 25 53.2 6 85.7 0.92 
O. tsutsugamushi + 
other pathogen(s) 23 42.6 22 46.8 1 14.3 0.92 
Total 54 100.0 47 100.0 7 100.0  
† P-values stratified by age (≥ 25 years/< 25years) and gender (m/f) 
 
3.2.5 Dengue virus 
Of 1,473 tested samples 5.4 % had a positive test result in the multiplex RT-PCR essay for 
dengue virus. As shown in table 26, 6.3 % of Group F subjects had a positive test result, 
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which was significantly more frequent than in Group N, in which 1.8 % of test results were 
positive (p = 0.01). 
 
Table 26: Multiplex dengue virus RT- and serotype-specific PCR results 
Dengue RT-PCR result 
 Total Group F Group N  
Results N % n % n % p-value† 
Negative 1,393 94.6 1,117 93.7 276 98.2 0.01 
Positive 80 5.4 75 6.3 5 1.8 0.01 
Total 1,473 100.0 1,192 100.0 281 100.0 
 
Serotype-specific PCR results 
 Total Group F Group N  
Results N % n % n % p-value† 
DENV- 1 22 27.5 21 28.0 1 20.0 0.23 
DENV- 1 and -2 1 1.2 1 1.3 0 0.0 n/a 
DENV- 2 44 55.0 41 54.6 3 60.0 0.09 
DENV- 3 5 6.3 4 5.3 1 20.0 0.77 
DENV- 4 8 10.0 8 10.6 0 0.0 0.38 
Total 80 100.0 75 100.0 5 100.0 
 
† P-values stratified by age (≥ 25 years/< 25years) and gender (m/f); n/a not applicable 
 
Overall; the most prevalent serotype was DENV-2 (55.0 %) followed by DENV-1 (27.5 %), 
DENV-4 (10.0 %) and DENV-3 (6.3 %). In 1 sample DENV-1 and -2 were detected 
simultaneously. Dengue viruses were also detected simultaneously with other pathogens, 
particularly with malaria parasites (6 P. falciparum, 21 P. vivax, 4 both), but also with 
Leptospira spp. (n = 5) and influenza A virus (n = 1). 
 
3.2.6 Influenza virus 
Of 1,475 tested throat-swab samples 7.7 % were positive for influenza virus (5.9 %  
influenza A virus, 1.8% influenza B virus). Further sub-typing of influenza A viruses by  
real-time PCR was conducted on 58 out of 87 samples and revealed that type H3N2 was the 
most prominent sub-type (35.6 %), followed by H1N1 (28.7 %) and H3N3 (2.3 %). As shown 
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in table 27, the prevalence of influenza viruses was significantly higher in the Group F than 
in the Group N (p < 0.01). Influenza A virus was more frequently detected in Group F  
(7.0 %) than in Group N (1.4%) (p = 0.01). Influenza B virus was not significantly more 
commonly detected in one group (Group F 1.8 %, Group N 1.1 %) (p = 0.77). 
 
Table 27: Influenza virus RT-PCR and influenza A sub-typing results in Groups F and N 
Influenza virus RT-PCR results 
 Total Group F Group N  
Results n % n % n % p-value† 
Negative 1,362 92.3 1,087 91.1 275 97.5 <0.01 
Influenza B 26 1.8 23 1.9 3 1.1 0.77 
Influenza A 87 5.9 83 7.0 4 1.4 0.01 
Total 1,475 100.0 1,193 100.0 282 100.0  
Influenza A sub-typing real-time PCR results 
 Total Group F Group N  
Results N % n % n % p-value† 
Subtype H1N1 25 28.7 24 28.9 1 25.0 0.18 
Subtype H3N2 31 35.6 31 37.3 0 0.0 0.05 
Subtype H3N3 2 2.3 2 2.4 0 0.0 n/a 
No sub-typing 29 33.3 26 31.3 3 75.0  
Total 87 100.0 83 100.0 4 100.0 
 
† P-values stratified by age (≥ 25 years/< 25years) and gender (m/f), n/a not applicable 
 
3.2.7 Bacteria from blood culture 
The Bacteriology Unit at IPC evaluated 1,128 blood cultures from the 1,193 febrile patients 
in this study. In 65 cases no blood culture bottles were available in the field. The results are 
presented in table 28. Positive bacterial growth was observed in 9.5 % of the bottles, but in 
8.7 % of these only floral bacteria, likely to be contamination, were identified  
(Staph. non-aureus, Corynebacteria spp., Polymicrobical flora, Pseudomonas fluorescens 
and Pseudomonas putida). The growth of pathogenic bacteria was only observed in 9 cases  
(0.8 %) of these bottles and was considered as evidence of community acquired septicemia 
(CAS). Among these patients, the bacteria identified included S. pneumoniae (n = 1), E. coli 
(n = 1), E. cloacae (n = 5), S. typhi (n = 1) and S. paratyphi (n = 1). In 2 cases CAS (E. cloacae 
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and S. paratyphi) was associated with P. vivax. These results were immediately reported 
back to the health center, which was thus able to contact the patient and prescribe the 
corresponding treatment. 
 
Table 28: Blood culture results after 1 week of incubation (Group F only) 
Blood culture result n % 
Negative 1,021 90.5 
Positive 107 9.5 
Total number of blood cultures  1,128 100.0 
Growth of pathogenic bacteria 
Streptococcus pneumoniae 1 0.1 
Enterobacter cloacae 5 0.4 
Escherichia coli 1 0.1 
Salmonella paratyphi 1 0.1 
Salmonella typhi 1 0.1 
Total 9 0.8 
Growth of bacteria considered as contamination 
Staphylococcus non-aureus 53 4.7 
Corynebacteria spp. 38 3.4 
Polymicrobical flora 5 0.4 
Pseudomonas fluorescens 1 0.1 
Pseudomonas putida 1 0.1 
Total  98 8.7 
 
3.2.8 Established diagnoses of malaria-RDT negative fever cases 
Upon consideration of the malaria RDT results in this study, illustrated in figure 34, one can 
see that only 32.1 % of the 1,193 febrile patients were malaria-RDT positive and 67.9 % 
were RDT-negative. In 37.0 % of these RDT-negative cases malaria parasites were detected 
using cytB-PCR as diagnostic method. Of these PCR-positive samples 43.6 % were identified 
as P. vivax, 32.0 % Plasmodium spp. plus a second pathogen (which means mostly low 
malaria-parasitemia), 18.3 % P. falciparum and 6.0 % mixed or other Plasmodium spp.  
(P. knowlesi, P. ovale). In 24.9 % of the RDT-negative cases, that were also negative for 
malaria by PCR, another pathogen was detected in the blood sample, namely influenza 
viruses (32.7 %), pathogenic Leptospira spp. (22.3 %), dengue virus (20.7 %),  
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O. tsutsugamushi (12.4 %), and in 11.9 % there was evidence of multiples of the above 
mentioned pathogens or CAS. In the remaining 38.1 % of the RDT-negative cases no 
pathogen could be detected, which indicates the need of further testing (see also 
discussion point 4.4.2). 
 
 
Figure 34: Study results dependant on malaria-RDT-status. In green: RDT positive cases (32.1 %); 
In red: RDT-negative cases (67.9 %) and the corresponding PCR results. 
 
3.3 Seasonal and geographical distribution of detected pathogens 
3.3.1 Seasonal trends 
Some of the detected pathogens, like malaria parasites or dengue virus, showed distinct 
seasonal patterns in their prevalence, whereas others (like Leptospira spp.) seem to be 
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equally present year round. As shown in figure 35, the highest numbers of malaria 
parasites were detected during the rainy season from July to September, when the 
breeding conditions for the vector (Anopheles dirus) are optimal. Furthermore, an overall 
decrease of malaria case numbers can be observed, from 302 cases in 2008 and 301 cases 
in 2009, to 122 cases in 2010. 
 
 
Figure 35: Seasonal prevalence of Plasmodium spp. prevalence in the study population from 
January 2008 to December 2010 (Pv = P. vivax, Pf = P. falciparum, Po = P. ovale, Pk = P. knowlesi). 
 
Concordant with the national surveillance data, an annual epidemic wave of dengue virus 
can be clearly distinguished, with an increase of case numbers annually from May to 
October shown in figure 36. For influenza viruses the seasonal trend was also concordant 
with the national surveillance data, with an annual increase in prevalence from October to 
January as shown in figure 37. 
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Figure 36: Seasonal prevalence of dengue virus in the study population from January 2008 to 
December 2010. 
 
 
Figure 37: Seasonal prevalence of influenza virus A and B in the study population from January 
2008 to December 2010. 
 
For pathogenic Leptospira spp. there was no particular seasonal trend observable, 
indicating that they are present year round. The peaks shown in figure 38 could indicate 
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small regional outbreaks. Similarly, O. tsutsugamushi and Rickettsia spp. did not show any 
particularities in their seasonal prevalence. 
 
 
Figure 38: Seasonal prevalence of pathogenic and non-pathogenic Leptospira spp. (L. spp.) in the 
study population from January 2008 to December 2010 
 
3.3.2 Geographical distribution 
As explained above, 2 of the study sites were chosen in western Cambodia (site C-1 and  
C-2), whereas the third one was located in eastern Cambodia (site C-3). The sites C-1 and  
C-2 recruited 621 and 650 subjects respectively, whereas site C-3 in Snoul recruited only 
204 individuals. The comparison of the distribution of malaria parasites between the 3 
sites, shown in figure 39, revealed that site C-1 showed the lowest percentage of malaria 
positive cases, whereas the highest percentage was detected in site C-3 (p< 0.01). In sites 
C-1 and C-2 P. vivax was more prevalent compared to site C-3, where P. falciparum 
accounted for the majority of positive cases (p < 0.01). Interestingly, site C-3 is located in a 
province classified as low-transmission-area for malaria, whereas sites C-1 and C-2 are 
located in an area of high transmission. Both of the detected P. knowlesi positive samples 
came from site C-2, the only P. ovale positive sample from site C-3. 
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Figure 39: Geographical distribution of malaria parasite prevalence and species (Pv = P. vivax,  
Pf = P. falciparum, Po = P. ovale, Pk = P. knowlesi) in the 3 study sites (C-1-3). 
  
As shown in figure 40, the prevalence of Leptospira spp. was around 10.0 % in all of the 3 
study sites (p = 0.42). Some differences could be observed in the species distribution. In 
site C-3 L. interrogans was the uniquely detected species, whereas most of the less 
frequent species (L. wolffii, L. santosaraii, L. kirschnerii, L. genomospecies1, L. kmetyi and  
L. noguchii) were detected in site C-1 only (p < 0.01). The non-pathogenic saprophyte  
L. parva was detected in 27 samples, most of them from site C-1 (p < 0.01). 
 
The distribution of dengue virus was similar in the 3 sites (p = 0.57) as shown in figure 41. 
However, it was observed that in site C-3 no dengue virus serotype 4 was detected and 
that in all 3 sites dengue virus serotype 2 was the most frequently detected serotype. 
There were no statistically significant differences in the serotype distribution between the 
3 sites (DENV-1 p = 0.78, DENV-2 p = 0.08, DENV-3 p = 0.40, DENV-4 p = 0.08). 
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Figure 40: Geographical distribution of Leptospira prevalence and species distribution in the  
3 study sites (C-1-3). 
 
 
Figure 41: Geographical distribution of dengue virus prevalence and serotypes (dengue 1-4) in the 
3 study sites (C-1-3). 
 
Influenza viruses were most frequently detected in site C-1 (p < 0.01), as shown in figure 
42. In C-1 over 80.0 % of the detected influenza viruses were influenza A viruses, whereas 
in C-3 almost 50.0 % were influenza B (p = 0.04). Since the sub-typing was not available for 
all detected influenza A viruses it is not possible to compare the distribution of subtypes 
between the 3 study sites.  
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Figure 42: Geographical distribution of influenza virus prevalence and virus subtype distribution 
in the 3 study sites (C-1-3). 
 
3.4 Association of laboratory results with clinical findings 
3.4.1 Fever and additional symptoms 
The mean duration of fever in the Group F was 2.6 days (range 1-10 days) and the mean 
fever temperature was 38.8 °C (range 37.8-42.2 °C), as shown in figure 43 (left). The most 
frequently reported symptoms in addition to fever were sore throat (41.7 %), cough  
(39.9 %), running nose (17.6 %), diarrhea (15.4 %) and vomiting (14.4 %), as shown in figure 
43 (right). Table 29 shows the recorded symptoms corresponding to the pathogens 
detected in the laboratory. Respiratory symptoms like cough, sore throat and running nose 
were significantly more frequent when influenza virus A or B was detected. Other than 
that, no statistically significant difference of the distribution of symptoms was observed for 
the different pathogens detected by PCR. 
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Figure 43: Left: Number of cases by measured body temperature [°C] in study population; 
Right: Frequency of additional symptoms to the fever [%]. 
 
Table 29: Recorded clinical symptoms matched with the different pathogens detected in 
the laboratory (Group F only) 
 
 
Clinical symptoms 
(multiple response was possible) 
 
 
Cough Sore throat 
Running 
nose Diarrhea Vomiting 
Pain 
Urinating Rash 
Ear- 
Ache 
La
bo
ra
to
ry
 re
su
lt 
Malaria 
parasites 
(n = 676) 
37.7 % 
[34.1; 
41.4] 
(n = 255) 
38.5 % 
[34.8; 
42.1] 
(n = 260) 
17.5 % 
[14.6; 
20.3] 
(n = 118) 
18.3 % 
[15.4; 
21.3] 
(n = 124) 
15.1 % 
[12.4; 
17.8] 
(n = 102) 
3.0 % 
[1.7;  
4.2] 
(n = 20) 
1.2 % 
[0.4; 
 2.0] 
(n = 8) 
3.8 % 
[2.4; 
 5.3] 
(n = 26) 
Pathogenic  
Leptospira  
(n = 111) 
40.5 % 
[31.4; 
49.7] 
(n = 45) 
51.4 % 
[42.1; 
60.6] 
(n = 57) 
20.7 % 
[13.2; 
28.3] 
(n = 23) 
18.9 % 
[11.6; 
26.2] 
(n = 21) 
20.7 % 
[13.2; 
28.3] 
(n = 23) 
2.7 % 
[0.0; 
5.7] 
(n = 3) 
0.9 % 
[0.0; 
2.7] 
(n = 1) 
3.6 % 
[0.1; 
 7.1] 
(n = 4) 
O. tsutsu-
gamushi 
(n = 47) 
57.4 % 
[43.3; 
71.6] 
(n = 27) 
55.3 % 
[41.1; 
69.5] 
(n = 26) 
19.1 % 
[7.9; 
30.4] 
(n = 9) 
36.2 % 
[22.4; 
49.9] 
(n = 17) 
19.1 % 
[7.9; 
30.4] 
(n = 9) 
4.3 % 
[0.0; 
 10.0] 
(n = 2) 
2.1 % 
[0.0; 
6.3] 
(n = 1) 
12.8 % 
[3.2; 
22.3] 
(n = 6) 
Dengue 
 virus 
(n = 75) 
37.3 % 
[26.4; 
48.3] 
(n = 28) 
53.3 % 
[42.0; 
64.6] 
(n = 40) 
20.0 % 
[10.9; 
29.1] 
(n = 15) 
29.3 % 
[19.0; 
39.6] 
(n = 22) 
24.0 % 
[14.3; 
33.7] 
(n = 18) 
2.7 % 
[0.0;  
6.3] 
(n = 2) 
2.7 % 
[0.0; 
6.3] 
(n = 2) 
2.7 % 
[0.0; 
 6.3] 
(n = 2) 
Influenza A  
or B virus 
(n = 106) 
87.7 % 
[81.5; 
94.0] 
(n = 93) 
88.7 % 
[82.6; 
94.7] 
(n = 94) 
51.9 % 
[42.4; 
61.4] 
(n = 55) 
10.4 % 
[4.6; 
16.2] 
(n = 11) 
19.8 % 
[12.2; 
27.4] 
(n = 21) 
3.8 % 
[0.1; 
 7.4] 
(n = 4) 
3.8 % 
[0.1;  
7.4] 
(n = 4) 
11.3 % 
[5.3; 
17.4] 
(n = 12) 
Cultured 
bacteria 
(n = 9) 
33.3 % 
[2.5; 
64.1] 
(n = 3) 
55.6 % 
[23.1; 
88.0] 
(n = 5) 
11.1 % 
[0.0; 
31.6] 
(n = 1) 
22.2 % 
[0.0; 
49.4] 
(n = 2) 
55.6 % 
[23.1; 
88.0] 
(n = 5) 
0.0 % 
(n = 0) 
0.0 % 
(n = 0) 
11.1 % 
[0.0; 
31.6] 
(n = 1) 
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Age group and gender have been compared to the laboratory diagnosis in tables 30 and 31. 
All types of pathogens were mainly detected in the age groups 10-19 and 20-29 years. Viral 
infections (dengue and influenza virus) were more frequently detected in the age group 10-
19 years than all other pathogens. Malaria parasites were more frequently detected in 
male study subjects (p = 0.02), whereas dengue virus was more frequently detected in 
females (p = 0.01). For the remaining pathogens no differences in gender distribution were 
observed. 
 
Table 30: Age group distribution compared to pathogens detected in the laboratory 
(Groups F and N) 
 
 
Age group 
 
 
< 10 
years 
10-19 
years 
20-29 
years 
30-39 
years 
40-49 
years 
≥ 50 
Years 
La
bo
ra
to
ry
 re
su
lts
 
Malaria parasites 
(n = 754) 
3.7 % 
[2.4; 5.1] 
(n = 28) 
32.4 % 
[29.0; 35.7] 
(n = 244) 
34.4 % 
[31.0; 37.7] 
(n = 259) 
14.9 % 
[12.3; 17.4] 
(n = 112) 
12.9 % 
[10.5; 15.3] 
(n = 97) 
1.9 % 
[0.9; 2.8]  
(n = 14) 
Pathogenic  
Leptospira spp. 
(n = 140) 
2.1 % 
[0.0; 4.5] 
(n = 3) 
31.4 % 
[23.7; 39.1] 
(n = 44) 
31.4% 
[23.7; 39.1] 
(n = 44) 
18.6 % 
[12.1; 25.0] 
(n = 26) 
12.9 % 
[7.3; 18.4] 
(n = 18) 
3.6 % 
[0.5; 6.6] 
(n = 5) 
O. tsutsugamushi 
(n = 54) 
3.7 % 
[0.0; 8.7] 
(n = 2) 
27.8 % 
[15.8; 39.7] 
(n = 15) 
38.9 % 
[25.9; 51.9] 
(n = 21) 
14.8 % 
[5.3; 24.3] 
(n = 8) 
14.8 % 
[5.3; 24.3] 
(n = 8) 
0.0 % 
(n = 0) 
Dengue virus  
(n = 80) 
8.8 % 
[2.6; 14.9] 
(n = 7) 
50.0 % 
[39.0; 61.0] 
(n = 40) 
28.8 % 
[18.8; 38.7] 
(n = 23) 
6.3 % 
[0.9; 11.6] 
(n = 5) 
3.8 % 
[0.0; 7.9] 
(n = 3) 
2.5 % 
[0.0; 5.9] 
(n = 2) 
Influenza A and B 
virus  
(n = 113) 
6.2 % 
[1.8; 10.6] 
(n = 7) 
59.3 % 
[50.2; 68.4] 
(n = 67) 
20.4 % 
[12.9; 27.8] 
(n = 23) 
6.2 % 
[1.8; 10.6] 
(n = 7) 
6.2 % 
[1.8; 10.6] 
(n = 7) 
6.2 % 
[1.8; 10.6] 
(n = 7) 
Cultured bacteria 
(n = 9) 
11.1 % 
[0.0; 31.6] 
(n = 1) 
11.1 % 
[0.0; 31.6] 
(n = 1) 
66.7 % 
[35.9; 97.5] 
(n = 6) 
0.0 % 
(n = 0) 
11.1 % 
[0.0; 31.6] 
(n = 1) 
0.0 % 
(n = 0) 
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Table 31: Gender distribution compared to pathogens detected in the laboratory 
(Groups F and N) 
 
 
Gender 
 
 
Female 
(n = 388) 
Male 
(n = 765) p-value 
La
bo
ra
to
ry
 re
su
lts
 
Malaria parasites  
(n = 754) 
60.8 % 
(n = 236) 
67.7 % 
(n = 518) 0.02 
Pathogenic Leptospira spp. 
(n = 140) 
13.6 % 
(n = 53) 
11.4 % 
(n = 87) 0.26 
O. tsutsugamushi  
(n = 54) 
4.1 % 
(n = 16) 
4.9 % 
(n = 38) 0.52 
Dengue virus  
(n = 80) 
9.5 % 
(n = 37) 
5.6 % 
(n = 43) 0.01 
Influenza A and B virus  
(n = 113) 
10.8 % 
(n = 42) 
9.3 % 
(n = 71) 0.41 
Cultured bacteria  
(n = 9) 
0.7 % 
(n = 3) 
0.8 % 
(n = 6) 0.64 
 
3.4.2 Clinical diagnosis and treatment 
The most frequent presumptive clinical diagnoses established at health center level were 
upper ARI (51.3 %) and malaria (35.6 %). Furthermore, typhoid fever and diarrhea 
accounted for 6.6 % and 4.8 % of the clinical diagnoses respectively. The remaining 1.7 % of 
patients were diagnosed with lower ARI and other diagnoses (“breast swollen”, “neck 
swollen”, sexually transmitted disease, oral infection). The most commonly prescribed 
drugs were amoxicillin (n = 449), followed by anti-malarials (mefloquine + artemisinin, 
dihydroartemisinin + piperaquin, chloroquine, duocotexin) (n = 424). Other frequently 
prescribed antibiotics were penicillin, ampicillin, cotrimoxazol and metronidazol. Less 
frequently, therefore grouped as “other antibiotics” in table 37, were erythromycin, 
aminomycin, ofloxacin, ciprofloxacin, cloxacillin, and nalicixic acid. Paracetamol as 
additional treatment was prescribed in over 95.0 % of the cases, independent of the 
diagnosis. Only around 1.0 % of the patients didn’t receive any treatment or it was not 
recorded correctly on the form. The clinical diagnosis compared with the laboratory 
diagnosis is shown in table 32 and the prescribed treatment compared with the laboratory 
diagnosis is shown in table 33. These tables show that 61.9 % of the malaria infections 
detected by PCR (419/676) were captured by the clinical diagnosis at the health center. In 
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42 of the clinically diagnosed malaria cases an additional pathogen was detected by PCR. 
The majority (68.5 %) of the laboratory confirmed malaria cases were treated with anti-
malarial drugs. Most of the cases with non-malaria pathogens were treated with 
amoxicillin, which can be used for mild forms of leptospirosis [35], but is not effective 
against O. tsutsugamushi and Rickettsia spp.. Of all detected cases of Leptospira spp.,  
57.7 % received an efficient antibiotic treatment whereas Rickettsia spp. or  
O. tsutsugamushi cases did not receive efficient drugs at all. Furthermore, all of the 
detected viral infections (dengue and influenza virus) were indiscriminately treated with 
antibiotics and paracetamol. 
 
Table 32: Clinically established diagnosis compared to the laboratory established 
diagnosis (Group F only) 
  
Clinical diagnosis 
  M
al
ar
ia
 
U
pp
er
 A
RI
* 
Lo
w
er
 A
RI
**
 
Ty
ph
oi
d 
fe
ve
r 
Di
ar
rh
ea
/D
ys
en
te
ry
 
O
th
er
s*
**
 
To
ta
l o
f c
as
es
   
[n
 (%
)] 
La
bo
ra
to
ry
 d
ia
gn
os
is 
Malaria parasites 377 132 1 17 16 1 543 (45.5) 
Malaria parasites + 
other pathogen 42 73 1 11 5 0 133 (11.1) 
Leptospira spp. 1 32 1 7 4 0 45 (3.7) 
O. tsutsugamushi 0 21 0 1 3 0 25 (2.1) 
Rickettsia spp. 0 1 0 0 0 0 1 (0.1) 
Dengue virus 0 33 0 7 2 0 42 (3.5) 
Influenza A and B virus 1 62 1 1 0 1 66 (5.5) 
Cultured bacteria 0 4 1 0 0 0 5 (0.1) 
Multiple pathogens 
(excl. malaria parasites) 0 8 0 3 0 1 12 (1.0) 
No pathogen detected 8 246 4 32 27 4 321 (26.9) 
Total of cases (n) 429 612 9 79 57 7 1193 (100.0) 
* Incl. pharyngitis, rhinitis, flu, viral infection, ear infection 
** Incl. cough with blood, pneumonia  
*** Breast swollen, neck swollen, sexually transmitted diseases, oral infection 
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Table 33: Laboratory diagnosis and prescribed treatment at health center level  
(Group F only) 
  
Prescribed treatment 
  
   An
ti-
m
al
ar
ia
ls
* 
Am
ox
ic
ill
in
 
Pe
ni
ci
lli
n/
Am
pi
ci
lli
n 
Co
tr
im
ox
az
ol
 
M
et
ro
ni
da
zo
l/M
eb
en
da
zo
l 
O
th
er
 A
nt
ib
io
tic
s*
* 
Pa
ra
ce
ta
m
ol
 (a
dd
.) 
N
on
e 
(o
r n
ot
 re
co
rd
ed
) 
To
ta
l o
f c
as
es
 (n
) 
Ef
fe
ct
iv
e 
tr
ea
tm
en
t (
%
) 
La
bo
ra
to
ry
 d
ia
gn
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Malaria parasites 372 104 15 26 21 5 523 8 543 68.5 
Malaria parasites + 
other pathogen 42 49 10 17 8 7 129 0 133 - 
Leptospira spp. 2 22 3 11 3 1 44 1 45 57.7 
O. tsutsugamushi 0 15 3 3 3 1 25 0 25 0.4 
Rickettsia spp. 0 0 1 0 0 0 1 0 1 0.0 
Dengue virus 0 24 3 9 4 2 42 0 42 - 
Influenza A and B virus 0 51 7 5 0 2 64 1 66 - 
Cultured bacteria 0 3 1 0 0 0 4 1 5 - 
Multiple pathogens 
(excl. malaria 
parasites) 
0 6 1 3 1 1 12 0 12 - 
No pathogen detected 8 175 28 64 26 14 315 1 321 - 
 Total of treatment 424 449 72 138 66 41 1160 11 1193  
* Mefloquine+artemisinin, dihydroartemisinin+piperaquin, chloroquine, duocotexin 
** Erythromycin, aminomycin, ofloxacin, ciprofloxacin, cloxacillin, nalicixic acid 
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4 Discussion 
4.1 Applied methods 
4.1.1 Study sites and sample size 
In all of the 3 sites the recruitment of the required sample size took longer than expected. 
Initially it was planned to recruit 450 febrile subjects (Group F) and 150 non-febrile subjects 
(Group N) in each site in 2 years. After the extension of the study duration for 1 additional 
year, study site C-1 had recruited 452 febrile subjects and 170 non-febrile subjects, study 
site C-2 recruited 587 febrile and only 75 non-febrile subjects, and study site C-3 recruited 
only 164 febrile and 38 non-febrile subjects. Various factors contributed to this delay in 
recruitment. Firstly the number of visitors of the health centers was overestimated. All 3 
health centers were located more or less close to a referral hospital which might have been 
consulted preferably. Furthermore, irregular opening hours in consequence of staff 
shortage at the health centers added to the low recruitment numbers.  In addition, 
Cambodian people are generally reluctant to give blood samples, especially when they are 
not actually sick, therefore difficulties occurred to recruit an independent asymptomatic 
Group N. In study site C-3 (Snoul) the situation was especially problematic since this was 
the first time that recruitment for scientific purposes took place in this health center, in 
comparison to C-1 and C-2 where numerous research projects have been carried out 
already. 
 
Another issue concerning the 3 study sites is a possible selection bias that cannot be 
completely ruled out. Since the health centers and their staff are supported and trained 
mainly by the CNM they became known to be specialized in malaria diagnostics and 
treatment. Thus it is conceivable that patients, who suspect that they may have malaria, 
primarily use the health centers as a first address for consultation, whereas patients who 
suspect they suffer from another or a more severe disease would primarily consult in a 
referral hospital or in the private sector. This would be an explanation for the high rate of 
malaria cases in this study population which will be discussed below in detail. Initially, the 
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study was planned in this setting because of the significant reduction of malaria in recent 
years in this area. 
 
4.1.2 Diagnostic methods 
4.1.2.1 Sample processing and quality control 
One of the study’s aims was to find a study protocol that is simple and suitable to be 
standardized, thus it could be used in other settings and countries. The idea was to have a 
set of PCRs that can all be run on the same sample, requiring 1 sole DNA-extraction from an 
EDTA-blood sample, even if this meant taking a loss in sensitivity for detection of Rickettsia 
spp. and O. tsutsugamushi. 
 
A sample exchange with the laboratory in Lao PDR for external quality control showed that 
the Cambodian laboratory was able to identify all of the positive samples from Lao PDR, 
whereas the laboratory in Lao PDR was not able to detect more than 20.0 % of positive 
Rickettsia- and O. tsutsugamushi-samples from Cambodia. For the other pathogens similar 
problems were observed (Leptospira spp. 21.0 %, P. vivax 75.0 %, and P. falciparum  
58.0 %). All of the Cambodian assays worked fine with the positive controls, as well as with 
the exchanged samples from Lao PDR, which shows that the problem lied in the quality of 
the blood- and DNA-samples and its degradation, rather than in the performance of the 
PCR assays. In retrospective, the DNA-extraction method could have contributed to the 
poor quality of the samples. The Qiagen® Kit is designed for extractions from fresh whole 
blood, whereas in this study, frozen packed blood cells were used, which are more viscous 
and might have restrained this method and result in non-pure DNA extracts. In addition, 
the storage conditions of blood- (-80 °C) and DNA-samples (-20 °C), as well as repeated 
thawing, possibly contributed to a further degradation of the sample quality [103]. This 
would explain why the results could not be reproduced on the samples which had been 
destabilized by this treatment. 
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4.1.2.2 PCR as diagnostic tool for non-malaria febrile illness 
The nested-PCR assays used in this study showed great potential to serve as diagnostic 
tools for the differential diagnosis of non-malaria febrile illness. Nevertheless, it cannot be 
used as diagnostic tool alone, clinical and epidemiological context of the patient still have 
to be examined carefully. Furthermore, it was shown that it is difficult to run all these 
different PCR assays on only 1 sole sample of the patient, considering the different  
host-cells and courses of infection of the investigated pathogens. Details on the 
performance and advantages of each assay will be discussed in the following. 
 
To begin with, the 16srRNA-PCR showed to be a sensitive and reliable tool for the detection 
of leptospiral DNA. Furthermore, it allowed the genetic determination of species and their 
relatedness by nucleotide sequencing. Still, it has to be considered that it has a limited time 
frame in the course of the infection and blood might not always be the appropriate sample. 
As mentioned earlier, the PCR could also be used on pure plasma or urine samples instead 
of whole blood [38, 96]. Moreover, the diagnostic RT-PCR assays for dengue and influenza 
viruses worked equally well, and the results produced in this study correspond to the 
national surveillance data. Thus, these assays could be useful to establish a standardized 
protocol for the differential diagnosis of non-malaria febrile illness in Cambodia. 
 
In contrast, the diagnosis of TG- and SFG-Rickettsia by nested PCR did not produce 
satisfactory results. Most positive PCR-results could not be confirmed in a second PCR-run. 
Also, the product of the gltA-assay was quite short (74 bp) for the nucleotide sequencing 
procedure, considering that the 20-50 bp of read after primer binding are generally poor 
quality, so that in many cases the sequencing result was not interpretable. A product size 
of more than 200 bp would be required for better results, which could be achieved by 
cloning the products into plasmids prior to sequencing. However, this technique was not 
available in this study setting. This is why, to rule out  contamination or other problems 
with the nPCR-assay, a realtime PCR-assay by Paris et al. [62] was performed retroactively 
on the samples with positive nPCR. Although the assay worked well with controls (DNA 
extracted from cultured organisms), none of the nPCR-results could be confirmed. This can 
be explained by the poor quality of the extracted DNA-samples in combination with the 
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already very low concentration of DNA in the samples due to the choice of sample (packed 
cells instead of buffy coat). The detection of O. tsutsugamushi was less problematic, but 
the product of the 47kDa-assay is also rather short for nucleotide sequencing (118 bp). To 
evaluate the genetic diversity of Cambodian O. tsutsugamushi strains the 56kDa gene 
target has shown to be suitable [58], however for observational or screening purposes by 
nested PCR the 47kDA target was sufficient. 
 
4.1.2.3 Benefits of PCR over microscopy and RDT in malaria diagnosis 
Compared to the PCR-results both microscopy and RDT were less sensitive and less specific 
in the detection and species determination of malaria parasites in this study. In the febrile 
Group F sensitivities for the detection of any malaria parasite were 71.3 % and 55.6 % for 
microscopy and RDT respectively. The sensitivity of RDTs did not increase when looking at 
P. falciparum detection only (58.9 %). In the asymptomatic Group N, where parasite 
density was low, the sensitivity of microscopy was only 19.2 %. Specificities of both tests 
were over 95.0 % in Group F as well as Group N. The lack of sensitivity of RDTs found in this 
study maybe be due to incorrect storing and handling of the tests, an effect that has been 
described before [14]. With RDT and microscopy as the only diagnostic tests a substantial 
proportion of parasite carriers would have been missed. The extend of this submicroscopic 
reservoir needs to be taken into account for effective surveillance, control and eradication 
programs [104-105]. Nevertheless, both techniques remain important tools in peripheral 
settings due to their feasibility and low cost. Especially RDTs will play an ever more 
important role in differentiation of malaria from other febrile illnesses in remote settings 
[14]. However, the quality of results from both of these methods rely on various factors, 
such as provision of high quality supplies, adequate work environment, storage facilities 
and external quality assurance. Both field microscopy and RDTs often fall short of these 
requirements at peripheral health services, and further improvement is desirable to a more 
accurate malaria management [14]. Furthermore, the results of this study underline the 
lack of performance of both microscopy and RDT in the case of low-level parasitemia in 
mixed or asymptomatic infections, which are extremely important in the context of 
malaria-eradication projects. The cytB-PCR is a highly sensitive and useful tool for large-
scale epidemiological surveys and field studies [95]. 
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4.1.2.4 Diagnostic value of CRP-level an clinical data for acute febrile illnesses 
Concordant to the national data, it was observed in this study that male patients in the 
working age are the population group which is most affected by acute febrile illnesses [16], 
since they accounted for the biggest fraction of the febrile Group F. This is due to risk 
factors like working outside, in the forest or in mines, which are associated with higher 
exposure to mosquitoes and other vectors. Other than that, the clinical evaluation of the 
subjects recruited for this study has not revealed any predictor symptoms or risk factors to 
differentiate between the different types of febrile illnesses. This is not surprising, 
considering that all of the evaluated infectious diseases have a very similar panel of clinical 
symptoms. To get a more global clinical picture of each individual it would have taken a 
broader clinical questionnaire and a trained physician for a full clinical examination, which 
was not available in the setting of this study. 
 
The evaluation of CRP-levels, as the only biological marker for infection in this study, did 
show an informative value for the presence of any infection (Group F vs. Group N), as well 
as for the cause of the infection (viral compared to bacterial/parasitic infection, see  
table 17). Thus, it should be considered to integrate the analysis of CRP-levels in an 
algorithm for the differential diagnosis of acute febrile illness. At least like this, viral 
infections could be more easily identified or ruled out as cause of the illness. Accessory 
information such as a full blood cell count could provide additional useful diagnostic clues 
[106]. 
 
4.2 Study results 
4.2.1 Malaria 
4.2.1.1 Malaria-PCR results in the national context 
A very high prevalence of malaria was observed in this study. Of 1,193 febrile patients 
recruited for this study 56.7 % were carrying malaria parasites, and even in the non-febrile 
Group N 27.7 % turned out to be malaria-PCR positive. This was a surprise, considering that 
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the study was designed for a setting in which malaria does not play such an important role 
anymore. On the one hand the high rates can be attributed to the higher diagnostic 
sensitivity of PCR compared to microscopy and RDTs [104-105], taking into account that 
the cytB-PCR detects also gametocytes. On the other hand this could be also due to a 
possible selection bias caused by the specialization in malaria diagnostic and treatment of 
the study sites. 
 
Interesting differences to the national data regarding the species distribution were 
observed. Whereas the national data suggests that 70.0 % of the malaria infections are 
caused by P. falciparum [16], in this study only 40.0 % of the malaria cases were identified 
as P. falciparum, whereas P. vivax was the predominant species (52.0 %). This can be 
explained by the higher sensitivity of PCR and nucleotide sequencing compared to RDT and 
microscopy for the detection of P. vivax, as was shown in table 20 and figure 33. The 
frequency of mixed Plasmodium infections (3.8 %) was comparable to the national data 
(5.0 %) [16]. 
 
In the Pailin area (sites C-1 and C-2), P. vivax was the predominant species even though this 
province is an area of high transmission for malaria and it was expected to find a bigger 
proportion of P. falciparum here. Surprisingly this species distribution did not apply to the 
Snoul area (site C-3) where P. falciparum was the predominant species, even though Kratie 
Province is considered as an area of low-transmission. Usually P. vivax is more likely to be 
found in areas of low-transmission [17]. This might be partially explainable by the Group N 
that has been bigger in Pailin and contributes significantly to the P. vivax case load. This 
could indicate that in populations in hyper-endemic areas like Pailin, asymptomatic P. vivax 
infections are common and might bare a possible protective effect against P. falciparum 
infections [105]. The seasonal trends of malaria prevalence observed in this study accord to 
the national data, confirming that the rainy season, from May to October, is the high 
season for malaria. 
 
Discussion 
94 
 
4.2.1.2 Importance of asymptomatic Plasmodium spp. infections 
It has to be taken into account that a high rate of asymptomatic P. vivax infections was 
observed in the Group N, as well as the high rate of P. vivax as co-infection with another 
pathogen. Similar findings are reported in a survey of asymptomatic mobile Cambodians at 
the Thai border, which found a malaria prevalence rate of 2.4 % mostly P. vivax with low 
parasitemia [107]. It is possible that a high chronic infection rate in the population has 
been established, due to the protective effects of cross-species immunity. It has been 
shown previously that the severity of malaria symptoms is reduced in patients that have 
been pre-exposed to different species and that an infection with P. vivax is likely to protect 
from severe complications in the course of a P. falciparum infection [105, 108-109]. This 
effect might explain the lower mortality rates from P. falciparum in Southeast Asia 
compared with Sub-Saharan Africa [108]. These asymptomatic parasite carriers can act as a 
reservoir which is very difficult to control [104-105, 109]. To get a more specific overview 
of the malaria situation in regard of eradication measures, mass-screening programs by 
PCR are currently being set up in several Cambodian provinces. 
 
4.2.1.3 Emergence of P. knowlesi infections in Cambodia 
For the first time in Cambodia, 2 cases of infection with the simian P. knowlesi have been 
detected in this study. Both of the P. knowlesi infections were confirmed by additional PCR 
amplification and sequencing at the Genomic Platform, Pasteur Institute, Paris, France 
(Genopole®). Blood spots on filter paper were also sent blind to the Malaria Research 
Centre, Faculty of Medicine and Health Sciences, University Malaysia, Sarawak where they 
were identified as P. knowlesi single infections by real time and nested PCR. This finding 
confirms the spread distribution of human knowlesi-malaria cases throughout Southeast 
Asia and highlights the impact of strategies aiming to eradicate malaria from humans and 
the extensive deforestation in this region [110]. 
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4.2.2 Identified causes of non-malaria febrile illness in Cambodia 
4.2.2.1 Leptospirosis 
Leptospirosis showed to play an important role as cause of undifferentiated febrile illness 
in this study population. 9.4 % of the Group F samples were positive for pathogenic 
Leptospira spp.. Interestingly, in the asymptomatic Group N 9.9 % also had a positive test 
result for pathogenic Leptospira spp.. This could be due to the fact that the Group N was 
recruited from family members or other accompanying persons, which were certainly 
exposed to the same risk-factors for the infection. However, compared to studies 
conducted in similar settings in Thailand and Lao PDR [25-26, 41], the results are not 
surprising, but underline even more the importance of this disease in the region. As already 
shown by the surveillance study of IPC and confirmed by this study, leptospirosis is a 
significant public health problem in Cambodia [44]. The awareness about leptospirosis 
needs to be raised urgently and more research on its epidemiology in Cambodia should be 
induced. Furthermore diagnostic tools for leptospirosis, such as PCR or MAT, should be 
made available in peripheral health services. 
 
L. interrogans was by far the predominant species in this study, followed by L. weilii, both 
of which are classified as human pathogens [34]. Since no serological tests were applied, no 
information on the serovar could be obtained. This might be subject to further 
investigations on the plasma samples in stock. However, L. genomosecies1, L. kirschnerii, 
L. santarosai and L. noguchii are classified as pathogen Leptospira, whereas L. wolffii and  
L. kmetyi belong to the intermediate group whose pathogenicity and significance remains 
unclear [34]. Taking into account that the sensitivity of the PCR could be increased by using 
a different sample (plasma, urine) as explained earlier, it is likely that results of this study 
still underestimate the actual prevalence of leptospirosis in the study population. 
 
4.2.2.2 Rickettsial infections and scrub typhus 
Regarding the above mentioned difficulties with the rickettsial PCR assays it is doubtable if 
their results can contribute to a better understanding of the epidemiology of Rickettsia 
spp. in Cambodia. However, the detected species are plausible causative agents of acute 
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febrile illness and their finding should induce further investigations on the subject. 
Serological tests could be run on the plasma samples in stock and surveillance studies, 
using and evaluating nested or realtime-PCR on fresh buffy coat samples should be 
considered. Surprisingly, no cases of R. typhii infections were detected which was 
suspected to be one of the most prevalent species in Cambodia, due to the results of 
studies conducted in Lao PDR and Thailand, where murine typhus was identified as a major 
cause of acute febrile illness. Further clues to the diagnostic of rickettsial diseases could be 
added by a detailed clinical exam and risk factor analysis. A case control study conducted 
on febrile patients in Thailand showed that rickettsial disease was associated with the 
patients’ report of rash or arthropod bite and a history of jungle trips. Furthermore, 
elevated liver enzymes and depressed platelet count were also useful differentiating 
markers of rickettsioses in the investigated population [28]. In addition, a study from 
Taiwan showed that rickettsial diseases (acute Q fever, scrub typhus and murine typhus) 
should be suspected in febrile patients who present with relative bradycardia, 
hepatomegaly, and elevated serum amino-transferases, but without leucocytosis [111]. 
These findings underline the importance to carefully look and ask for any history of 
arthropod bites or eschars in non-malarial febrile patients, as well as the importance of a 
full blood count and hepatic evaluation, to differentiate rickettsial diseases from other 
febrile illnesses. 
 
O. tsutsugamushi, the causative agent of scrub typhus, was identified in 3.9 % of the Group 
F samples. In addition in the asymptomatic Group N 2.5 % of the samples were positive for 
O. tsutsugamushi too, which could be due to a similar exposure to risk-factors as already 
explained for leptospirosis. Being an intracellular organism which infects white blood cells, 
the sample choice (packed blood cells) was not ideal and it can be assumed that a different 
sample choice (buffy coat, peripheral blood mononuclear cells or skin-biopsies from 
eschar) could have resulted in a higher positivity rate. Nevertheless, these results 
emphasize the importance of scrub typhus in Cambodia and express the need of further 
research on the topic. To investigate the genetic relatedness of the different strains the 
56kDA-PCR assay [58] could be applied on the samples in stock, but regarding the sample 
quality problems with reproducibility have to be expected here, too. 
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4.2.2.3 Dengue fever and influenza infections 
In 6.3 % of Group F, dengue virus was identified as the cause of non-malaria febrile illness. 
This figure is rather high, considering that patients were over the age of 7 years and were 
recruited in very rural, low-transmission areas for dengue fever, which is commonly more 
present in urban settings and young children [69]. In Group N, 1.8 % of samples were 
positive for dengue virus. These are considered as primary, asymptomatic infections. The 
observed annual epidemic wave is concordant with the national surveillance data [16]. 
 
Influenza viruses were identified in 8.9 % of the Group F samples and 2.5 % of the Group N. 
In total, 77.0 % of them were subtype A (most prevalent strains H3N2 and H1N1) and  
33.0 % subtype B. This distribution as well as the seasonal findings is corresponding to the 
national surveillance data [75]. 
 
These results underline the importance of clinical training for health center staff to be able 
to recognize a viral infection and be aware of possible complications. Both, dengue and 
influenza infections were associated with a significantly lower CRP-level in the samples 
than malaria or bacterial infections (see table 17). Therefore, analysis of CRP-levels could 
be a possible helpful tool to distinguish viral infections as cause of non-malaria febrile 
illnesses in the future. Additional information could be obtained by a full blood count. A 
study from the Thai-Burmese border showed that patients with confirmed dengue 
infection had lower white blood cell counts (4.8 vs. 7.2, p < 0.01) and platelets (147 vs. 162, 
p = 0.03) than patients with non-dengue infections (typhoid fever, murine typhus, scrub 
typhus and leptospirosis) [112]. Furthermore, this work suggests that, in a clinical setting, a 
combination of at least 2 tests (IgM antibody ELISA, NS-1 antigen ELISA and/or realtime  
RT-PCR) are required to confidently diagnose acute dengue infection from a single blood 
specimen. The RT-PCR used in this study showed to be the most sensitive tool for the early 
diagnosis of dengue fever. Although cheap and field-deployable PCR systems are not yet 
available, progress has been made in the development and refinement of current 
techniques, which may result in nucleic acid detection becoming the standard for rapid 
dengue diagnosis even in resource-poor settings like rural Cambodia [112]. 
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4.2.2.4 Bacteria from blood culture 
The Department of Bacteriology of IPC evaluated blood culture bottles of the 1,128 febrile 
patients recruited in this study. Not only was this a logistic challenge, but also a cost-
intensive measure. The results were disappointing, only 9 bottles (0.8 %) grew pathogen 
bacteria. Antibiotic resistance was tested on the positive cultures, the result of which was 
immediately transmitted to the health center staff, which would track down the patient 
and administer the correct treatment. It has to be considered that in this study setup 
several factors reduced the sensitivity of blood culture for the diagnosis of typhoid fever 
and other bacterial infections. First of all, only 1 bottle per patient, and only 5 ml of blood 
per bottle had been available, sensitivity would have increased with the number of bottles 
and the amount of blood administered to each bottle [24]. According to current guidelines, 
at least 2 sets of bottles with a minimum of 10 ml venous blood should be taken from adult 
patients with suspected bacteremia [113]. In addition, it was not evaluated if the patient 
did self-treat with antibiotics before consulting at the health center, which was probably 
the case and further reduces the sensitivity of blood culture [77, 80-81, 113]. The costs and 
lack of storage and incubation facilities in peripheral health services make blood culture a 
diagnostic tool reserved for special indications rather than routine diagnostics. Comparing 
these results to the ones of the simultaneous NMFI-study (see also 4.2.4) in Lao PDR, which 
was based in provincial hospitals it is remarkable that in Lao PDR 3.3 % of the blood culture 
bottles (the same bottles as used in the Cambodian study) grew pathogenic bacteria (of 
which 72.0 % were S. typhi). The difference is probably due to the different setting, 
considering that patients at provincial hospitals are more sick (more likely to have 
community acquired septicemia) as those coming to a peripheral health center. In addition 
in Lao PDR 2 bottles with 5 ml blood were taken from each patient, which increases the 
sensitivity significantly [24]. 
 
4.2.3 Simultaneous detection of pathogens 
A high percentage of multiple simultaneously detected pathogens in 1 blood sample was 
observed in this study. In total 13.6 % of the samples showed evidence for the presence of 
more than 1 pathogen at the same time. Most frequently, these included malaria parasites 
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(P. falciparum and P. vivax) and a second pathogen (Leptospira spp., Rickettsia spp.,  
O. tsutsugamushi or dengue virus). This seems to be an observation made more and more 
frequently due to the increase of interest in the above mentioned pathogens. A recent 
study in Thailand investigated possible acute co-infections in Thai malaria patients and 
found serological evidence for scrub typhus- (15.0 %), leptospirosis- (7.7 %) and murine 
typhus- antibodies (23.2 %) simultaneously to the P. falciparum-infection [114]. However, 
in this study only serological tests were applied and often there was no convalescence 
sample to differentiate between acute or previous exposure to the pathogen. The authors 
recommend to use culture or PCR to get a clearer picture of the prevalence of multiple 
infections in malaria patients [114]. Reports of malaria co-infections with other pathogens 
such as HIV or helminthes are numerous especially from sub-Saharan Africa. In Southeast 
Asia, however, reports on co-infections in malaria patients remain rare. Malaria in 
Southeast Asia is often associated with outside working conditions like logging, mining and 
agriculture, activities that put people at risk for leptospirosis, rickettsiosis and scrub typhus 
too, so it is likely to find simultaneous infections with more than 1 of these pathogens. 
Concurrent infections of malaria parasites and dengue virus are rare but have been 
reported from endemic areas before, where dengue viruses spread more and more to rural 
areas [115-117]. Additional dengue fever should be suspected if a malaria patient presents 
with prolonged fever (> 7 days), bleeding manifestations, retro bulbar headache, severe 
myalgia, thrombocytopenia or anemia [116-117], and an additional NS1-antigen test should 
be applied in these cases [115]. In many cases of malaria co-infections the involved species 
is Plasmodium vivax, in a rather low parasite density, as was shown in table 21 (parasite 
densities [parasites/µl blood] by microscopy regarding infection status). These cases could 
be interpreted as chronic asymptomatic infections with P. vivax plus a simultaneous acute 
infection with another pathogen. Unfortunately nothing is known about the interactions of 
these pathogens in co-infections so far, but it can be assumed that multiple infections 
complicate malaria and lead to treatment failure [114]. The awareness of the possibility of 
multiple infections should be raised and physicians should be suspicious of it in malaria 
cases with poor treatment response or atypical manifestations. In such cases an additional 
treatment with doxycycline, which is effective against all of the above-mentioned bacterial 
pathogens, could be a solution. 
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Within this study, 6 cases showed evidence of the simultaneous presence of pathogenic 
Leptospira spp. and O. tsutsugamushi, 3 of them even with additional malaria parasites. 
Reports from Thailand and Taiwan are describing similar findings. In Thailand, a study of 22 
rice farmers with suspected leptospirosis, showed that 41.0 % had serological evidence of 
concurrent scrub typhus [118]. In Taiwan a retrospective analysis of co-infected patients 
was conducted, and concluded that, since the 2 diseases share main risk-factors (like rice 
farming), co-infection is not unusual and clinicians should be alert in cases of treatment 
failure or severe cases [119]. This awareness is very important because the first-line 
treatment for leptospirosis (penicillin) is not effective against scrub typhus 
(chloramphenicol) and vice versa, and untreated mortality rates for both diseases are high. 
Tetracycline antibiotics would present a choice of therapy that would cover both infections 
[118-119]. Other co-infections observed in this study were 5 cases of pathogenic Leptospira 
and dengue virus, as well as 1 case of O. tsutsugamushi and 1 case of influenza A virus with 
dengue virus. 
 
4.2.4 Study on non-malaria febrile illness in Lao PDR 
Simultaneously to this study, a partner study in Lao PDR was conducted by the Wellcome 
Trust-Mahosot Hospital-Oxford Tropical Medicine Research Collaboration (LOMWRU), 
Centre for Malariology, Parasitology & Entomology, Vientiane – funded by WHO/WPRO 
and FIND. The study settings in Lao PDR were different from the ones in Cambodia, so the 
results of the 2 studies are not comparable but rather complement each other. In Lao PDR 
the study was set up in 2 provincial hospitals, in the north and in the south of the country. 
1,595 out- and in-patients were recruited for the study and convalescence samples were 
taken after 14 days to perform serological tests. The inclusion criteria were the same as in 
Cambodia, except that the lower age limit was 5 years in Lao PDR and 7 years in Cambodia. 
The samples taken were tested for the same diseases, except for influenza which was not 
tested in Lao PDR and Japanese encephalitis which was not tested in Cambodia  
(no convalescence samples). The results found in Lao PDR showed a very different pattern 
than the ones from Cambodia. In 66.1 % of the cases in Lao PDR no diagnosis could be 
established and malaria was only found in 1.2 % of the samples. Most frequent diagnoses 
by blood culture, PCR and serology were scrub typhus (8.7 %), dengue fever (8.3 %), 
Discussion 
101 
 
Japanese encephalitis (7.0 %), leptospirosis (3.9 %) and CAS (2.9 %) which was most 
commonly caused by Salmonella enterica serovar typhi. Rickettsia spp. (R. typhii and  
SFG-Rickettsia) were detected in 1.0 % of the samples by PCR and 7.0 % of the patients had 
elevated IgM-titers for R. typhii. In 1.3 % of the samples there was evidence for multiple 
pathogens [unpublished results]. These results underline the importance of scrub typhus, 
leptospirosis and dengue fever as common causes of non-malaria febrile illness in 
Southeast Asia. Furthermore it is interesting to see the high rate of JEV detected in Lao 
PDR, which would indicate promoting public vaccination against JEV. In Cambodia JEV could 
not be evaluated since PCR is not an appropriate tool for diagnostic and no convalescence 
samples were available for serological testing. The higher rate of community acquired 
septicemia is most probably due to the fact that the patients were recruited in a hospital 
which means that they were in a more severe condition than the out-patients recruited in 
the health centers in Cambodia. 
 
4.3 Clinical implications of the study results 
The diagnosis of non-malaria febrile illness in resource limited, rural areas remains a 
challenge [1]. The comparison of the clinical with the biological diagnoses in this study 
showed that whilst the clinical management of malaria is working well in Cambodia, the 
majority of malaria-RDT negative febrile patients did not receive an appropriate treatment. 
Furthermore, malaria RDTs showed a low sensitivity compared to microscopy and PCR and 
showed to be not sufficient to rule out malaria in this setting. Therefore, if RDT is negative 
but malaria is clinically suspected, a second test (microscopy or ideally PCR) should be run 
for confirmation. Furthermore, the results of this study indicate some important clues for 
the differential diagnosis of acute febrile illness in health centers. To begin with, typhoid 
fever and community acquired septicemia seem to be rather uncommon in this setting, 
even though it should be kept in mind that the applied diagnostic method is likely to miss 
bacterial blood stream infections, due to prior self-treatment with antibiotics and lack of 
sensitivity. On the other hand, malaria remains highly frequent and is often associated with 
other pathogens which can explain treatment failure. Furthermore, the burden of 
submicroscopic, low-parasitemia malaria was shown to be high, also amongst 
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asymptomatic people. Minor Plasmodium species and mixed species infections are likely to 
get more and more important while P. falciparum-malaria is rolling back. In addition, 
dengue and influenza viruses contributed significantly to the causes of febrile illness and 
cannot be treated with antibiotics. Therefore clinical training or additional tests to 
distinguish these viral infections from malaria and bacterial infections should be implied to 
reduce the unwarranted use of antibiotics and anti-malarials. Finally, the choice of 
empirically used antibiotics for new treatment algorithms should include effectiveness 
against Leptospira, Rickettsia and O. tsutsugamushi (e.g. doxycycline). At the same time, 
more research and surveillance is needed to determine the epidemiology of leptospirosis 
and rickettsial diseases in Cambodia. 
 
4.3.1 Malaria 
As mentioned earlier, the clinical data recorded for this study did not reveal any predictive 
clinical features to distinguish malaria from other febrile illnesses. This is partially due to 
the simple structure of the questionnaire, and the fact that the clinical examination in the 
health centers was not performed by a medical doctor. More detailed and precise 
questions and a full clinical exam would have allowed a more specific analysis of risk factors 
(e.g. working conditions, living situation, ITN coverage in household) and clinical features 
(e.g. hepatomegaly, splenomegaly, jaundice, and anemia). However in a setting like this, 
trained physicians are rarely available, and a questionnaire on this scale would have been 
difficult to complete for the health center staff. A complete blood count would provide 
valuable information on the severity of the infection, but is unfortunately not feasible in 
peripheral health centers at the moment. Furthermore it has been shown in a similar study 
that complete blood count did not provide discriminatory information for malaria, 
leptospirosis, rickettsiosis and dengue fever [32]. Nevertheless, it could be shown that the 
clinical diagnosis together with the RDTs performed in the field, succeeded to identify  
61.9 % (419 out of 676) of the malaria cases correctly and provide the patient with the 
appropriate treatment. 
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4.3.2 Non-malaria febrile illness 
Whereas the clinical presentation of the patients did not show any specific clues that could 
have helped to establish a differentiated diagnosis of febrile illness, CRP-analysis did prove 
to be beneficial to distinguish malaria and bacterial from viral infections. Hematological 
parameters and Procalcitonin as a marker for bacterial infections could be added to 
support the decision making for antibiotic treatment [120]. Most malaria-negative cases 
were clinically diagnosed as upper ARI and treated indiscriminately with antibiotics (mostly 
amoxicillin). Only 14.0 % of the malaria-negative cases received a treatment that was 
effective against the responsible pathogen identified in the laboratory. These findings 
underline the urgent need of specific diagnostic tools and clinical training of the health 
center staff for the effective management of malaria negative fever. 
 
4.3.3 Developing a treatment algorithm for malaria RDT-negative fever 
The current algorithm for malaria suspected cases was shown in figure 6. Patients with 
negative RDT for malaria are supposed to be referred to a hospital, especially if the case is 
severe and if patients are pregnant and children less than 5 years old. To develop an 
updated algorithm on management of malaria negative patients based on the results of 
this study, important considerations are: 
 
• Regional disease burden and seasonality of infectious diseases 
• Clinical condition of patients and severity of disease (case fatality rates with and 
without treatment) 
• Availability and level of health care facilities and services 
 
Further research is needed to identify disease burden and laboratory gaps in each level of 
health care. To develop clinical guidelines it is imperative to involve physicians, nurses and 
other health care professionals from various levels of health care as well as the policy 
makers [1]. Intervention packages have to be in line with the current clinical management 
efforts and the Ministry of Health's planning for human resources, facility upgrades and 
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laboratory strengthening. The following information would be needed to improve the 
diagnostic procedure for malaria-negative fever patients: 
 
• Additional symptoms, clinical manifestation (full clinical exam by a physician) 
• Local disease endemics and its seasonal variations 
• Link between disease and patient occupation (risk factor analysis) 
• Blood testing (complete blood count, platelets, liver enzymes) 
• Information on self-medication prior to consulting the health facility 
 
Malaria RDTs are currently the most important diagnostic tool available in peripheral 
health centers. As shown in figure 34, 67.9 % of the febrile patients in this study had a 
negative malaria RDT result. Many of them (37.0 %) were still carrying malaria parasites 
that could not be detected by the RDT. This shows that by negative RDT alone, malaria 
cannot be ruled out. For 24.9 % of the RDT-negative cases another etiology of fever was 
found, of which most were of viral origin (32.7 % influenza virus and 20.7 % dengue virus). 
These findings indicate that for the development of an updated algorithm in a region 
where malaria still is among the leading causes of febrile illness, it should be considered 
that patients with clinically suspected malaria but negative malaria-RDT should be tested 
for malaria using other more sensitive methods to detect non-falciparum- or falciparum-
malaria cases with low parasitemia. If these additional tests do not reveal malaria as a 
result, the health professional has to determine between a viral and a bacterial cause of 
the fever, using clinical clues and blood analysis including a complete blood count and  
bio-markers like CRP or alternatively PCT. If the results point towards a bacterial cause of 
the fever, empiric antibiotic treatment with effectiveness against Leptospira spp. and  
O. tsutsugamushi, e.g. doxycycline should be prescribed. If the results point towards a viral 
cause of the fever (dengue or influenza virus) treatment should include paracetamol and 
fluids as well as surveillance or hospital-referral of the patient to prevent complications like 
DHS. 
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Figure 44: Example of a malaria-RDT negative case management algorithm. 
 
4.4 Implications on further trials and diagnostic development 
4.4.1 New diagnostic tools for acute febrile illness in the tropics 
Developing novel pathogen detection methods is very expensive and should be 
accompanied by extensive epidemiological background research and cost-effectiveness 
studies. Requirements for a sub-national (e.g. regional hospital) clinical diagnostic test 
would be: 
 
• High sensitivity of tests (90.0-95.0 %) for on-spot decision of clinicians 
• Staff training on laboratory equipment operation 
• Staff supervision and knowledge management 
• Use of commercial tests, if not available homebrew assay with external quality 
assurance and -control 
 
For scrub typhus and rickettsial diseases common diagnostics include either serology (lack 
of sensitivity) or culture (lack of feasibility), both of which are not adequate for field 
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conditions. PCR showed to be a good diagnostic tool for scrub typhus in this study but is 
hard to establish in peripheral settings. New techniques like LAMP PCR essays and a new 
serological RDT (by AccessBio®) are currently evaluated in Lao PDR and present promising 
options for the future [121]. Future NMFI trials should assess these methods and confirm 
positive results by culture. Furthermore the collaboration between different laboratories in 
Lao PDR, Cambodia and Thailand should be intensified to establish a local network that can 
easily exchange samples, compare results and techniques, assess new diagnostic tests and 
contribute to a larger epidemiological understanding of rickettsial diseases in the 
Indochinese region. Study investigators in further NMFI trials should follow-up the 
treatment and recovery of patients as this would strengthen the analysis of results. 
 
Many different serological test and RDTs for the rapid diagnosis of leptospirosis have been 
evaluated in the last years, some of them showing promising results. For example, ELISA 
and DST (IgM dot-ELISA dipstick test) showed significantly higher sensitivity with early 
acute-phase sera than the reference or first-generation methods (MAT and IHA) while 
retaining high specificity and could be evaluated for the rapid detection of leptospirosis in 
the field [122]. The nPCR used in this study worked well but is time-consuming and 
sensitive to contamination, which is why it should be considered to additionally assess 
realtime PCR and LAMP PCR in future trials. Furthermore, these results should be 
compared to MAT (WHO/AO/OIE Collaboration centre), and culture in blood clot (Mahosot, 
Lao PDR). In general it should be tried to collect a larger number of samples by sentinel 
sites and during outbreaks, as well as conducting a prevalence study to better understand 
the epidemiology and meaning of symptomatic and asymptomatic carriage of  
Leptospira spp.. 
 
Positive results of blood cultures were rare in both, Cambodia and Lao PDR, and the 
prevalence of typhoid fever was by far lower than expected. This was surprising and maybe 
partially explained by the used technique, as explained earlier. To date the Widal-test was 
used in both countries sub-nationally but lacks specificity and accuracy [80]. Rapid 
diagnostic tests like Tubex™ and Typhidot® showed to be of low diagnostic value in 
peripheral settings, too [79]. The EnterocheckWB®-test [81] as well as recent serological 
dipstick tests [80] showed better results and could be assessed in further NMFI trials. A 
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new antigen test based on blood cultures is currently being evaluated in Lao PDR, 
depending on the results it should be considered to assess this test in Cambodia, too. 
 
Both, the RT-PCR used in Cambodia, as well as the NS1 ELISA used in Lao PDR showed very 
good performance for diagnosis of dengue fever. New NS1-based RDTs are promising for 
dengue diagnostic in peripheral health care settings, especially when combined with 
IgM/IgG tests [123] and could be used as one of first-line tests for differential diagnosis of 
fever, especially during the dengue season. In Vietnam a recent study showed that the 
introduction of dengue RDTs to a peripheral health post through free market principles 
improved the quality of the diagnosis and decreases the prescription of antibiotics [124]. 
However, this effect is only sustainable and cost effective in combination with clinical 
training of health workers. 
 
Last but not least, the influenza RT-PCR was shown to be a reliable test with a great 
performance but can currently be effectuated in central laboratories only. There is a variety 
of rapid diagnostic antigen-based tests that could be used in the field, especially during the 
influenza season. In Taiwan, where the same main subtypes of influenza A virus are 
circulating than in Cambodia (H1N1, H3N2), 4 rapid tests that also detect influenza B, have 
been currently evaluated and showed that the Formosa rapid diagnostic test fulfilled all 
criteria to be used in peripheral primary health care centers [125]. Furthermore the clinical 
training of heath center staff is essential to the process of distinguishing influenza from 
other febrile illness. 
 
4.4.2 Etiologies of NMFI beyond the investigated pathogens 
In the recruited Group F 26.8 % of the patients did not show any positive test result and 
thus the cause of their fever remains unknown. A variety of other pathogens come into 
consideration as cause for the fever, not all of which can be evaluated. For example, it has 
to be recalled that HIV infections, viral hepatitis and tuberculosis have not been evaluated 
due to ethical reasons but are likely to contribute to the burden of febrile illness. The 
parallel NMFI-study in Lao PDR found a high percentage of Japanese encephalitis in their 
study population, thus it would be interesting to test the Cambodian samples for this virus. 
Discussion 
108 
 
Unfortunately only serological testing would be conclusive and convalescence samples 
would be needed to evaluate this disease. A combined Flavivirus MAC-ELISA (JE–Dengue 
IgM Combo ELISA; Panbio® Diagnostics, Australia) was run on samples of patients with 
more than 5 days of fever, which applied only in 10 cases. Of these 10 samples, 2 had a 
positive result for JEV and 3 samples were positive for dengue virus. This underlines the 
importance to think about JEV as cause of febrile illness, especially in cases of prolonged 
fever or additional signs of meningitis. 
 
Another viral disease that could be interesting to evaluate in the future is Chikungunya 
virus, regarding that there were several outbreaks reported from Thailand in 2008 and 
2009 [126]. Further tests could include viral infections like Epstein-Barr-virus, Hepatitis A-, 
Hepatitis E-, Coxsackie virus and bacterial infections such as q-fever, brucellosis and 
melioidosis. Analysis by bacteriological methods like API 20E/NE gallery and culture of 
blood and additional samples like pus (from abscesses) or sputum would be helpful to 
determine the prevalence of melioidosis and other bacterial infections in a future study. 
4.4.3 Lessons learned for further NMFI trials 
Since this was the first time a NMFI trial was conducted in Cambodia it provides highly 
valuable information for the planning and design of further trials on the subject in 
Cambodia as well as in other countries. Further trials in Cambodia should include district 
hospitals to compare the disease burden to the one in health centers and eliminate the 
possible selection bias for malaria present in health centers. Since the recruitment was 
strongly depended on the rainy season it could be considered to limit a further trial to the 
wet season only and thereby increase the cost-effectiveness. Given that there is limited 
financial resource for NMFI-studies adequate funding should be sought from a single 
source to support and coordinate the whole activity. Piggy-backing on existing malaria 
activities in conducting the studies is recommended. Another important question to be 
asked is if it is useful to recruit control groups which are exposed to the same risk factors 
and might carry the same diseases, without being febrile on the day of recruitment. The 
prevalence of asymptomatic infections might be evaluated separately by a pure prevalence 
study. 
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On the clinical side, it is essential to use a standardized and revised data form with a 
stronger focus on the clinical exam (ideally performed by a medical doctor), as well as 
documentation of hematological parameters if available. Furthermore, questions about 
previous self-treatment and health care seeking behavior should be added. Additionally, 
epidemiological information and risk factor exposure should be included in the form and a 
follow-up of patients could give additional information about the outcome (mortality, 
morbidity). On the laboratory side, standardized and refined techniques and protocols for 
all pathogens should be applied in accordance with all study centers, so the data would be 
comparable between different sites e.g. in Lao PDR and Cambodia. Furthermore, new rapid 
diagnostic tests for NMFI as mentioned above should be assessed at the same time. Paired 
serum samples should be collected from all patients to be able to perform serological 
analyses. It should be considered to include additional pathogens in the screening (e.g. by 
multiplex-PCR for respiratory pathogens), and which added value this would have in terms 
of treatment (diseases for which treatment is not available anyway). For quality assurance 
of results, external quality control should be established from the beginning of the study. 
Moreover, central data management and coordination should be developed to ensure 
standardized methods, data entry and analysis at all sites. Data collectors should have 
sufficient training to perform detailed clinical assessment. International collaboration is 
needed for research dissemination and utilization. The study results from Lao PDR and 
Cambodia should be published in parallel papers and disseminated by national partners in 
their countries. Lastly, organization of local symposia maybe considered to present the 
results and their implications to national programs, and to promote awareness of the topic. 
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5 Summary 
5.1 Summary in English 
Malaria has long been among the major health problems in Southeast Asia. In the past 
decade, the Cambodian government successfully implemented diverse strategies to fight 
malaria. The number of reported malaria cases, as well as case fatality rates, continue to 
decrease ever since. However, with the introduction and wide distribution of RDTs for 
malaria, it also turned out that in many clinically suspected malaria cases, no malaria 
parasites could be detected. There are currently no clear algorithms on management and 
treatment of patients with negative malaria-RDT in peripheral health posts. This poses 
problems in terms of public health, e.g. treating non-malarial patients with anti-malaria 
drugs or non-treatment of patients with other potentially fatal febrile illnesses. Therefore, 
improving clinical guidelines and diagnostic procedures is highly important. As a first step 
towards developing an algorithm for malaria-RDT negative fever management at peripheral 
health posts, a cross-sectional observational study was designed to investigate the causes 
of acute undifferentiated febrile illness in rural areas of Cambodia. From January 2008 until 
December 2010 1,475 study subjects have been recruited in 3 different sites, 2 of them at 
the western, and one of them at the eastern border of the country. Among the study 
subjects 1,193 were febrile out-patients (Group F, age 7-49 years, body-temperature 
 ≥ 38.5 °C for not longer than 8 days) and 282 were non-febrile individuals who have been 
recruited as a comparative control group (Group N, most of them healthy accompanying 
persons). Of each subject, 15 ml whole blood, a blood smear and a nasopharyngeal throat 
swab were collected and sent to the central laboratory at the Cambodian Pasteur Institute 
in Phnom Penh for molecular, microscopic and bacteriological investigation. All samples 
were tested for malaria parasites (by RDT, microscopy and PCR), Leptospira spp., Rickettsia 
spp., O. tsutsugamushi (by PCR and sequencing), and dengue and influenza virus (by RT-
PCR). In addition, blood culture bottles for the diagnosis of community acquired septicemia 
were tested within Group F. In 73.2 % of the 1,193 febrile outpatients, at least 1 pathogen 
could be identified in the taken samples, while in 26.8 % the etiology of the fever remained 
unknown. Most frequent pathogens detected amongst all recruited subjects, including 
asymptomatic Group N, were P. vivax (26.4 %), P. falciparum (20.7 %), pathogenic 
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Leptospira spp. (9.5 %), dengue virus (5.4 %), influenza virus A (5.9 %), O. tsutsugamushi 
(3.7 %), influenza virus B (1.8 %), Rickettsia spp. (0.2 %) and bacteria from blood culture 
(Salmonella spp., E. coli, S. pneumoniae, E. cloacae) (0.8 %). Furthermore, 2 cases of human 
infection with P. knowlesi were reported for the first time in Cambodia. The analysis of 
CRP-levels showed that CRP was significantly lower in subjects with viral infections than in 
bacterial infections and malaria, thus this marker could be used to rule out viral infections. 
The analysis of the clinical questionnaire did not provide useful information to help 
establish a clinical diagnosis. Difficulties occurred with the diagnostics of rickettsial disease 
and further research in collaboration with the study partners in Lao PDR should be 
enhanced on this subject. Given that 26.8 % of the study participants remained 
undiagnosed, it should be considered to conduct further tests on the stored samples. These 
could include tests for Japanese encephalitis virus, Chikungunya virus, Epstein-Barr-virus, 
Hepatitis A virus, Hepatitis E virus, Coxsackie virus and bacterial infections such as q-fever, 
brucellosis and melioidosis. However, the high incidence of a number of treatable causes of 
NMFI opened several questions on the need for revised clinical guidelines and better 
diagnostic tools. This study showed that of 1,193 febrile patients 67.9 % were malaria-RDT 
negative on admission, 37.0 % of which were actually carrying malaria parasites detected 
by more sensitive tests. This means that malaria cannot be ruled out by using RDT as the 
only diagnostic test in this kind of setting. In 24.9 % of the RDT-negative cases, other causes 
of febrile illness were detected in the samples, the majority of which were viruses (32.7 % 
influenza virus, 22.3 % Leptospira spp., 20.7 % dengue virus, 12.4 % O. tsutsugamushi, 
11.9 % multiple pathogens and bacteria from blood culture). Lastly, it was shown that this 
kind of study protocol was feasible in a peripheral, non-hospital setting in rural areas of 
tropical countries like Cambodia. 
 
These findings are helpful to establish a clinical algorithm and are making clear that tools to 
differentiate viral from bacterial disease as well as more sensitive diagnostic tests for 
malaria are needed urgently in rural areas of Cambodia. 
  
Summary 
112 
 
5.2 Summary in German 
Malaria war lange Zeit eines der vorherrschenden Gesundheitsprobleme in Südost Asien. In 
den letzten zehn Jahren wurden in Kambodscha erfolgreich verschiedene Strategien im 
Kampf gegen Malaria implementiert. Sowohl die Zahl der gemeldeten Malaria Fälle, als 
auch die Letalität sinken seitdem kontinuierlich. Durch die Einführung und landesweite 
Verteilung von Malaria-Schnelltests wurde jedoch gleichzeitig klar, dass in vielen der 
klinisch als Malaria diagnostizierten Fälle gar keine Malaria Parasiten nachgewiesen werden 
konnten. Aktuell gibt es keine klaren Richtlinien wie Patienten, deren Schnelltest für 
Malaria negativ ist, behandelt werden sollten. Dies birgt Probleme für das 
Gesundheitswesen, wie zum Beispiel die Fehlbehandlung von Malaria-negativen Patienten 
mit Antimalaria-Medikamenten oder die Nicht-Behandlung von Patienten mit potenziell 
tödlichen Fiebererkrankungen. Als ersten Schritt zur Entwicklung einer Leitlinie für das 
Management und die Behandlung von Malaria-negativen Fiebererkrankungen wurde eine 
beobachtende Querschnittstudie durchgeführt um die Ursachen für akute, undifferenzierte 
Fiebererkrankungen in ländlichen Gebieten Kambodschas zu untersuchen. Von Januar 2008 
bis Dezember 2010 wurden insgesamt 1475 Personen in drei verschiedenen ambulanten 
Gesundheitszentren rekrutiert, zwei davon nahe der westlichen und eines an der östlichen 
Landesgrenze. 1193 der rekrutierten Personen waren ambulante Patienten mit Fieber 
(Gruppe F, Alter 7-50 Jahre, Körpertemperatur ≥ 38,5 °C, Fieber nicht länger als 8 Tage), die 
restlichen 282 Personen wurden als fieber-freie Vergleichsgruppe rekrutiert (Gruppe N, 
hauptsächlich gesunde Begleitpersonen). Von jedem Individuum wurden 15 ml Vollblut, ein 
Blutausstrich und ein Rachenabstrich abgenommen und zur molekularen, mikroskopischen 
und bakteriologischen Untersuchung in das zentrale Labor des Pasteur Institutes in der 
Hauptstadt Phnom Penh geschickt. Alle Proben wurden auf Malaria Parasiten (Schnelltest, 
Mikroskopie und PCR), Leptospiren, Rickettsien, O. tsutsugamushi, Dengue und Influenza 
Virus (PCR/RT-PCR), sowie ambulant erworbene bakterielle Sepsis (Blutkulturen) getestet. 
In 73,2 % der 1193 Fälle konnte mindestens ein Erreger in den Proben nachgewiesen 
werden, während in 26,8 % keine Ursache für das Fieber gefunden werden konnte. Die am 
häufigsten nachgewiesenen Erreger in allen Proben, inklusive der asymptomatischen 
Vergleichsgruppe, waren P. vivax (26,4 %), P. falciparum (20,7 %), pathogene Leptospira 
spp. (9,5 %), Dengue Virus (5,4 %), Influenza Virus A (5,9 %), O. tsutsugamushi (3,7 %), 
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Influenza Virus B (1,8 %), bakterielle Sepsis (Salmonella spp., E. coli, S. pneumoniae, E. 
cloacae) (0,8 %) und SFG-Rickettsia spp. (0,2 %). Außerdem wurde, zum ersten Mal in 
Kambodscha, in zwei Fällen P. knowlesi nachgewiesen. Die Analyse von CRP-
Konzentrationen zeigte dass CRP bei viralen Infektionen signifikant niedriger war als bei 
bakteriellen Infektionen und Malaria, daher könnte dieser Parameter zum Ausschluss von 
viralen Infektionen genutzt werden. Die Auswertung des klinischen Fragebogens konnte 
keine hilfreichen Informationen zur Diagnostik beitragen. Die Diagnostik von Rickettsien 
gestaltete sich als schwierig, und weiterführende Forschung in Zusammenarbeit mit den 
Studienpartnern in Laos ist notwendig um ein besseres Verständnis dieser Erreger und 
ihrer Bedeutung in Kambodscha zu erlangen. Da nach wie vor bei 26,8 % der Patienten in 
Kambodscha kein Erreger nachgewiesen werden konnte, sollte in Betracht gezogen 
werden, weitere Tests durchzuführen. Denkbar wären zum Beispiel Tests für Japanische 
Enzephalitis Virus, Chikungunya Virus, Epstein-Barr-Virus, Hepatitis A Virus, Hepatitis E 
Virus, Coxsackie Virus oder bakterielle Infektionen wie Q-Fieber, Brucellose und 
Melioidose. Die hohe Zahl von behandelbaren Fieberursachen, die in dieser Studie 
nachgewiesen wurde konnten, unterstreicht die Notwendigkeit der Überarbeitung der 
aktuellen klinischen Richtlinien und der Verbesserung diagnostischer Mittel in ländlichen 
Gebieten Kambodschas. Es konnte gezeigt werden, dass die Mehrheit der ambulanten 
Patienten Malaria-Schnelltest negativ waren (67.9 %). In 37.0 % dieser RDT-negativen 
Patienten konnten mittels sensitiverer Methoden dennoch Malaria Parasiten 
nachgewiesen werden. Dies bedeutet, dass der Malariaschnelltest unter den 
vorherrschenden Bedingungen ungeeignet zum Ausschluss von Malaria war. In weiteren 
24.9 % der Schnelltest-negativen Patienten konnten andere Erreger nachgewiesen werden, 
diese waren hauptsächlich Viren (32.7 % Influenza Virus, 22.3 % Leptospira spp, 20.7 % 
Dengue Virus, 12.4 % O. tsutsugamushi, 11.9 % mehrere oder andere Erreger). Zusätzlich 
konnte gezeigt werden, dass eine große Studie wie diese auch außerhalb des 
Krankenhausmilieus in tropischen Ländern wie Kambodscha überhaupt durchführbar ist. 
 
Diese Ergebnisse tragen zur Findung klinischer Leitlinien zur Behandlung von akuten 
Fiebererkrankungen bei und verdeutlichen, dass sowohl Mittel zur Unterscheidung von 
viralen und bakteriellen Erkrankungen als auch sensitivere Tests zur Malaria Diagnostik in 
ländlichen Gebieten Kambodschas dringend benötigt werden. 
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9 Appendices 
9.1 Socio-demographic indicators of Cambodia 
Table 38: Socio-demographic indicators of Cambodia (source: Ministry of Health, 
Cambodia, 2007) 
Population 
 
Total 
     
14,363,519 
 
Urban 
     
15.0 % 
 
Rural 
     
85.0 % 
 
Males 
     
48.3 % 
 
Females 
     
51.7 % 
 
Gender ratio (number of males for 100 
females) 
  
93.5 
 
Distribution of population by age group 
   
  
0-4 years 
    
11.1 % 
  
0-14 years 
    
38.6 % 
  
5-14 years 
    
27.5 % 
  
15-49 years 
    
26.0 % 
 
Annual Population Growth Rate 
   
1.81 % 
 
Male life expectancy at birth 
   
58 
 
Female life expectancy at birth 
   
64 
 
Number of households 
    
2,530,000 
 
Average household size 
    
5.1 
 
Population density per km² 
   
74 
Health 
 
Infant Mortality Rate 
    
65 per 1,000 live births 
 
Under 5 Mortality Ratio 
    
83 per 1,000 live births 
 
Maternal Mortality Ratio 
    
472 per 100,000 live births 
 
Crude Birth Rate 
    
25.6 per 1,000 population 
 
Contraceptive Prevalence Rate (any method) 
  
27.0 % 
 
Households with access to safe drinking water 
  
44.0% 
  
Urban 
    
72.0 % 
  
Rural 
    
40.0 % 
 
Households with toilet facility within premise 
  
22.0 % 
  
Urban 
    
55.0 % 
  
Rural 
    
16.0 % 
Education 
 
Adult literacy (age >15) 
    
73.6 % 
  
Male 
    
84.7 % 
  
Female 
    
64.1 % 
  
Urban (both sexes) 
   
83.8 % 
  
Rural (both sexes) 
   
71.7 % 
Economics 
 
Government expenditures on health care per capita per year 4.64 US$ 
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9.2 Flowchart of Cambodia’s health system structure 
 
 
 
Source: CNM Annual Progress report, 2010, Cambodia. 
  
Population at risk of contracting malaria 3,020,000 people of 3,648 villages  
living within 2 km of the forest 
Provincial level 
National level 
Ministry of Health 
National Centre for 
Parasitology, 
Entomology & 
Malaria Control 
 
Contracting ODs 
(only 9 of the 77 ODs) 
24 Provincial Health Directorates 
(18 with complete package of support, 6 with HW training only) 
24 Provincial Malaria Teams 
(Supervisor & 2 assistants) 
77 Referral Hospitals 
992 Health Centers 
107 Health Posts 
OD Malaria Teams 
3,000 Village Malaria 
Workers (2 per village) 
3,438 Village Health      
Volunteers 
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9.3 Leading causes of mortality and morbidity in Cambodia 
Table 39: Leading causes of mortality and morbidity in inpatient care, Cambodia 2005 
and 2010 (source: WHO, National Health Statistics 2005 and 2010). 
Year Leading causes of morbidity Number of cases Rate per 100,000 population 
20
05
 
1. Acute respiratory Infections 2,236,262 17,084.44 
2. Diarrhea 356,273 2,721.51 
3. Tuberculosis 21,406 163.52 
4. Traffic accidents 14,035 107.21 
5. Dengue Hemorrhagic Fever 9,965 76.12 
6. Malaria 6,412 48.98 
7. Dysentery 5,129 39.18 
8. Meningitis 1,692 12.92 
9. Mine accidents 438 3.35 
10. Breast cancer 393 3.0 
20
10
 
1. Acute respiratory Infections 78,288 555.23 
2. Diarrhea 49,347 349.98 
3. Tuberculosis 28,384 201.30 
4. Typhoid fever 15,252 108.17 
5. Dengue fever 12,500 89.10 
6. Gynecological pathology 11,190 79.36 
7. Traffic accident 10,591 75.11 
8. High blood pressure 10,036 71.18 
9. Cataract 6,092 43.21 
10. AIDS 5,038 35.73 
 Leading causes of mortality Number of cases Rate per 100,000 population 
20
05
 
1. Acute respiratory Infections 818 6.25 
2. Tuberculosis 313 2.39 
3. Malaria 296 2.26 
4. Road accidents 281 2.15 
5. Dengue Hemorrhagic Fever 190 1.45 
6. Meningitis 163 1.25 
7. Diarrhea 38 0.29 
8. Mine accidents 31 0.24 
9. Other tetanus 28 0.21 
10. Liver cancer 20 0.15 
20
10
 
1. Acute respiratory Infections 1,135 8.05 
2. Traffic accidents 495 3.51 
3. High blood pressure 468 3.32 
4. AIDS 280 1.99 
5. Tuberculosis 261 1.85 
6. Cardiovascular disease 256 1.82 
7. Meningitis 196 1.39 
8: Dengue 38 0.30 
9. Other tetanus 32 0.23 
10. Liver cancer 17 0.12 
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9.4 Main health problems among inpatients in Cambodian hospitals  
Table 40: Main health problems and fatality rates among inpatients in Cambodian 
referral hospitals by age group (source: Ministry of Health, Cambodia, 2007). 
 
Age group 
 
0-4 years 5-14 years 15-49 years ≥50 years Total 
Disease Cases Deaths Cases Deaths Cases Deaths Cases Deaths Cases Deaths 
Diarrhea 4,962 7 812 2 1,936 22 482 3 8,192 34 
Dys-
entery 926 2 378 0 723 0 222 0 2,249 2 
Cholera 15 0 0 0 12 0 6 0 33 0 
ARI 16,228 375 5,693 31 6,895 182 5,231 150 34,047 738 
Simple 
malaria 409 1 755 1 2,608 2 290 0 4,062 4 
Severe 
malaria 299 20 546 35 1,592 142 212 25 2,649 222 
Simple 
dengue 3,996 1 6,203 0 676 0 19 0 10,894 1 
Severe 
dengue 1,475 86 3,365 143 405 22 6 0 5,251 251 
Typhoid 
fever 699 3 2,818 5 4,349 9 895 1 8,761 18 
Total 29,009 495 20,570 217 19,196 379 7,363 179 76,138 1,270 
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Table 41: Main health problems and fatality rates among inpatients in Cambodian 
national hospitals by age group (source: Ministry of Health, Cambodia, 2007). 
 Age group 
 0-4 years 5-14 years 15-49 years ≥50 years Total 
Disease Cases Deaths Cases Deaths Cases Deaths Cases Deaths Cases Deaths 
Diarrhea 6,503 16 101 0 143 2 70 3 6,817 21 
Dys-
entery 1,400 1 65 0 36 0 36 0 1,537 1 
Cholera 3 0 1 0 5 2 0 0 19 2 
ARI 18,778 280 1,380 14 926 23 465 30 21,549 347 
Simple 
malaria 15 0 34 0 43 0 12 0 104 0 
Severe 
malaria 198 1 193 1 56 12 13 1 460 15 
Simple 
dengue 1,315 0 2,425 1 102 0 1 0 3,843 1 
Severe 
dengue 5,872 103 9,896 102 7 2 1 0 15,776 207 
Typhoid 
fever 86 0 265 0 132 1 56 0 539 1 
Total 34,170 401 14,360 118 1,450 42 654 34 50,644 595 
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9.5 List of all currently recognized Rickettsia species 
Table 42: List of all currently recognized Rickettsia species  
(Source: Renvoise et.al, 2008 [48]). 
Species  Pathogenicity or disease 
Typhus group   
   Rickettsia typhi Murine typhus 
   Rickettsia prowazekii Epidemic typhus 
   Rickettsia Canadensis Unknown pathogenicity 
Not classified  
   Rickettsia belli Unknown pathogenicity 
Spotted-fever-group  
   Rickettsia akari Rickettsialpox 
   Rickettsia australis Queensland tick typhus 
   Rickettsia asiatica Unknown pathogenicity 
   Rickettsia felis Flea-borne spotted fever 
   Rickettsia Helvetica Aneruptive fever 
   Rickettsia tamurae Unknown pathogenicity 
   Rickettsia massiliae Spotted fever 
   Rickettsia aeschlimannii Spotted fever 
   Rickettsia montanensis Unknown pathogenicity 
   Rickettsia rhipicephali Unknown pathogenicity 
   Rickettsia sibirica subsp. sibirica Siberian tick typhus 
   Rickettsia rickettsii Rocky Mountain spotted fever 
   Rickettsia sibirica subsp. mongolitimonae LAR 
   Rickettsia slovaca TIBOLA-DEBONEL* 
   Rickettsia africae African tick bite fever 
   Rickettsia conorii subsp. Conorii Mediterranean spotted fever 
   Rickettsia conorii subsp. Israelensis Israeli spotted fever 
   Rickettsia conorii subsp. Caspia Astrakhan fever 
   Rickettsia conorii subsp. Indica Indian tick bite typhus 
   Rickettsia heilongjiangensis Far Eastern tick-borne rickettsiosis 
   Rickettsia japonica Japanese or oriental spotted fever 
   Rickettsia peacockii Unknown pathogenicity 
   Rickettsia raoulti DEBONEL-TIBOLA* 
   Rickettsia parkeri Spotted fever 
   Rickettsia honei Flinders Island spotted fever 
Species described but not yet recognized  
   Rickettsia amblyommii Unknown pathogenicity 
   Rickettsia andeana Unknown pathogenicity 
   Rickettsia hulinii Unknown pathogenicity 
   Rickettsia cooleyi Unknown pathogenicity 
   Rickettsia martinet Unknown pathogenicity 
   Rickettsia tarasevichiae Unknown pathogenicity 
   Rickettsia monacensis Spotted fever 
   Rickettsia marmionii Australian spotted fever 
* TIBOLA (tick-borne lymphadenitis) or DEBONEL (dermacentor-borne necrosis erythema lymphadenopathy) 
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9.6 Consent form sheet 
 
CONSENT FORM SHEET 
PROTOCOL TITLE: 
A cross-sectional observational study to identify the causes of acute non-malaria febrile Illness in 
out-patients in rural Cambodia.  
 
VOLUNTARY CONSENT TO PARTICIPATE: 
The study is sponsor by WPRO in collaboration with the National Centre for Parasitology, 
Entomology and Malaria Control in Phnom Penh and the University of Munich and funded by 
USAID. The project is under the direction of Dr. Siv Sovannaroth from the National Centre for 
Parasitology, Entomology and Malaria Control (Monivong Blvd., Phnom Penh, Cambodia, P.O. box 
1062, Tel.: 855 23 211 926/216 855 16 364 537, Fax. 855 23 996 202) 
 
I hereby confirm that I fully understand what they has been explained in the information sheet by 
project representatives in a way that is understandable and satisfactory to me. I have been 
informed of the advantages and disadvantages of this research study that I shall be given. 
I do not require further information to make my decision as to whether or not I want to donate 
blood. 
 
 
___/___/___          _________________               _________________ 
 
Date (dd/mm/yyyy)  Name of participant      Signature or fingerprint  
  
 
 
___/___/___          _________________               _________________ 
 
Date (dd/mm/yyyy)  Name of witness                     Signature or fingerprint  
 
 
 
 
___/___/___          _________________               _________________ 
 
Date (dd/mm/yyyy)  Name of field investigator     Signature  
 
 
 
Thank you very much for your cooperation. 
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9.7 Example of clinical data sheet 
 
1 Basic info 
Country site 
C-
1 Visit-Nr.   1 ID-Nr. Visit-date 
Age 23 Gender F C-1-0133 01.05.2009 
2 Medical History 
Days ill 3 Days fever 3 Days cough 1 Days diarrhea 
0 
Days sore throat 1 Days stiff neck 0 Days pain to urinate 0 Days running nose 
0 
Days vomiting 0 Days rash 0 Days earache 0 
 
 
3 Symptoms at presentation (1=positive, 0=negative) 
Fever °C 39 Cough 1 Diarrhea 0 
 
Sore throat 1 Running nose 0 Meningism 0 
 
Earache 0 Rash 0 Malaria RDT 1 
 
Pain to urinate 0 Vomiting 0 Malaria species P. falciparum 
4 Presumptive diagnosis 
Malaria 
5 Treatment 
A+M, Paracetamol 
6 Collected specimen sent to laboratory 
EDTA blood 1 Blood culture 1 Throat swab 1 Malaria slide 
1 
Dry tube 1 Serum 1 Clot 1 Filter paper 
1 
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9.8 Review of study results on acute febrile illness 
Table 43: Review of study results on acute febrile illness (Tara Müller, 2010) 
Study title Causes of acute 
febrile illness in 
rural Thailand 
Etiologies of 
acute febrile 
illness in Thailand 
Arthropod borne 
disease: the 
leading cause of 
fever in 
pregnancy on the 
Thai-Burmese 
border 
Causes of fever 
in adults on the 
Thai-Myanmar 
border 
Etiologies of 
obscure fever in 
children at a 
university hospital 
in northeast 
Thailand 
Author Suttinont, et al. Leelarasamee, et 
al. 
McGready, et al. Ellis, et al. Sripanidkulchai, et 
al. 
Country Thailand Thailand Thailand Thailand Thailand 
Study period 2001-2002 1991-1993 2004-2006 1999-2002 2002-2003 
Study population 
845 patients in 5 
different 
hospitals 
1,137 Out-
patients from 10 
community-
based hospitals 
203 pregnant 
women in 
antenatal clinics  
613 in- and 
out-patients at 
AFRIMS in a 
rural area 
25 children with 
obscure fever in a 
university hospital 
Malaria Excluded excluded 24.2 % (slide) 
25.3 % 
(slide)  -  
Leptospirosis 
36.9 % 
(Culture/ 
MAT/IFAT) 
1.1 % 
(MAT) 
2.4 % 
(MAT/Culture) 
17.0 % 
(ELISA/MAT) 
8.0 % 
(IFA/MAT) 
Murine typhus 
2.8 % 
(MIA/ 
Westernblot) 
5.3 % 
(Weil-Felix-
Test/Serology) 
7.1 % 
(RealtimePCR/ 
Invitro-isolation/ 
Serology) 
1.5 % 
(IFA) 
0.0 % 
(IFA) 
SFG-Rickettsia 
1.3 % 
(MIA/ 
Westernblot) 
 -   - 3.3 % (IFA)  -  
Scrub typhus 
19.9 % 
(MIA/ 
Westernblot) 
7.5 % 
(Weil-Felix-
Test/Serology) 
5.7 % 
(Realtime PCR/ 
In-vitro-isolation/ 
Serology) 
1.1 % 
(IFA) 
0.0 % 
(IFA) 
Dengue fever 5.2 % (ELISA) 
5.7 % 
(ELISA) 
9.5 % 
(ELISA) 
1.5 % 
(ELISA) 
40.0 % 
(ELISA) 
Japanese 
encephalitis  
0.4 % 
(ELISA) 
0.6 % 
(ELISA)  - 
0.2 % 
(ELISA) 
0.0 % 
(ELISA) 
Influenza 4.6 % (ELISA) 
6.0 % 
(ELISA)  -  -   -  
Q-fever  -   -  - 
14 of 133 
screened 
cases* (ELISA) 
 -  
Septicemia 0.8 % (Culture) 
3.2 % 
(Widal test/ IFAT)  - -  - 
Chikungunya 
Fever  -  
1.1 % 
(ELISA)  -  -   -  
Melioidosis 0.4 % (Culture)   
7 of 44 
screened 
cases* (ELISA)  
Gastroenteritis 
or typhoid-fever  -   -  
1.4 % 
(Culture) 
3.4 % 
(Realtime-PCR)  -  
Others  -   -  31.3 %  26.8 % 4.0 % 
No diagnosis 
established 31.7 % 61.3 % 19.0 % 52.0 % 48.0 % 
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Table 43: Review of study results on acute febrile illness (Tara Müller, 2010) 
Study Title The etiology of 
acute pyrexia of 
unknown origin 
in children after a 
flood 
Febrile illness in 
Malaysia - an 
analysis of 1,629 
hospitalized 
patients 
Murine Typhus 
and Leptospirosis 
as causes of 
acute 
undifferentiated 
fever, Indonesia 
Etiology of 
acute 
undifferentiate
d febrile illness 
in the Amazon 
Basin of 
Ecuador 
Syndromic 
surveillance: 
etiologic study of 
acute febrile illness 
in dengue 
suspicious cases 
with negative 
serology 
Author Pradutkanchana, 
et al. 
Brown, et al. Gasem, et al. Manock, et al. Silva, et al. 
Country Thailand Malaysia Indonesia Ecuador Brazil 
Study Period 2000 1975-1979 2005-2006 2001-2004 2008 
Study Population 
180 pediatric 
patients with 
acute fever in a 
referral hospital 
1,629 
hospitalized 
patients from 
rural areas 
67 In- and 70 
Out-Patients in 
hospital 
533 Patients at 
2 Hospitals 
144 patients at a 
central public 
health laboratory 
Malaria  -  6.2 % (slide)  -  
12.5 % 
(slide) - 
Leptospirosis 27.2 % (IFA/MAT) 
7.0 % 
(Hemolytic HL) 
10.0 % 
(PCR/MAT/ELISA) 
13.2 % 
(ELISA) 
13.9 % 
(Bio-Manguinho-
test) 
Murine typhus 0.0 % (IFA) 
0.5 % 
(IFA) 
7.0 % 
(IFA)  -   -  
SFG-Rickettsia 0.0 % (IFA) 
0.3 % 
(IFA) 
0.0 % 
(IFA) 
5.9 % 
(ELISA)  -  
Scrub typhus 1.1 % (IFA) 
19.3 % 
(IFA/Mouse- 
inoculation) 
0.0 % 
(IFA)   - 
Dengue fever 29.4 % (HI) 
7.0 % 
(Mosquito 
inoculation/ 
Culture) 
 -  
5.3 % 
(Realtime-
PCR/IFA) 
11.8 % 
(ELISA) 
Japanese 
encephalitis   -   -   -   -   -  
Influenza  -   -   -   -   -  
Q-fever  -   -   -  4.90 % (ELISA)  -  
Septicemia  -  0.4 % (Culture)  -   -   -  
Chikungunya 
fever  -   -   -   -   -  
Melioidosis  -   -   -   -   -  
Gastroenteritis 
or typhoid-fever  -  
7.4 % 
(Widal-Test)  -   -   -  
Others  -   -   -  
3.3 % 
(viral 
infections, 
brucellosis 
RT-PCR) 
3.9 % 
(Rubella) 
No diagnosis 
established 39.5 % 37.1 %  -  59.9 % 72.9 % 
* These results were not felt to be convincing evidence of acute infection and were not included in the etiologic 
diagnoses. 
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